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Abstract 
 
Surveillance is the first line of defence against disease, whether to monitor endemic cycles 
or to detect emergent epidemics. Knowledge of disease in wildlife is of considerable 
importance for managing risks to humans, livestock and wildlife species.  Recent public 
health concerns (e.g. Highly Pathogenic Avian Influenza, West Nile Virus, Ebola) have 
increased interest in wildlife disease surveillance. However, current practice is based on 
protocols developed for livestock systems that do not account for the potentially large 
fluctuations in host population density and disease prevalence seen in wildlife.  
A generic stochastic modelling framework was developed where surveillance of wildlife 
disease systems are characterised in terms of key demographic, epidemiological and 
surveillance parameters.  Discrete and continuous state‐space representations respectively, 
are simulated using the Gillespie algorithm and numerical solution of stochastic differential 
equations. Mathematical analysis and these simulation tools are deployed to show that 
demographic fluctuations and stochasticity in transmission dynamics can reduce disease 
detection probabilities and lead to bias and reduced precision in the estimates of 
prevalence obtained from wildlife disease surveillance. This suggests that surveillance 
designs based on current practice may lead to underpowered studies and provide poor 
characterisations of the risks posed by disease in wildlife populations. By parameterising the 
framework for specific wildlife host species these generic conclusions are shown to be 
relevant to disease systems of current interest. 
The generic framework was extended to incorporate spatial heterogeneity. The impact of 
design on the ability of spatially distributed surveillance networks to detect emergent 
disease at a regional scale was then assessed. Results show dynamic spatial reallocation of a 
fixed level of surveillance effort led to more rapid detection of disease than static designs.   
This thesis has shown that spatio‐temporal heterogeneities impact on the efficacy of 
surveillance and should therefore be considered when undertaking surveillance of wildlife 
disease systems. 
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Chapter 1 
Introduction 
 
Wildlife diseases have the potential, not only to impact greatly on the populations of 
wildlife species themselves, but also on human and livestock populations. A demonstrative 
example of how detrimental zoonoses can be to human health and the economy is the 
recent swine flu pandemic in 2009, which has origins in both domestic pigs and wild boar 
(Shoham 2011). The disease outbreak started in Mexico and the USA and quickly spread 
worldwide followed by vast media coverage. The official worldwide death toll according to 
the World Health Organisation (WHO) as of 28th March 2010 was 17,483 (Girard et al. 
2010). As well as the impact on human health, the economic  impact of Mexico alone was 
estimated as > $3.2 billion (Girard et al. 2010). Wildlife diseases also have the opportunity 
to affect biodiversity and conservation efforts (Daszak et al. 2000; Smith et al. 2009; Pagán 
et al. 2012). Mathematical modelling is a tool which can be (and is widely) used to simulate 
disease systems (Renshaw 1991; Keeling & Rohani 2007) by manipulating equations in order 
to gain insights into the behaviour of the modelled system. Mathematical modelling will be 
used in this thesis in such a way to understand the effect that host fluctuations, disease 
dynamics and spatial heterogeneities have on the efficacy of wildlife disease surveillance. 
The literature surrounding wildlife disease is reviewed in the next sections and the impact it 
has on human health, wildlife health and conservation and the economy is outlined to show 
the importance of wildlife disease research.   
 
1.1 Wildlife diseases and Humans 
 
There is an increasing understanding in the literature that wildlife diseases pose a threat to 
human health (Bengis et al. 2004; Belant & Deese 2010; Kuiken et al. 2011). The World 
Organisation for Animal Health (OIE) stated in an editorial that ‘Surveillance of wildlife 
diseases must be considered equally as important as surveillance and control of diseases in 
domestic animals’ (Vallat 2008). In a comprehensive literature review carried out by Talyor 
et al, it was reported that out of all the infectious organisms known to be pathogenic to 
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humans, 61% were zoonotic. It was also found that out of the 175 diseases considered to be 
“emerging”  (Lederberg et al. 1992), 75% were zoonotic (Taylor et al. 2001). This was higher 
than expected by the authors and is indicative of the importance of wildlife disease 
research in terms of predicting and controlling emerging outbreaks, and promoting human 
health and safety. In comparison with human and livestock systems, with wildlife disease 
there are many added complications in terms of population demography and habitat 
location, and even though momentum is building behind wildlife disease research it is still 
the most poorly understood (Jones et al. 2008).  
There are many examples of zoonotic diseases in humans for which wildlife species act as 
an intermediary for disease transmission. Nipah is an RNA virus initially detected in pigs in 
Malaysia in 1999 (when at the same time it appeared that pig farmers were suffering from 
an outbreak of viral encephalitis), it is closely related to the Hendra Virus discovered in 1994 
in Australia. Host infection by Nipah virus is associated with a marked respiratory and 
neurological syndrome which can be followed by the sudden death of pigs. In the later 
stages of the initial outbreak of this disease, Nipah was characterised as causing a high 
mortality rate in humans when it emerged that the same causative agent was to blame for 
both the pig and pig farm workers mysterious illnesses. The outbreak had devastating 
consequences for the Malaysian Peninsular’s pig farming industry with an overall loss of 
1.08 million pigs and a reduction in pig farms from 1885 to 829 (Nor et al. 2000). Although 
the catalyst of the original outbreak of Nipah virus in pig farmers was domestic pigs (Chua et 
al. 1999), the natural host for the disease is fruit bats. The main drivers associated with the 
spread of this virus were identified as deforestation, drought and the expansion of pig 
farming in Malaysia. Fruit bats were forced to move out of their natural habitat as a result 
of depleting resources available to them, and nearby agricultural areas with productive fruit 
orchards were an appealing choice. These areas were also home to a large number of pigs 
which increased the chance of transmission from bat to pig and as a knock on effect, from 
pig to human in the initial outbreak (Bengis et al. 2004). The subsequent 2001 Indian and 
Bangladeshi outbreaks of Nipah virus were assumed to be caused by the ingestion of fruit 
and fruit related products that had been contaminated with fruit bat saliva and urine (WHO 
2004). 
Hantavirus Pulmonary Syndrome (HPS) is an infectious respiratory disease which is endemic 
to the Americas. The natural host of HPS is thought to be rodents, and is typically carried by 
the deer mouse (peromyscus maniculatus) in the United States. Transmission from wildlife 
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to humans is through the respiratory route as a result of air‐borne dispersion of rodent 
excretions (Bengis et al. 2004), and a study carried out in 1998 of 177 cases of HPS in 29 
states, estimated the case‐fatality proportion to be 45% (Young et al. 1998). Outbreaks of 
Hantavirus in humans in the United States have frequently been linked to changes in 
environmental conditions which are highly favourable to the rodent populations (Epstein 
1995). The HPS epidemic in the American Southwest of 1993 followed an abundance of 
rainfall increasing the food sources available for the deer mice. The high population 
densities driven out of their burrows by flooding increased the chance for the virus to 
flourish and transmit within rodent populations and eventually onto human populations 
(Epstein 1995) which can be likened to the perturbation effect (Tuyttens et al. 2000; Carter 
et al. 2007). Human activities such as herding livestock and cleaning out rarely used rodent 
infested areas have been attributed to increasing the risk of human exposure to HPS 
through contact with infected urine and faeces (Armstrong et al. 1995).  
Avian Influenza (perhaps the highest profile wildlife disease threat given volume of past 
epidemics and the risk of a pandemic outbreak in the future (Swayne 2009)) is an infectious 
viral disease found in birds (particularly wild water fowl) caused by strains of the flu virus 
not unlike the strains found in humans. In wild bird populations it often causes no clinical 
signs. Some forms of avian influenza have mutated in such a way that they are able to 
transfer from birds to humans populations. An example of this was demonstrated in 1997, 
when an outbreak of H5N1 (previously thought to only infect birds) was first reported in 
Hong Kong causing 18 cases of infection with a 33% mortality rate. The clinical progression 
in humans of this Influenza strain can be categorised into three stages. The first stage of the 
illness would usually show mild upper respiratory tract infection and fever, or be 
asymptomatic. The second stage is marked by additional symptoms of severe pneumonia, 
haematological liver and renal abnormalities. Finally the third stage shows a highly 
developed illness of acute respiratory distress syndrome, multiple organ malfunction and 
ultimately death (Tam 2002). The incidence of human infections reported in all major 
outbreaks of Avian Influenza to date has happened in people who have high level of 
interaction with poultry. It is thought these infections represent direct bird‐to‐human 
transfer of the virus, as fortunately there appears to have been negligible human‐to‐human 
spread. Nevertheless, the adaptation and mutation of these poultry viruses could lead to a 
new sub‐type of Influenza which is capable of sustaining itself within a human population 
alone. This is a key concern to public health services around the world as the threat of a 
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highly contagious new pandemic could be potentially looming ever closer (Bengis et al. 
2004). 
 
1.2 Wildlife disease and conservation  
 
Biodiversity can also be affected by the emergence and spread of wildlife diseases. If the 
pathogen in question induces a high enough mortality rate in the host, there is a risk of 
losing entire populations of species and endangering many others; disease induced 
reductions in population size may significantly increase the chance of local extinction due to 
demographic fluctuations. Recent outbreaks have demonstrated this, for example in 
Australia the chytrid fungus Batrachochytrium dendrobatidis (Bd) is thought to be behind 
the fall in population size and perceivable extinction of at least 14 high‐elevation species of 
rainforest frog (Retallick et al. 2004). This fungus is not unique to Australia, and it’s affects 
on the amphibian community can be felt worldwide. Using information from a “last year 
observed” database, Marca et al deduced that the frog genus Atelopus has undergone 67 
species extinctions since 1980 (Marca et al. 2005), which have been generally attributed to 
Bd. Bd has been categorised as an amphibiotic emerging infectious agent (Daszak et al. 
1999) and is considered to be pandemic. In 2008 the World Organisation for Animal Health 
reported Bd as a notifiable pathogen (OIE 2008). 
The impact of pathogens on wildlife conservation can be damaging when endangered or 
threatened species are affected by an outbreak of an infectious pathogen. The Tasmanian 
devil population has continually declined by up to 90% from 1996 when a debilitating and 
aggressive facial cancer tumour was first reported known as Tasmanian Devil Facial Tumour 
Disease (DFTD) (McCallum et al. 2007). This has caused the Tasmanian Devil, which was 
originally listed as “low‐risk” in terms of endangerment in 1996, to be officially categorised 
an “endangered” species as of 2008 by the International Union for Conservation of Nature 
(IUCN) Redlist (Hawkins et al. 2008). In the conservation biology literature emphasis is 
placed on the possible adverse consequences of wildlife disease due to a decline in genetic 
diversity (Epps et al. 2005; Schmid et al. 2009). The lasting effect of a decline in genetic 
diversity within a population is the reduction in the ability to adapt to changes, for example 
loss of habitat or fragmentation. A more immediate disadvantage is the incapacity to resist 
pathogen infection. DFTD is a prime example of how loss of genetic diversity within 
populations amplifies the risks posed by disease (Jones et al. 2004). This case highlights the 
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importance of surveillance and early action against emerging diseases threats; as DFTD was 
not quickly identified it has already spread across a large range of the species which makes 
eradication difficult (McCallum 2008). 
 
Canine distemper (CDV) is a viral disease affecting the respiratory tract, gastrointestinal 
system, skin, reproductive tract, eyes, and nervous system. It is classified as producing 
clinical signs such as nasal discharge, transient fever, diarrhoea, and weight loss. CDV has 
been recognised as a pathogen of domestic dogs, however numerous CDV infections of wild 
species have been documented (Leisewitz et al. 2001). In 1994, the Serengeti National Park 
lion population were subjected to a devastating outbreak of canine distemper. This led to 
the over‐all population reducing in size by approximately one‐third (i.e. 1000 animals) 
(Roelke‐Parker et al. 1996), a significant blow to the conservation and protection effort of 
the Serengeti National Park. However, as a consequence of intense monitoring of the lion 
prides, detailed observations were collected on the incidence of CDV and their movement. 
From this data it was deduced that it was unlikely lion movement patterns could account 
for the spread of the disease, which eventually led to the exploration of other potential 
reservoirs of the pathogen (Haydon 2008). It has been suggested that the most probable 
reservoir for CDV in the Serengeti lion epidemic was the domestic dogs of the local villages. 
Between 1991 and 1993, the seroprevalence of CDV increased in their population which 
preceded the 1994 outbreak in lions (Roelke‐Parker et al. 1996).   This 1994 outbreak of 
canine distemper illustrates quite clearly the risks posed by wildlife disease but also to the 
great advantages of surveillance. It would have been impossible or at the least very difficult 
to determine how the outbreak evolved without such rich data collection. 
 
1.3 Wildlife diseases and the livestock industry 
 
When a disease is classified as notifiable, it is required by law that it is reported to 
government authorities if discovered. This can lead to restrictions placed on the movement 
of livestock from affected premises and subsequently impact on the “disease status” of a 
country possibly leading to a ban on trade until the country is considered “disease free”. 
Therefore, there is potential for tremendous economic impacts when wildlife disease can 
transmit to livestock. Bovine TB (bTB), caused by Mycobacterium bovis, is a focal point for 
wildlife control because of the adverse consequences of the disease on livestock production 
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(Donnelly & Hone 2010) and the significant affect it has on trading as a result of EU trading 
standards and procedures (Caffrey 1994; DEFRA 2011). bTB is categorised as a bacterium 
which causes chronic incapacitating disease in cattle, humans and various wild species, 
including the badger (Meles meles) (Bengis et al. 2004). During the comprehensive 
Randomised Badger Culling Trial (RBCT), designed to establish if culling badgers reduced TB 
in cattle, badgers were shown to  be a source of infection to cattle (DEFRA 2013). The trial 
results suggested that culling of badgers over a fixed area of 150km2 would lead to an 
average of 16% reduction in bTB incidence in cattle in the local area. However, there are 
also negative impacts of culling which can lead to an increases in disease e.g. the 
perturbation effect as mentioned previously (Prentice et al. 2014). This situation has put a 
strain on the economy as infected cattle have decreased production of milk and infected 
carcasses will be seized at abattoirs if detected  (Amanfu 2006; Firdessa et al. 2012). Known 
infected cattle herds are put on a trade lockdown as required by the EU trading standards 
and are prohibited from moving until bTB free status is achieved. There are also added 
economic problems which come with the slaughtering of infected cattle. It is estimated that 
approximately 28,000 cattle were slaughtered in 2012 through bTB infection (DEFRA 2012) 
and the burden of compensation falls on the government or else must be absorbed by the 
individual infection sites which could result in farms going out of business if the financial 
impacts of the cull are too great.  
Schmallenberg is an emerging livestock virus that has been detected in parts of Europe and 
the UK and it is transmitted via vectors such as mosquitoes and midges to the livestock 
hosts (DEFRA 2012) and wild ruminants (ECDC 2012). The virus is characterised by the host 
showing clinical signs including a decrease in milk production, watery diarrhoea, and 
occasional fever (Elbers et al. 2012), and there have also been reports of congenital 
malformations in ruminants (van den Brom et al. 2012). DEFRA has stated that the most 
likely cause of Schmallenberg in the UK is due to infected midges being blown across the 
channel, most probably from France (Conraths et al. 2013). Although this is not a notifiable 
disease as yet, it is being closely monitored and any farmers who encounter the disease or 
suspicious symptoms are advised to contact their local vet. Impact assessments by the EFSA 
(2012) and Harris (2014) suggest that if this virus were to spread further across the UK and 
Europe it is likely to have serious adverse economic impacts on the farming industry (EFSA 
2012; Harris et al. 2014) as meat and milk production could be badly hampered. 
17 
 
Foot and mouth disease (FMD) is an infectious virus affecting ruminants and is 
characterised by clinical signs including loss of appetite, sudden death of young, lameness, 
blisters and reduced milk yield. Although recent outbreaks have been predominantly in 
livestock, wild ruminants can also play a role in the introduction and spread of FMD (Condy 
et al. 1969; Ward et al. 2007). The disease can have severe consequences for animal health 
and the economics of the livestock sector as exemplified by the 2007 outbreak in the UK. 
During August and September 2007, FMD caused large disruptions to the farming sector 
and cost hundreds of millions of pounds in control efforts and slaughtered animals (Cottam 
et al. 2008). For example in Scotland there was an export ban on live animals imposed until 
the close of the year, the effect of this was a reduction of market prices, although the real 
measure of this depends on the initial state of the market before the outbreak. This 
represented a considerable cost to farmers of livestock and in turn also represented losses 
to the overall agricultural supply chain (Scottish Government 2008). The burden of a 
restriction on movement requires farmers and other branches of the agricultural supply 
chain to diverge from the usual procedure and these effects can be exacerbated if farmers 
keep their stock for a longer period because of lower market prices, all of which 
demonstrate extra cost and strain on the livestock economy.    
 
1.4 Wildlife Disease Surveillance 
 
Surveillance is the first line of defence against wildlife disease and the threats it can pose. 
Wildlife disease surveillance aims to limit and end outbreaks of disease before they have 
the ability to cause major damage to public, livestock and wildlife health (Belant & Deese 
2010) . When used in an efficient and comprehensive manner, surveillance can be 
instrumental in controlling and overcoming disease outbreak (FAO 2011). There is an 
increasing recognition of the necessity of wildlife disease surveillance (Jebara 2004; Kuiken 
et al. 2011). However, there are a range of issues associated with surveillance of wildlife 
disease, e.g. poor knowledge of basic ecology and distribution of host species, this makes it 
particularly challenging even when compared to surveillance in livestock and humans. 
The wildlife disease surveillance strategies currently undertaken in Europe are few and far 
between (Artois et al. 2001). The protocols for these activities are still informal and as of yet 
there is no structure in place to facilitate coordinated surveillance/reporting of wildlife 
disease between countries (Kuiken et al. 2011). As previously mentioned, there is an 
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increasing acknowledgement that greater priority should be placed on wildlife disease 
surveillance, driven in part by the numerous examples of zoonotic outbreaks in the human 
population (SARS, Swine Flu, Avian Influenza etc). Leading international wildlife 
organisations and influential veterinary editorials have highlighted the importance of 
wildlife surveillance effort. The director general of the world health organisation for animal 
health (OIE) asserted that “Surveillance of wildlife diseases must be considered equally as 
important as surveillance and control of diseases in domestic animals” as well as concluding 
that the surveillance of wild animal disease is essential (Vallat 2008). In the first EWDA 
meeting for wildlife health surveillance on 15th October 2009 in Brussels, 25 representatives 
presented summaries of the wildlife health surveillance in their respective countries. Based 
on these summaries Kuiken et al. (2011) showed that there are significant differences in 
surveillance approach across Europe. The number of surveillance schemes in action per 
country, the intensity of those schemes, the number of animals examined, effort in terms of 
the number of people employed, and the sources of funding vary greatly. The authors 
categorised the differences in surveillance in each country by three different levels; no 
general surveillance, partial general surveillance and comprehensive surveillance, of which 
the UK fell into the later. As a result of this, there was a consensus among the participants 
that wildlife health surveillance in Europe would profit from a more formal network of 
people actively contributing to this research area (Kuiken et al. 2011). 
When undertaking surveillance of a given population (i.e. a group of individuals of the same 
species interacting within some defined area), the task becomes a lot easier if the 
population is closely managed (i.e. livestock), but unfortunately this is not the case when 
considering wildlife populations. Compared with surveillance in livestock there are many 
added complications to wildlife disease surveillance, for example locating the population, 
estimating accurately the size of the population and understanding the demography and 
transmission dynamics of the population including interactions with other populations and 
the wider community (i.e. other species). These added complications can make it difficult to 
obtain the samples required of a successful surveillance system (Nusser et al. 2008).  Many 
wildlife surveillance strategies depend on methodologies based on protocols developed for 
livestock systems. However, as discussed, wildlife populations are considerably more 
complex and to date there has not been a detailed exploration of whether methods used in 
livestock are suitable for application to wildlife populations.  
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Wildlife disease surveillance can be characterised under two broad categories, active 
surveillance and passive surveillance. Passive surveillance can be generally defined as the 
discovery and testing of naturally occurring deceased hosts (i.e. animals that have not died 
for the initial purpose of surveillance). There are instances of routine collection of hunter‐
killed samples and collection of road‐kill animals, but a primary difficulty of passive 
surveillance is that the strategy generally relies on members of the public identifying and 
delivering a case for diagnostic testing (Rhyan & Spraker 2010). The potential of passive 
surveillance is hard to realise in practice since disease detection is quite frequently time 
sensitive (i.e. sensitivity of diagnostic tests may reduce sharply with time since death) and 
the incentive for the general public to report a case is relatively low. There is also a 
considerable chance of bias in the sample when relying on passive surveillance especially if 
the host‐pathogen dynamic features significant disease induced mortality or if behaviour of 
infected individuals reduces or increases the chance that deceased individuals are 
encountered. Active surveillance in the context of this thesis is defined as the capture and 
subsequent testing of individuals driven by surveillance related objectives. A primary 
difficulty with this type of surveillance is that it can be more costly than other options and 
only limited funding is available (Lancoua et al. 2005). In livestock systems active and 
passive surveillance strategies are much simpler to implement, and as highlighted 
previously wildlife systems are much more complex. There are numerous complications 
when gathering samples in the field, including dynamic aspects of population turnover, 
habitat effects on density and distribution in space and time, behavioural aspects affecting 
sampling e.g. elusive nocturnal species trap shyness of animals etc. These complications 
typically result from dynamic processes which are subject to stochastic fluctuations making 
it more difficult to design and implement randomised sampling strategies. 
In summary, both passive and active surveillance have the potential to be effective tools for 
wildlife disease research, but they can suffer shortcomings including under‐reporting, and 
difficulties in designing effective surveillance strategies due to the complexity of host‐
pathogen systems (Stallknecht 2007). There is therefore a need to address these problems 
systematically; in particular there have been calls for improved pan‐European mechanisms 
including defined standard protocols and data sharing (Genovesi & Shine 2002; Kuiken et al. 
2011; “WILDTECH Report Summary” 2014). This is a long term goal which would aim for a 
coordinated approach to surveillance and monitoring, to offer increased protection from 
disease outbreaks and incursions. For this to work, unquantifiable biases need to be 
minimised (e.g. human behaviour in passive systems) and/or accounted for in subsequent 
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analysis.  For the purposes of this thesis, we investigate only active surveillance as the 
characterisation of biases in passive surveillance requires a focus on specific surveillance 
scenarios and here we wish to explore generic aspects of wildlife disease surveillance. For 
example, results not shown indicate the ability of passive surveillance to detect disease 
depends strongly on the level of disease induced mortality and the rate at which the 
animals decay. 
The key statistics we subsequently use to characterise the performance of wildlife disease 
surveillance systems are reviewed here. There are several statistics that can be estimated 
using surveillance information which give valuable information about the population itself, 
disease status and surveillance efficacy. However, in this thesis there are two primary 
statistics of interest used to investigate surveillance performance and the effect of 
population demography and disease transmission on surveillance efficacy, the estimate of 
prevalence and the probability of detection. 
1.4.1 The Probability of Detection 
 
The simplest and most widely used approach to estimating the probability of disease 
detection is to assume constant prevalence p and an effective infinite population size (i.e. 
assume sampling is with replacement/the population size is not finite). These assumptions 
lead naturally to a binomial formula for the probability of detecting disease from n samples. 
 
                                                                 =  1 − (1 −  )                                                              (1) 
where n = the sample size  
           a = the probability of detecting disease 
           p = the prevalence 
 
The above formula can be used to carry out a power calculation as follows. Re‐arranging 
equation (1) in terms of n, gives an estimate of the sample size required to obtain a 
probability of detection a given an assumed prevalence p can be derived. 
 
                                                                        =
   (    )
   (    )
                                                                    (2) 
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This required sample size increases rapidly as prevalence tends to 0, as demonstrated in 
Figure 1.1. This can lead to “over sampling” especially for smaller populations, since the 
underlying assumption is that the population is infinite. To counteract this effect which 
would lead to the repeated sampling of individuals, a number of authors (Martin et al. 
1987; Artois et al. 2009a; Fosgate 2009) have considered modifying this approach based 
upon the hyper‐geometric distribution which accounts for finite population sizes. This 
approach leads to the following sample size calculation 
  
                                             =   1 − (1 −  ) /   × [  − 0.5(  − 1)]                                        (3)                                                        
 
 
where N = the total population size 
           D = the total number of diseased individuals within the population 
            p  =
 
 
= prevalence 
 
Figure 1.1 shows equation (3), demonstrating the effect of modifying equation (2) to 
account for finite population sizes. Without this modification, at low prevalence, the sample 
size required to detect disease presence can be greater than the population itself. As noted 
above this would entail sampling the same individuals more than once which is clearly 
inefficient and given perfect tests completely unnecessary, at least if the disease status of 
individuals is assumed not to change over time. This is of course consistent with the 
assumption of unvarying prevalence on which both equations (1)‐(3) rely. The hyper‐
geometric correction implemented in equation (3) ensures the maximum sample size 
required is capped at the total population size.  
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Figure 1.1:  Effect of disease prevalence on the sample size required to detect disease. 
Plots are shown for varying levels of diseased individuals when the probability of detection 
a = 0.5 for both equation (2) and (3). Plot 1.a shows the effect of number of diseased 
individuals on sample size requirement described by equations (2) and (3) for a fixed 
population size of 100 (i.e. maximum prevalence is 0.1). Plot 1.b shows the effect of number 
of diseased individuals on sample size requirement from equations (2) and (3) for a fixed 
population size of 1000 where again maximum prevalence is 0.1. 
Equations (3) can be re‐arranged to give an equation for the probability of detection for 
finite sized populations analogous to equation (1): 
 
                                                       = 1 −  1 −
 
     . (     )
 
 
       (4) 
 
Note that equation (1) is the form that will be used herein when referencing the binomial 
equation for the probability of detection. 
1.4.2 Estimating the True Prevalence: Bias and Standard Deviation 
 
In addition to simply detecting the presence of disease, surveillance may also be called 
upon to accurately estimate the prevalence in a population. However, as we show in this 
Equation (2)
Equation (3)
n n
D D
(a) (b)
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thesis achieving this can be quite difficult in the face of demographic fluctuations within the 
population. In contrast the standard approach is to ignore such fluctuations and assume 
constant prevalence p and population size. This leads to the conclusion that the number of 
infected individuals in a sample of n individuals, from a population with prevalence p, is 
drawn from a binomial distribution with Bin(n,p). Which has mean np and variance     
np(1-p). Therefore under these assumptions we find that the binomial estimate of 
prevalence is np/n =p and therefore 
 
                     E[surveillance estimate of prevalence]= E[true prevalence]                        (5) 
 
i.e. the bias of the surveillance estimate (under the above assumptions) is equal to 0.  
Given the variance in the binomial estimate of the number of infected cases in a sample of 
size n, the standard deviation (std dev) in the corresponding estimate of prevalence from 
surveillance is: 
 
                                                   
    (    )
 
=     (1 −  )/                                                               (6) 
as before, p =prevalence and n = sample size. 
As with the probability of detection in equation (4), there can be corrections made to 
equation (6) to account for the finite size of the population. Frequently in survey research, 
samples are taken without replacement and from a finite population of size N. In this 
instance, and especially when the sample size n is proportionally not small (i.e. n/N > 0.05), 
a finite population correction factor (fpc) is used as a pre‐factor on the right hand side of 
equation (6) to define both the standard error of the proportion. The finite population 
correction factor is expressed as: 
 
                                                         =      −     − 1                                                                    (7) 
 
Figure 2 show the bias and standard deviation using the binomial theory based on the 
assumptions of constant population size and prevalence. As stated above, the binomial 
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equation does not predict any bias in the surveillance estimate of prevalence as the 
predicted prevalence is equal to the true prevalence, p. However, the error in this estimate 
is non‐zero and varies with true prevalence, as can be seen in Figure 2.b. Note that the 
correction factor in equation (7) is less than 1 for any N>2 and sample size n>1, and 
therefore the error in the estimated prevalence shown in Figure 2.b will be reduced when 
accounting for the finite size of populations.  
 
 
 
 
 
 
 
 
Figure 1.2: Using binomial theory to estimate the expected bias and std dev in the 
surveillance estimate of prevalence. Plots are shown for sample size n = 10 and varying 
levels of prevalence in the population for equation (5) and (6). Plot 2.a shows the predicted 
bias in the prevalence estimate from surveillance. Plot 2.b shows the predicted std dev in 
the prevalence estimate from surveillance.  
1.4.3 Improving wildlife disease surveillance 
 
In recent years, in line with the heightened interest in wildlife disease discussed above, a 
number of authors have identified a need for both improved implementation and 
methodological developments to enhance the design and evaluation of wildlife disease 
surveillance (Stallknecht 2007; Hadorn & Stärk 2008; Artois et al. 2009a; Ryser‐Degiorgis 
2013). In order to effectively do this, it is important to consider the ecology of the 
population under surveillance as this will have an impact on the results obtained (Béneult et 
al. 2014). A strategy that worked for one type of natural population may not necessarily 
work as well in another. Understanding how the dynamics of the host‐pathogen interaction 
affect the efficacy of surveillance is key, and potentially the most important step towards 
improvement of surveillance systems. However such effects have yet to be systematically 
considered in the literature. There have, however, been attempts to improve wildlife 
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disease surveillance design by incorporating weighting schemes based on habitat suitability 
of the observed population (Nusser et al. 2008; Walsh & Miller 2010). However, there are 
also other factors that should be taken into consideration if required, for example dispersal 
of populations, population fluctuations, disease stability, seasonality and environmental 
change. In this thesis we use mathematical modelling to explore how key ecological 
processes that govern wildlife populations, in particular demographic fluctuations, 
stochastic disease dynamics and spatial heterogeneity, impact on surveillance. Simulation 
modelling could make a positive contribution to this area, as testing out scenarios in the 
field is either very monetarily costly and/or time consuming or altogether unfeasible. By 
running simulations, what is expected from different surveillance strategies in a wide range 
of host‐pathogen systems can be explored. Using such studies, it would be possible to 
better understand the results obtained from a given surveillance strategy.  
 
1.5 Modelling Wildlife Populations, Disease and Surveillance 
 
Mathematical modelling is a tool, or more correctly a set of tools, used to represent 
different mechanisms in the natural world, and in particular enables prediction of system 
level impacts that results from interactions between multiple mechanisms (Lucio‐Arias & 
Scharnhorst 2012). Such techniques have a long established role in mathematical biology. 
Translating descriptions of biological processes, such as host‐pathogen interaction, into 
mathematical language is beneficial for many reasons, for example, the precise 
mathematical language aids in formulating ideas and recognising underlying assumptions as 
well as utilising mathematical techniques to manipulate equations in order to gain insights 
into the behaviour of the modelled system. Unfortunately non‐linearities and population 
heterogeneities, which are of key importance in many biological systems, make such formal 
analysis of associated mathematical models difficult and typically intractable. However a 
key advantage of this approach to biological research is the use of computers in performing 
calculations and running simulations. This is a considerable time saver and also enables the 
exploration of many scenarios that would be unfeasible to study in the field. There are, 
however, compromises to be made with this approach. As with most natural interacting 
systems, the dynamics of a host‐pathogen interaction are potentially extremely complicated 
and it is important to identify the key elements to include within the model since 
encompassing every aspect is typically unfeasible and such a comprehensive approach is 
unhelpful in terms of generating insights/understanding into how the studied system works. 
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“In principle models should be developed from the simple to the complex” (Murray 2002) 
and this ethos has been adopted throughout this thesis. With every added complexity 
introduced to the model description, the longer and more intensive are the methods 
required to handle the equations. Insights obtained from relatively simple model structures 
are more generic and can also aid in the understanding of more complex models. 
1.5.1 Temporal Modelling of Wildlife Populations with Disease 
 
When simulating natural populations it is essential to account for key demographic 
processes in the model, e.g. births, deaths and immigration. An example is shown in Figure 
1.3 which illustrates a population subject only to birth governed by a logistic growth rate. In 
this thesis, a primary interest is that of pathogen transmission, and we model both primary 
and secondary transmission. Primary transmission occurs when a susceptible from the 
modelled population becomes infected by routes including, infected water sources, 
contaminated food, and transmission from an individual outside the modelled population. 
Secondary transmission occurs when a susceptible individual from the modelled population 
becomes infected through contact with an infected individual within the modelled 
population. Vertical and pseudo vertical transmission represent the infection of offspring 
and young individuals by parents. However, unless such transmission is infallible vertical 
and pseudo vertical mechanisms are not capable of sustaining infection and in this thesis 
we do not consider such routes. Nonetheless such mechanisms could easily be incorporated 
as part of the models presented here. As well as these elements describing demographic 
processes and disease dynamics it will be important to model key aspects of the process 
surveillance in order to assess how it performs in differing circumstances. 
Compartmental models have been used frequently to describe host‐pathogen systems in 
wildlife disease research (Renshaw 1991; Murray 2002) as they aim to reduce the 
complexity of host‐pathogen dynamics into a manageable number of disease status 
“compartments”. There are many different examples of such compartmental models; some 
of the more well‐known include SI, SIS, SIR, SIRS and SEIR. In these compartmental models S 
represents a susceptible state, I an infected state, E a latent state (i.e. infected but not yet 
infective), and R represents a recovered state (recovered from disease and no longer 
infectious or able to be infected). There are two broad categories of mathematical 
modelling which can utilise such compartmental structure, deterministic and stochastic. In 
both cases the model state space typically represents the number of individuals in each 
category. Deterministic models ignore the random fluctuations that can be observed in real 
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systems, solving standard differential equations simultaneously to update the model at 
discrete time steps. The deterministic nature of these models means that, starting from a 
given input they will always return the same output. Continuous time stochastic models 
incorporate random variation by utilising probabilistic equations to determine a series of 
events which update the model at randomly generated time intervals and potentially (for 
multiple event types) in a manner that is also stochastic in nature. Such stochastic processes 
naturally lend themselves towards not only population level representations (e.g. where 
numbers of susceptible and infected individuals are tracked) but also to individual based 
models where the disease status over time of each member of the population is 
represented. There are pros and cons for both deterministic and stochastic approaches and 
the differences between them are now demonstrated with a simple birth‐death process SI 
example. 
A Simple Compartmental Model Worked Example 
 
 
 
 
Consider the components of the state space S(t) and I(t) which represent the number of 
susceptible and infected individuals respectively at time t. Birth is represented by logistic 
growth defined by Verhulst (1845), and since this is a feature embedded throughout the 
models used in this thesis a more detailed explanation is required. Deterministic logistic 
growth is defined by the following equation: 
  
  
=     1 −
 
 
  
 
where N is the total population (S + I), r the intrinsic growth rate and K the carrying capacity. 
Figure 3 demonstrates a population experiencing deterministic logistic growth over time 
until reaching the carrying capacity, K. All individuals born via logistic growth are 
susceptible, which implies no vertical or pseudo vertical transmission.   
 
 
S I 
28 
 
 
 
 
 
 
  
 
 
 
 
Figure 1.3: An example of a logistic growth curve A Plot is shown to demonstrate how the 
population increases over time using the logistic growth equation. Despite an initial 
exponential increase growth is ultimately limited by the carrying capacity, K. 
If there is also a per capita death rate, d, and a density dependent secondary transmission 
with contact rate  . The deterministic approach then describes an SI model with births and 
deaths as: 
 
                                                           
  
  
=     1 −
 
 
  −     −                                                  (8) 
 
                                                           
  
  
=     −                                                                             (9) 
Given that   =   +   
 
The biological mechanisms underlying this model are summarised in Table 1 below, which 
shows the rate at which each event occurs as well as the associated change in the 
population. In the next section we describe how the basic model description shown in Table 
1.1 can be implemented as a stochastic model. 
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Table 1.1: SI model with rate and effects for each event type. A table is shown which 
contains the rates of all events which can occur at each time step with the associated effect 
on the state space. This model can be implemented as a discrete state space stochastic 
process or with a continuous state space, as a deterministic model using ordinary 
differential equations or an analogous system of stochastic differential equations (see text 
for details). 
Figure 1.4 demonstrates how S, I and N population sizes develop over time using both the 
deterministic and discrete state space stochastic approach (described below).  
 
  
 
 
 
 
 
 
Figure 1.4: Deterministic and Stochastic Time Trajectories. Shown here is the total 
population (green), the susceptible population (blue) and the infected population (red) over 
time for both a deterministic and discrete state space stochastic Gillespie implementation 
of an SI model with births and deaths. The parameter values used are   = 1,   = 0.06, 
  = 5 ,   = 50, and starting with initial conditions of    S = 39, I = 1.   
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As Figure 1.4 shows, the outcome of a stochastic and deterministic simulation, although 
following roughly the same pattern, can be quite different.  Deterministic modelling has its 
merits, but in the interests of understanding the impacts of variability on the dynamics of 
host‐pathogen systems, a stochastic approach has been used in the models developed in 
this thesis. 
The mechanisms summarised in Table 1.1 can be used to formulate an integer valued 
discrete state space continuous time Markov process. This then provides a natural 
stochastic description of the assumptions implicit in equations 8 and 9 (made explicit in 
Table 1.1). Under this Markov process, the probability that a given event occurs during a 
short time interval (t, t+ Δt ) is given by its rate multiplied by Δt. The stochastic model can, 
and in some of the models of this thesis will, be simulated using the Gillespie algorithm 
defined by Gillespie (1979). To run Gillespie’s algorithm, starting from time t when the 
system is in state x(t), the time to the next event,    , is randomly chosen from an 
exponential distribution with parameter,        ( ( )), which is the total rate (i.e. the sum 
of the rates of all possible events) evaluated at time t. The event, then occurs at time  +    
and is chosen from the set of possible events with probabilities given by the rate of each 
possible event divided by        ( ( )). The derivation of the exponential waiting time 
distribution for a Markov process which is the basis of the Gillespie algorithm is as follows. 
Let – 
 
        ( ) = probability that no event has occurred up to time t , 
 w hen starting at  (0)at time t = 0. 
 
Then considering the change in        ( )  over a small time    gives, 
 
    +     |  ( )  =       |  ( )   1 −          ( )     
 
Where to first order in   , 1 −          ( )    = probability that no event has occurred in 
a small time interval ( , +    ) i.e. 1‐ the probability that one of the set of possible events 
did occur. 
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Rearranging this equation and taking the limit as    → 0 we find 
 
  (  | (0))
  
 ≡  lim
  →  
    +     |  ( )  −      |  ( )  
  
=  −     |  ( )         ( ( ))  
 
⇒  
1
 (  | )
  (  |  ( ))
  
=  −         ( )  
 
⇒   
1
 
   
 
 
=  −             
 
 
 
 
⇒ ln      |  (0)  − ln   0 |  (0)  =  −         (0)   
 
⇒       |  (0)  =             ( )    
 
This last line follows on noting that, by definition, nothing has happened at time t=0 and so 
   0 |  (0)  = 1. Note that this equation forms the basis of the Gillespie algorithm since it 
shows that the time to the next event has an exponential distribution.   
 
For the model described in Table 1 
       =     1 −
 
 
  +     +    +    
 
Thus starting at time t and the time is advanced to  +   with the inter event waiting time 
drawn from the exponential distribution. i.e.,   ~  exp          ( )   where  ( ) =
{ ( ), ( )} represents the state space at time t. After the time to the next event is 
calculated, the event which has occurred is chosen randomly by generating a number from 
the uniform distribution,   ~    (0,        ). The next event is:  
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                Birth                       <      1 −
 
 
  
                                   Death of S       <      1 −
 
 
  +    
                                   Death of I       <      1 −
 
 
  +    +    
                                   Infection        <      1 −
 
 
  +    +   +      
 
Note alternative orderings of event types (and associated rates) are allowed but the order 
used does not affect the statistical properties of the model. The state space is updated 
accordingly, the rates are recalculated and the above process is repeated until some 
maximum time,      , or an alternative stopping criteria, is reached. An alternative 
stochastic approach which ignores the discrete nature of populations (and hence is closer in 
spirit to the deterministic model) is that of stochastic differential equations (SDE’s). The 
Gillespie implementation, e.g. of the SI model described above, is a continuous time 
discrete state‐space Markov process in which the number of infected individuals (I) and 
total individuals (N = S+ I) are represented as integer variables.  
Table 1.2 shows the expectation and variance of the updates that would be obtained during 
a small time interval from the Gillespie algorithm implementation of the model based on 
the description of events shown in Table 1.1. (i.e. from the discrete state space SI model 
with births and deaths). Comparison with Table 1.2 enables both drift e.g. fN,B(X(t)) and 
diffusion e.g. gN,B(X(t)) functions to be identified 
However the SDE approach makes use of continuous variables to represent the state space. 
Using the simple compartmental example above, we can represent the change in the 
system state variables during an infinitesimally small time interval dt as the following set of 
stochastic differential equations: 
 
   ( ) =     ,    ( ) +    ,     ( ) +    ,    ( )   +    ,     
( )      
+     ,    ( )     ( ) +     ,     ( )      ( ) 
+    ,    ( )     ( )  ( ) +    ,     ( )      ( ) 
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  ( ) =    ,    ( ) +   ,     ( ) +   ,    ( ) +   ,     ( )      
+    ,    ( )     ( ) +    ,     ( )      ( ) 
+   ,    ( )     ( ) +   ,     ( )      ( ) 
 
The reader will notice that here we have chosen to represent the dynamics in terms of the 
numbers of infectives and the total size of the population rather than using the number of 
susceptibles and another variable. Therefore the state space at time t is now represented 
by the vector  ( ) = {  ( ), ( )}. The quantities BB(t), BDS(t), BDI(t), B2ry(t) are independent 
Brownian motions corresponding to each of the four event types. For small but finite dt the 
quantities dBB(t), dBDS(t), dBDI(t), dB2ry(t) can be interpreted as independent draws, from a 
zero mean Gaussian with variance dt, for each event type and each time point 0,dt,2dt, ... 
,Tϵ(0,T).  Thus e.g. E[dBB(t)]=0, E[dBB(t)dBB(t)]=dt and E[dBB(t)dBDS(t)]=0. The so called drift 
term    ,    ( )  represents the expected change in population size N associated with the 
birth event conditional on the system being in state  ( ), whereas the diffusion term 
   ,    ( )  represents the variance in this update. There are analogous drift and diffusion 
quantities corresponding to each state variable for each event type. These are detailed in 
Table 1.3. 
 
 
 
 
 
Table 1.2: Expectations and variance-covariance rates. Expectations and variance‐
covariances in changes (during the time interval t to t+δt) to the state space {I(t),N(t)} 
associated with each event type in the discrete state‐space model described above for the 
SDE implementation. All such quantities are shown to first order in δt.  
 
 
 
E-
type 
Event E[δN|X(t)] E[δI|X(t)] Var[δN|X(t)] Var[I|X(t)] Cov[δN,δI
|X(t)] 
B Birth 
 
    1 −
 
 
     
0  
    1 −
 
 
     
0 0 
DS Death of S −     0      0 0 
DI Death of I −     −                    
2ry Secondary 
Trans-
mission 
 
 0       
  
0 
 
            
  
0 
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Table 1.3: Expectation and variance-covariance. Expectation and variance‐covariances in 
changes (during the time interval t to t+dt) to the state space {I(t),N(t)} associated with each 
event type in the SDE model as described above. All such quantities are shown to first order 
in dt.   
The SDE implementation is the diffusion limit of the Gillespie implementation if it is 
constructed in such a way that the first and second order moments of the stochastic 
updates in the differential equations correspond with those of the Gillespie 
implementation. This ensures that the results are consistent between the two 
implementations.  It is easy to see that this consistency is achieved if the values of the drift 
and diffusion terms in the SDE model are chosen by comparing Tables 1.2 and 1.3. This then 
suggests, for example that    ,    ( )  =    (1 −   /  ) and    ,    ( )  =    (1 −   /  ) 
with assignments corresponding to other combinations of event types and state space 
variables made in an analogous manner (i.e. matching up the entries describing 
expectations and variances in  updates shown in Tables 1.2 and 1.3). For events which 
change both state space variables the above formulation also ensures that associated 
updates also have the correct covariance, between changes in N and I. 
There are pros and cons to both the SDE and Gillespie implementations, for example the 
Gillespie algorithm is computationally more intensive whereas using SDEs is faster and 
therefore facilitates more accurate estimation of model statistics (i.e. a greater number of 
realisations can be run). However, the discrete nature of the state‐space under the Gillespie 
algorithm represents a more natural description of the population and the processes that 
affect it. In particular, it provides a more accurate representation of population dynamics 
for small populations. 
 
E -
type 
Event E[δN|X(t)] E[δI|X(t)] Var[δN|X(t)] Var[I|X(t)] 
B    ,    ( )      ,    ( )        ,    ( ) 
 
      ,    ( ) 
 
   0 
DS    ,     ( )      ,     ( )        ,     ( ) 
 
      ,     ( ) 
 
   0 
DI    ,    ( )       ,    ( )        ,    ( ) 
 
      ,    ( ) 
 
      ,    ( )   ,    ( )    
2ry     ,     ( ) dt    ,     ( )        ,     ( ) 
 
      ,     ( ) 
 
   0 
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1.5.2 Spatial Temporal Modelling of Wildlife Populations, Disease and Surveillance 
 
As well as describing the temporal ecological interactions in wildlife systems, mathematical 
models can also include spatial temporal dynamics. Research has shown how extrinsic 
spatial heterogeneity (i.e. habitat and land use), has an impact on disease prevalence and 
persistence (Hagenaars et al. 2004). This finding is important in terms of disease 
surveillance and this is taken into consideration in practice by targeting known habitats of 
wildlife species (Nusser et al. 2008). However, as far as we are aware, there has been no 
research or practical application which has addressed how intrinsic spatial heterogeneity 
(i.e. as generated by demographic fluctuations and disease dynamics) will affect surveillance 
and the efficacy of surveillance strategies.  
The implementation of spatial stochastic models used in this thesis (see Chapter 4) builds 
on the basis of a non‐spatial model, incorporating dynamics and time increments as 
described in section 1.5.1. within a spatial meta‐population. Here each node or “patch” in 
the defined space updates through time via birth, death and immigration events etc. Every 
patch is connected in the spatial area by a distance kernel describing the spread of disease 
between patches and it is this mechanism which controls the spread of disease from patch 
to patch. The distance kernel decays with distance and thus limits the extent to which each 
patch can transmit disease. The closer the patches are, the more likely they are to pass 
disease to one another. Because every process added to the model increases complexity, 
the simulations become ever more computationally expensive. There are many uses for 
both spatial and non‐spatial modelling approaches (Tilman & Kareiva 1997), small scale 
spatial heterogeneity is less significant (i.e. a single population) and it is these instances 
when non‐spatial methods may be more appropriate. However, when dealing with large 
scale meta‐populations, as can be seen in this thesis, spatial heterogeneity is an important 
factor to include. 
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1.6 The Thesis 
      
1.6.1 Aims 
 
The overall aim for this thesis is to investigate how attributes of wildlife populations affect 
surveillance efficacy. We focus primarily on the statistical calculations of prevalence 
estimation and the probability of detecting disease. This is implemented in a generic 
exploration and then subsequently with more specific examples. 
1.6.2 Thesis structure 
 
Chapter 2 
Chapter 2 uses a non‐spatial stochastic simulation model to implement a systematic 
exploration of the effects of pathogen transmission and host population dynamics on the 
efficacy of disease surveillance systems. Our results suggest that for the vast majority of 
disease systems this leads to over confidence in terms of both the power to detect disease 
and the bias and precision of prevalence estimates obtained. Accounting for such ecological 
effects will permit improvements to surveillance systems and better protection against 
emerging disease threats. 
Chapter 3 
Chapter 3 utilises the results in Chapter 2 and applies these findings to two worked 
examples of disease systems in the wild: badgers and tuberculosis; and rabbits and 
paratuberculosis. We show that similar effects to those characterised in Chapter 2 can be 
seen in these disease systems and we explore other sources of complexity and bias which 
have the potential to affect surveillance efficacy. This demonstrates the potential of the 
non‐spatial stochastic model to be used to quantify effects in real systems and also shows 
its potential as a tool to explore the potential impacts of known or putative sources of bias, 
illustrating the power of our approach to inform surveillance. 
Chapter 4 
Chapter 4 extends the non‐spatial model used in Chapter 2 and 3 to explore spatial aspects 
of wildlife disease and wildlife disease surveillance and their subsequent effects on 
surveillance efficacy. This chapter focuses on disease incursion events, representing 
emerging or re‐emerging disease threats, and in particular the amount and extent of spatial 
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spread of disease in the system at the point of first detection by the surveillance system. 
Different spatial surveillance designs are considered and compared to give a better 
understanding of the key mechanisms driving surveillance performance in spatial settings. 
Chapter 5 
Chapter 5 is a general discussion which brings the results from the preceding chapters into 
the wider research context. 
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Chapter 2 
 
 
 
 
The Ecology of Wildlife Disease 
Surveillance  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This Chapter was originally written in the style of a paper with the intention of submitting to 
Ecology Letters. Submitted September 2014, First Author: Laura Walton. 
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2.1 Abstract 
 
We present the first systematic exploration of the effects of stochasticity in pathogen 
transmission and host population dynamics on the efficacy of wildlife disease surveillance 
systems. The design of wildlife disease surveillance currently ignores fluctuations in these 
processes. Our results suggest that for many wildlife disease systems this leads to bias in 
surveillance estimates of prevalence and over confidence in assessments of both the 
precision of prevalence estimates obtained and the power to detect disease. Neglecting 
such effects thus leads to poorly designed surveillance and ultimately to incorrect 
assessments of the risks posed by disease in wildlife. Understanding such ecological effects 
will enable improvements to wildlife disease surveillance systems and better protection 
against endemic, emerging and re‐emerging disease threats. Our results suggest a need for 
a wider exploration of the impacts of ecology on wildlife disease surveillance. 
 
2.2 Introduction 
 
Surveillance is the first line of defence against disease, whether to monitor endemic cycles 
of infection (Ryser‐Degiorgis 2013) or detecting incursions of emerging or re‐emerging 
diseases (Daszak et al. 2000; Kruse et al. 2004; Lipkin 2013). Identification and 
quantification of disease presence and prevalence is the starting point for developing 
disease control strategies as well as monitoring their efficacy (OIE 2013). Knowledge of 
disease in wildlife is of considerable importance for managing risks to humans (Daszak et al. 
2000; Jones et al. 2008) and livestock (Frölich et al. 2002; Gortázar et al. 2007), as well as 
for the conservation of wildlife species themselves (Cunningham 1996; Daszak et al. 2000; 
Evenson 2008).  
Recent public health concerns e.g. Highly Pathogenic Avian Influenza (Artois et al. 2009b), 
Alveolar Echinococcosis (Eckert & Deplazes 2004) and West Nile Virus (Valiakos et al. 2014), 
have heightened interest in wildlife disease surveillance (Vallat 2008) and led to a growing 
recognition that current approaches need to be improved (Mörner et al. 2002). For 
example, there is no agreed wildlife disease surveillance protocol shared between the 
countries in the European Union (Kuiken et al. 2011). Furthermore several authors have 
argued that improvements are needed to the structure, understanding and evaluation of 
wildlife disease surveillance (Bengis et al. 2004; Gortázar et al. 2007).    
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Much current practice for wildlife disease surveillance (Artois et al. 2009a) is based on ideas 
developed for surveillance in livestock including calculation of sample sizes needed for 
accurate prevalence estimation (Grimes & Schulz 1996; Fosgate 2005) and detection of 
disease within a population (Dohoo et al. 2005). A common feature of these methods is that 
they ignore fluctuations in host populations and disease prevalence. These assumptions 
lead naturally to sample size calculations (for both disease detection and prevalence 
estimation) and other analyses, based on the binomial distribution and associated 
corrections for finite sized populations such as the hyper‐geometric distribution (Artois et 
al. 2009a; Awais et al. 2009). Fosgate (2009) reviews current approaches to sample size 
calculations in livestock systems and emphasises the importance of basing analyses on 
realistic assumptions about the system under surveillance.   
However, although constant population size and prevalence may often be reasonable 
assumptions for the analysis of livestock systems, they are considerably less tenable in 
wildlife disease systems that are typically subject to much greater fluctuations in host 
population density and disease prevalence.  For example, practicalities and changes in 
population density make it much harder to obtain a random sample of hosts of the desired 
sample size in wildlife disease surveillance programmes (Nusser et al. 2008) compared with 
livestock systems.  Furthermore the importance of temporal (Renshaw 1991; Wilson & 
Hassell 1997), spatial (Huffaker 1958; Lloyd & May 1996; Tilman & Kareiva 1997) and other 
forms of heterogeneity (Read & Keeling 2003; Vicente et al. 2007; Davidson et al. 2008) in 
population ecology and in particular their role in the dynamics and persistence of infectious 
disease has long been recognised (Anderson 1991; Smith et al. 2005). However, such effects 
have yet to be systematically accounted for in the design of surveillance programmes for 
wildlife disease systems, or in the analysis of the data obtained from them. Although there 
have been some attempts to account for spatial heterogeneities in the design of wildlife 
disease surveillance by incorporating weighting schemes based on habitat suitability of the 
observed population (Nusser et al. 2008; Walsh & Miller 2010), we are not aware of any 
attempts to account for temporal fluctuations in prevalence or host population size. Here 
we address this gap by assessing the impact of stochastic fluctuations in host demography 
and disease dynamics on the performance of surveillance in a non‐spatial context.  
We demonstrate analytically that correlations in fluctuations of prevalence and population 
density bias prevalence estimates obtained from surveillance. Simulations, using logistic 
models of population growth and susceptible‐infected disease dynamics, support this 
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finding and further show that variation in prevalence estimates can be considerably higher 
than would be apparent from standard calculations based on constant population size and 
prevalence. We also explore the impact of fluctuations in population density and prevalence 
on the ability of surveillance to detect the presence of disease. An approximate argument 
indicates that, in comparison with the detection rate obtained by assuming constant 
prevalence, the true probability of disease detection is reduced by fluctuations, and this is 
confirmed by subsequent simulation.  The potential range of possible detection rates is 
assessed by simulating a spectrum of host‐pathogen systems at two sampling levels to 
demonstrate the potential range of performance that could be expected when surveillance 
is deployed in the absence of knowledge of the underlying wildlife disease system.  
 
2.3 Methods 
 
2.3.1 Stochastic Model Description 
 
The model represents a host population subject to demographic fluctuations (births, deaths 
and immigration) and the transmission of a single pathogen. At each point in time t, the 
state‐space represents the total population size N(t), with I(t) of these infected and        
S(t) = N(t) - I(t) susceptible. In addition the prevalence is then given by p(t) = I(t)/N(t). 
The birth rate of individuals is logistic, rN(1 – N/k), with intrinsic growth rate r and carrying 
capacity k reflecting the assumptions that population growth is resource limited. Individuals 
have a per capita death rate μ and immigration occurs at a constant rate ν. 
A proportion γ of immigrants are infected, but otherwise all individuals enter the 
population (through birth or immigration) as susceptible since we assume vertical and 
pseudo‐vertical transmission are negligible. Susceptible individuals become infected 
through primary transmission (contact with infectious environmental sources including 
individuals outside the modelled population) and secondary transmission (contact with 
already infected individuals from within the population). Primary transmission occurs at 
rate β0 S(t) while secondary transmission occurs at rate βS(t)I(t).   
Disease surveillance is incorporated into the model in the form of active capture, testing 
and release at per capita rate α for both susceptible and infected individuals. All 
surveillance testing is undertaken assuming perfect tests, which means that our measures 
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of the performance of surveillance reflect a best case scenario. A summary of this 
conceptual model is given in Table 2.1 which shows all demographic, epidemiological and 
surveillance events with their corresponding rate and effect on the state‐space. 
2.3.2 Statistics generated from the model 
 
Since we allow immigration of susceptible and infected individuals neither the population 
nor the disease will become extinct and we therefore assume that long term averages are 
equivalent to ensemble expectations (typically approximated by averages over many 
realisations of the process). Each simulation is run for a period of time to allow the 
population to reach equilibrium before long run averages are calculated. For example, the 
expected mean E[N] and variance Var[N] of the population size are recorded along with 
the expected mean E[p] and variance Var[p] of disease prevalence. Similarly other statistics 
such as the covariance between the prevalence and population size are calculated as 
required.  
During a so called surveillance bout individuals are captured at per capita rate α, and both 
the total number and the number of infected individuals caught are recorded. Note this 
could be easily extended to account for imperfect disease diagnostics by recording the 
number testing positive but here we assume perfect tests. When the surveillance bout 
ends, either because a target number of individuals has been caught or because an upper 
time limit has been reached, the sample prevalence is recorded. In addition, if at least one 
infected individual was caught we note that disease was detected. Therefore over repeated 
surveillance bouts it is straightforward to estimate the probability of detection PD  (the 
proportion of bouts where disease is detected) and the mean E[p̂surv] and variance 
Var[p̂surv] of the prevalence estimates obtained from active surveillance. 
2.3.3 Model Implementation 
 
The model is implemented  as a continuous time continuous state space Markov process, 
based on a set of coupled Stochastic Differential Equations, SDEs (see e.g. Mao 2007) and 
simulated using the Euler‐Maruyama algorithm (see e.g. Higham 2001). For details see 
section 1.1 in Appendix 1. The model is also implemented as a continuous‐time discrete‐
state space Markov process (also described in section 1 in Appendix 1), which is simulated 
using Gillespie’s exact algorithm (Gillespie 1976). The SDE implementation has been 
constructed so that it is the diffusion limit of the Gillespie implementation. To achieve this, 
the first and second order moments of the stochastic updates in the differential equations 
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are chosen to correspond with those of the Gillespie implementation, ensuring that the 
results are consistent between the two implementations.  The Gillespie algorithm is 
computationally more intensive whereas using SDEs is faster and therefore facilitates more 
accurate estimation of model statistics (i.e. a greater number of realisations can be run) and 
more extensive exploration of parameter space. However, the discrete nature of the state‐
space under the Gillespie algorithm is a more direct implementation of the model described 
in Table 2.1 and provides a more accurate representation of population dynamics for small 
populations. 
 
 
 
 
T
a
b
l
e
  
Table 2.1: Model structure. Event, Rate and Effect on the State Space of the model. 
Conceptually the effect of each event affects an individual and this is reflected in the 
discrete nature of the corresponding changes in the state space. However, given this 
underlying conception of the model there are a number of different implementations which 
can be considered including via the Gillespie algorithm and stochastic differential equations 
(see text for details). 
  
Event Rate Effect 
Birth   (1 −   / ))   →   + 1 
Death of Susceptible      →   − 1 
Death of Infected      →  − 1 
Susceptible 
Immigration 
(1 −  )     →   + 1 
Infected  
Immigration 
     →  + 1 
Primary  
Transmission 
      →   − 1 
   →  + 1 
Secondary 
Transmission 
      →   − 1 
  →  + 1 
Susceptible Capture 
and Release 
     →   
Infected Capture and 
Release 
       →   
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2.4 Results 
 
2.4.1 Estimating Prevalence 
 
In order to develop an understanding of the properties of wildlife disease surveillance using 
the above model we now develop expressions describing prevalence estimates obtained by 
continuous surveillance i.e. continuously deployed effort resulting in per capita capture rate 
α. 
Consider the interval [0,T] during which the population history is                                       
ℋ [0,T ] = {(N(t ),p(t )): t Є [0,T]} where N(t) and p(t) represent the population size and 
disease prevalence at time t Є [0,T] respectively (see above). Let nT represent the total 
number, and iT the number of infected individuals sampled during this time interval. 
Conditional on the history ℋ [0,T ] the expectations of these quantities are 
E   | ℋ [0, ] =  ∫    ( )   
 
 
   and    E   | ℋ [0, ] =  ∫    ( ) ( )   
 
 
. 
Assuming perfect testing (as we do throughout this paper) the surveillance estimate of 
disease prevalence is simply the ratio pŝurv(T ) = iT/nT. If the stochastic process 
representing the disease system is ergodic, and given the inclusion of immigration (see 
above) we can rule out extinction, the long time limit of this estimate can be equated with 
its ensemble average (expectation over all histories) i.e.,  
lim →     ̂   ( ) = E[  ̂   ]= lim →    
 
 
∫   ( ) ( )   
 
 
 
 
∫   ( )   
 
 
=
 [  ( ) ( )]
 [  ( )]
. 
This can be re‐expressed in the more suggestive form 
 
                                 E[  ̂   ]=  E[ ( )]+  
   [  ( ), ( )]
E[  ( )]
                                                        (1) 
 
Thus when the covariance Cov[N(t),p(t )] = E[N(t )p(t )] - E[N(t )]E[p(t )] between the 
population size and the prevalence is non‐zero the surveillance estimate of prevalence is a 
biased estimate of the true prevalence, E[p(t)]. Since Cov[N(t),p(t)] will be zero when 
either N(t) or p(t) are constant, this result leads to our first and most important conclusion, 
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namely that demographic fluctuations and stochasticity in disease dynamics undermine the 
efficacy of surveillance.  
2.4.1.1 Effect of host demography and disease dynamics 
 
We now focus on surveillance estimates of prevalence based on finite sample sizes, and 
compare these to the continuous sampling theory prevalence estimate (see equation 1). 
Using the SDE implementation of the full model, Figure 2.1 illustrates how population 
fluctuations and disease dynamics in the host‐pathogen system affect the efficacy of 
surveillance (in terms of the bias and variance of estimated prevalence). These results are 
generated by simulating the system for a range of values of the death rate μ, with other 
parameters fixed. As the death rate increases the expected population size decreases and 
demographic fluctuations increase. For a given rate of disease transmission β, increasing the 
death rate reduces expected prevalence, and therefore simulating for different values of μ 
generates the range of prevalence values shown.  Details of the parameterisations used are 
given in Table S.1.1 (see section 1.2 in Appendix 1). The resulting relationship between 
demography and expected prevalence for particular disease characteristics (here a fixed 
transmission rate, β) is illustrated in Figures 2.1.a and 2.1.b which show increasing 
population size and lower demographic fluctuations as expected prevalence increases. 
Simulations not shown here show that our results generalise, holding for transmission rates 
relative to a recovery rate (governing an additional transition from I to S) and death rates 
relative to birth rate, r.     
Figure 2.1.c shows the bias in the surveillance estimate of prevalence E[p̂surv] - E[p(t )] 
obtained from the same set of simulations. Results shown are based on 106 surveillance 
bouts with sample size m  = 10, where for each bout sampling is conducted at rate α until 
10 individuals have been caught and tested. The bias predicted by continuous sampling 
theory (which does not account for sample size) is also shown, and in this case is extremely 
accurate i.e. it agrees with simulation results. Figure 2.1.c shows the bias in surveillance 
estimates of prevalence for four different transmission rates. It is important to note that the 
results shown are conditioned on the underlying prevalence E[p(t)], and therefore for a 
given prevalence the populations associated with higher transmission rates are more 
variable than those with lower β.  We therefore conclude that such variability increases the 
bias of surveillance estimates of disease prevalence.  Finally, Figure 2.1.d shows the 
standard deviation in surveillance estimates of prevalence obtained from the same set of 
simulations. Comparison with the variability in prevalence estimates expected under the 
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zero fluctuation assumption reveals that fluctuations in our simulated wildlife disease 
system considerably reduce the precision (increase the variance) of estimates obtained by 
surveillance. The variability of these estimates also increases with demographic 
fluctuations. Thus, the dynamics of the host‐pathogen interaction are integral in 
determining the efficacy of surveillance in terms of prevalence estimation. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Effect of host demography and disease transmission. Data are shown for a 
range of values of the death rate μ which controls the stability and size of the population, 
and thus determines disease prevalence for a given transmission rate, β. For β=1 plot 2.1.a 
shows that expected population size increases with expected prevalence E[p(t)] (i.e. as μ 
decreases) whilst plot 2.1.b shows that the coefficient of variation of the population size 
decreases.  For the four values of β  indicated and fixed sample size m=10, plot 2.1.c shows 
the bias E[p̂surv] - E[p(t )], and plot 2.1.d the standard deviation in surveillance estimates of 
prevalence, versus the expected value of true disease prevalence in the system, E[p(t)]. 
Results shown are based on 106 surveillance bouts using the SDE implementation of the 
model (see text) using the set of parameter values described in Table S.1.3 section 1.2 in 
Appendix 1. 
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2.4.1.2 Surveillance design 
 
An important determinant of surveillance efficacy is the design of the surveillance strategy 
itself. Figure 2.2 shows how the bias and variance of the estimate of prevalence changes as 
the intensity of surveillance (measured by the capture rate α) increases for fixed sample size 
(Figures 2.2.a and 2.2.c), and as the sample size, m , increases for a fixed capture rate 
(Figures 2.2.b and 2.2.d). For low capture rates and as α→ 0  the continuous sampling 
estimate given in equation (1) provides an accurate prediction for the level of prevalence 
estimated from surveillance based on fixed sample size, which as we saw above is a biased 
estimate of the true prevalence E[p(t)]. However, increasing the capture rate reduces bias, 
and as α increases this bias tends to zero. In addition, for large capture rates, the precision 
of the surveillance estimate of prevalence matches the variability of the underlying wildlife 
disease system (see Figure 2.2.c). Thus for low capture rates the bias in surveillance 
estimates of prevalence is well described by continuous sampling theory (equation 1). 
However, for larger capture rates the properties of the surveillance estimate of prevalence 
increasingly reflect the expected true prevalence (i.e. bias reduces) and the variability in the 
prevalence of underlying disease system. In contrast, increasing sample size improves 
precision, but not bias (Figure 2.2.b). However, the precision is lower and improves less 
quickly with increasing sample size than that predicted by the standard approach that 
neglects fluctuations (see Figure 2.2.d). 
 
 
 
 
 
 
 
 
  
 
48 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Effect of surveillance design. In all plots results are shown for three wildlife 
disease systems with (β, μ): (1, 0.43) solid lines; (1, 0.4) dashed; and (0.1, 0.43) dot‐
dashed. Plots 2.2.a and 2.2.b show expected values of the surveillance estimate of 
prevalence (purple), the true prevalence (blue) and the continuous sampling theory 
prediction (black, see text for details). Plots 2.2.c and 2.2.d show the expected standard 
deviation (denoted, σp) in both the true (blue) and the surveillance estimated (purple) 
prevalence. Plots 2.2.a and 2.2.c are plotted against a range of values of the capture rate α, 
for m  = 10, and 2.2.b and 2.2.d versus a range of sample sizes m for α = 0.1.  Plot 2.2.d also 
shows the constant prevalence estimate of the standard deviation based on the binomial 
(green). Parameter values used are described in Tables S.1.4 and S.1.5 (see section 1.2 in 
Appendix 1). 
 
Figure 2.2 is based on simulated systems for which average host life spans are in the range 
of 2.3‐2.5 time units and these results show bias in prevalence estimates for capture rates 
well above such levels. This suggests that demographic fluctuations will lead to bias in 
surveillance based estimates of prevalence unless surveillance intensity is high (i.e. 
corresponding to capture rates high enough to allow for individuals to be captured multiple 
times during their lifetimes). This does not imply that all individuals need to be tested, but 
just that the required samples should be gathered quickly relative to demographic 
fluctuations in order to reduce such bias. Nonetheless such capture rates are rare and only 
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occur in the most intensively sampled populations (see e.g. Delahay et al. 2000). Additional 
numerical results (not shown) indicate that as the sample size increases the capture rate 
required to obtain unbiased estimates increases, but even for large sample sizes when 
sampling is instantaneous sampling (i.e. α→∞ ) bias is zero and the standard deviation in the 
surveillance estimate of prevalence corresponds to that of the underlying wildlife disease 
system as shown above.  
 
2.4.2 The Probability of Detection 
  
In many cases the primary goal of wildlife disease surveillance is detection of disease rather 
than quantification of prevalence e.g. for emerging or re‐emerging disease where detection 
is a precursor to further action, including heightened surveillance. If prevalence is assumed 
constant and equal to the long term, ensemble, average prevalence E[p] of the wildlife 
disease system, then the probability that disease is detected in a sample of size m  is given 
by 
 
                          =  (E[ ],  ) =  1 − (1 − E[ ])                                     (2) 
 
This formula, based on simple binomial arguments, and variants that also assume constant 
prevalence, are the standard basis for sample size calculations (see e.g. Fosgate 2009). 
However, we now demonstrate that PDBin is a misleading estimate of the probability of 
detection if prevalence fluctuates.  
In real systems prevalence varies with time and therefore when conducting surveillance the 
prevalence values at the times each of the m  samples are collected will vary. Nonetheless, 
for simplicity here we assume that the prevalence during a given surveillance bout (i.e. the 
collection of m  consecutive samples) is constant and denoted p. The results shown in Figure 
2.3.a, which compare the probability of detection measured directly in model simulations 
with approximations based on averaging over prevalence fluctuations both within and 
between and only between surveillance bouts, demonstrate that this is an accurate 
approximation.  Then the expected probability of detection for sample size m  is defined as     
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                           = E[ ( ,  )]=  E[1 − (1 −  )  ]                                              (3) 
 
where the expectation is over the between bout prevalence distribution P(p).  For a single 
sample   m = 1, equation (3) reduces to a linear form so that PD = PDBin = E[p]. However, 
if m  > 1 , then equation (3) is non‐linear and therefore PD ≠  PDBin. To illustrate this, we 
Taylor expand PD  by assuming that the difference between the bout prevalence p and the 
long term average prevalence is small i.e. p = E[p ] + Δp. Then noting that E[Δp] = 0 and 
var[p ] = E[Δp2 ] yields 
 
   ≅        +
 
 
   [ ] 
   ( ,  )
   
 
    [ ]
+   .  .  
 
This suggests (to leading order) that the true probability of detection will be lower than 
PDBin, since the second derivative ∂2f(p,m )/∂p2 = -m (m - 1)(1 - p)m  –2 is negative for 
sample size m > 1  and p = E[p]. In addition, the size of this deviation depends on the 
sample size and the variance in prevalence.  Although the conclusions drawn are broadly 
correct, when compared with simulation results, the above Taylor expansion does not 
provide an accurate approximation to the probability of detection. However, analytic 
progress can be made with the following alternative approach. The approximation               
(1 - p)m  ≈ e-pm   holds for m  large (and is already accurate even for m  = 10) and enables us 
to write the probability of detection as  
 
   = 1 − E [(1 −  )
  ]≅ 1 − E[      ]= 1 −    (  )                                    (4) 
 
where M p(m ) ≡  E[e -pm ] is the moment generating function associated with the between 
bout prevalence distribution P(p). This suggests that if we could parameterise a suitable 
distribution to approximate P(p) then we could use the corresponding moment generating 
function to calculate the probability of detection.  
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2.4.2.1 Effect of host demography and transmission dynamics 
 
The results shown in Figure 2.3 demonstrate the effect of host demography, transmission 
dynamics and surveillance design on the probability of detection. These results are obtained 
from the simulations described in Figure 2.1, except for those in Figure 2.3.d where these 
simulations are rerun for different values of the capture rate.  
Figure 2.3.a suggests that a moment‐generating function approximation (equation 4) based 
on the actual distribution of prevalence between surveillance bouts would be a very 
accurate approximation. Figure 2.3.b illustrates this approximation using an assumed 
gamma distribution parameterised with the mean and variance of P(p). Although the 
gamma approximation is not completely successful it does provide a more accurate 
prediction of PD  than PDBin and could improve sample size calculations in situations where 
simulation was not possible, but information about prevalence fluctuations was available. 
Moreover, the results of Figure 2.3.a show that such approximations could be improved by 
assuming a more accurate representation of the prevalence distribution P(p). Crucially 
these calculations support the conclusion that the true probability of detection is less than 
obtained when ignoring fluctuations i.e. less than PDBin.  Figure 2.3.b also shows the impact 
of biased prevalence estimation on disease detection for the case β = 0.1. Figure 2.1 
demonstrated that in this case surveillance results in inflated estimates of prevalence 
E[p̂surv] > E[p(t)]. Ignoring the effect of fluctuations would therefore lead to an estimated 
detection probability even greater than PDBin which is based on the true average prevalence 
E[p]. 
Figure 2.3.c shows the effect of interactions between disease dynamics and demography. As 
in the case of prevalence estimation, conditioned on a given expected prevalence, larger 
contact rates β are associated with greater fluctuations in the underlying wildlife disease 
system (i.e. greater transmission rates are needed to sustain a given prevalence). Here 
larger fluctuations translate into reduced probability of detection. In Figure 2.3.c for β = 1.0 
the probability of detection is only a little above the line PD = E[p] which corresponds to a 
single sample m  = 1.  Thus, in comparison with the zero fluctuation approximation PDBin, 
fluctuations reduce the effective sample size, for the β = 1.0 case from m = 10 to close to 
m = 1.  Results not shown indicate that reduction in effective sample size increases with 
sample size (and see Figure 2.4). Figure 2.3.d shows the effect of capture rate on the 
probability of detection with more intense surveillance effort actually reducing the 
probability of detection. This is consistent with the above observations regarding β, since 
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less intense effort means that the required sample size takes longer to gather which 
reduces between bout fluctuations in prevalence.  
 
 
 
  
 
 
 
 
 
 
 
Figure 2.3: Effect of host-pathogen and surveillance dynamics on probability of detection.  
Results based on simulations used for Figure 2.1 (for details see Table S.1.6 in section 1.2 in 
Appendix 1). Plot 2.3.d estimated PD  versus approximations based on modifcations of 
equation (3) accounting for fluctuations in prevalance (i) within and between bouts and (ii) 
between bouts only. Plot 2.3.c shows PDBin based on both E[p] (green) and E[p̂surv] (black) 
and (for β = 0.1) PD  and the approximation (equation 4) based on an assumed gamma 
distribution. Plot 2.3.a shows PDBin (green) and PD  for various values of β  (as shown 
yellow (β = 0.01); orange (β = 0.04); red (β = 0.1); purple (β = 1.0)) versus actual 
prevalence E[p]. (b) shows PDBin (green) and PD  for β = 0.1 and the three capture rates α 
= 0.01, 1.0, 10.  In plots 2.3.a, 2.3.b and 2.3.c the black line indicates PD = E[p(t )]. 
 
2.4.2.2 Limits to disease detection in wildlife disease systems 
 
Given that the nature of host demography and disease dynamics in wildlife disease systems 
will often be poorly understood, we carried out simulations similar to those explored above 
for a wide range of different host‐pathogen combinations.  These simulations focus on 
assessing the impacts of fluctuations on the ability of surveillance systems to detect disease 
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across a wide spectrum of wildlife disease systems.  Since we focus on probability of 
detection the results are conditioned on the presence of disease and simulations are run 
using the Gillespie implementation of our model which explicitly handles the discrete 
nature of small populations. The details of these simulations, including the range of 
parameter combinations used, are described in detail in Table S.1.5 (see section 1.2 in 
Appendix 1).   
Figure 2.4 shows how the probability of detection from surveillance, compares to the zero 
fluctuation approximation PDBin, at two different sampling levels, across this broad range of 
wildlife disease systems. Depending on the level of fluctuations in the system, the effective 
sample size can range from the actual number of samples taken all the way down to m ≈  1. 
These results suggest that ignoring the effect of fluctuations when designing surveillance 
could lead to studies that are underpowered in terms of disease detection. These results 
are consistent with those of Figure 2.3 based on the SDE implementation. 
 
 
 
 
 
 
 
 
Figure 2.4: Fluctuations reduce power to detect disease. The two panels show the 
probability that disease is detected (conditional on non‐zero prevalence) for target sample 
sizes 10 and 20. Each coloured dot represents the average of 100‐1000 realisations of the 
model implemented using the Gillespie algorithm that met the sample target for a 
particular combination of parameters representing a distinct host‐pathogen system (for 
details see Table S.1.7 in section 1.2 in Appendix 1). The green dashed line in both graphs 
represents PDBin the probability of detection assuming constant prevalence (see equation 
2). It can be seen that PDBin generally over‐estimates the power of the sample in that it 
predicts a larger probability of detection than is realised in the stochastic simulations. 
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2.5 Discussion 
 
We believe this paper represents the first systematic exploration of the impact of pathogen 
transmission dynamics and demographic aspects of host ecology on wildlife disease 
surveillance efficacy. We have developed a generic framework in which surveillance in 
wildlife disease systems is characterised in terms of key demographic and epidemiological 
parameters alongside those representing the process of surveillance. Results were obtained 
using a combination of mathematical analysis and simulation, with different 
parameterisations used to represent a broad range of wildlife disease systems. We 
conclude that demographic and disease fluctuations reduce the power of surveillance to 
detect disease, and both bias and reduce the precision of estimates of prevalence obtained. 
Current approaches to the design and analysis of surveillance in wildlife disease systems are 
largely based on methods developed for livestock (Grimes & Schulz 1996; Dohoo et al. 
2005; Fosgate 2005) and typically ignore temporal fluctuations in prevalence and host 
population size. These assumptions lead to conclusions that, in the absence of extrinsic 
sources of bias, e.g. variation in habitat quality (Nusser et al. 2008; Walsh & Miller 2010) or 
biased capture (Tuyttens et al. 1999), surveillance produces unbiased estimates of 
prevalence, and associated statistical power is determined completely by sample size and 
the underlying prevalence of disease. Our results demonstrate that such conclusions are 
not, in general, justified in wildlife disease systems where fluctuations bias prevalence 
estimates and reduce their precision compared with what would be expected in the 
absence of fluctuations. Similarly we find that the probability of disease detection increases 
with prevalence and sample size but at rates that progressively reduce as demographic and 
disease fluctuations increase. This suggests that wildlife disease surveillance programmes 
based on current theory are underpowered and produce biased results.   
Here we have introduced a framework within which surveillance design is characterised by 
both sample size m , and the capture rate α instead of simply sample size. Moreover, in this 
extended framework the performance of surveillance is assessed in light of the ecology of 
the wildlife disease system of interest (i.e. for particular population and disease 
parameters). A key insight is that sample capture (e.g. time taken to reach the sample 
target) is dependent on both the surveillance design and the ecology of the host (Nusser et 
al. 2008), represented here in terms of demography. Our results show that surveillance 
design (choice of m  and α) can have a large impact on bias and precision of prevalence 
estimation and on the power to detect disease. Bias in prevalence estimates increases and 
55 
 
the precision of such estimates reduces with more unstable populations and greater 
fluctuations in disease. Such bias can be reduced by increasing capture rate, but for fixed 
sample size this also reduces the ability to detect disease. However, simulation results 
suggest that for all but the most intensive wildlife disease surveillance programs (Delahay et 
al. 2000) typical capture rates are not sufficient to eliminate bias. In contrast increasing 
sample size does not affect bias, but does improve statistical power in terms of both 
precision of prevalence estimates and disease detection. However, as sample size increases 
such improvements in power are not as fast as would be expected if fluctuations were 
ignored, as they are in current surveillance design and analysis. 
The framework introduced here could be extended to account for details of particular 
wildlife disease surveillance programmes including the sensitivity and specificity of 
diagnostic tests, application to specific host populations and pathogens, multiple diagnostic 
test results (that are increasingly available), aspects of syndromic surveillance (Dórea et al. 
2011) and more complex deployment strategies than those considered here. 
Characterisation of the outcome of surveillance e.g. in terms of bias, precision and 
probabilities of disease detection would aid the identification of efficient designs and 
interpretation of any results obtained. However, the development of more formal statistical 
analyses that account for demographic fluctuations and stochastic disease dynamics 
remains the subject of future research.  
Surveillance is a critical prerequisite for defining and controlling wildlife disease risks and 
our results suggest that current approaches to the design and analysis of wildlife disease 
surveillance ignore fundamental aspects of ecology leading to inadequate assessment of 
risk. Moreover, these problems (unknowingly under powered studies and biased results) 
are likely to be very widespread given that the ecology of many wildlife species and the 
pathogens to which they are exposed, lead to significant temporal fluctuations in both 
population size and prevalence (Anderson & May 1979; Anderson 1991; Renshaw 1991; 
Wilson & Hassell 1997).   
There is much current interest in quantifying risks from wildlife disease (Daszak et al. 2000; 
Jones et al. 2008) and this is stimulating debate on the need to improve wildlife disease 
surveillance (Bengis et al. 2004; Butler 2006; Gortázar et al. 2007; Béneult et al. 2014). This 
paper contributes to this debate, highlighting the need to consider the ecology of wildlife 
disease systems when designing or analysing surveillance programs (Béneult et al. 2014), 
emphasizing the importance of temporal heterogeneities induced by demographic 
stochasticity and disease dynamics. Further research is needed to assess the impacts of 
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alternative and complimentary heterogeneities including intrinsic and extrinsic forms of 
spatial heterogeneity and other population structures. There is a rich literature describing 
the effects of such heterogeneity in ecology and epidemiology (Huffaker 1958; Lloyd & May 
1996; Tilman & Kareiva 1997; Keeling et al. 2000; Read & Keeling 2003; Keeling 2005; 
Vicente et al. 2007) and our results suggest that these are likely to important, but as yet 
unexplored, impacts on the efficacy of wildlife disease surveillance. 
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Chapter 3 
 
 
 
 
An Approach to Assessing Wildlife 
Disease Surveillance in Real Systems: 
tools and applications 
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3.1 Abstract 
 
We show how the theoretical framework presented in Chapter 2 can be further developed 
and applied as a tool to assess the outcomes of wildlife disease surveillance in real systems. 
In so doing, the effects on surveillance of fluctuations demonstrated in Chapter 2 are 
quantified for two real host populations. Our results show, using examples of badger and 
rabbit populations, that the impact of demographic fluctuations and stochasticity of disease 
dynamics on surveillance efficacy is a justifiable concern for current control strategies of key 
wildlife populations and diseases. Using these tools we also offer novel analyses of 
recognised sources of bias in natural populations i.e. disease induced mortality, diagnostic 
test sensitivity and trappability. These are shown to either further contribute to, or mask 
the bias occurring from natural stochastic fluctuations within the population. Understanding 
these subtle effects and the impact they have on surveillance efficacy is key in the pursuit of 
better control strategies, which ultimately offer protection for wildlife, livestock and 
humans against the threat of disease. 
 
3.2 Introduction 
 
Chapter 2 identified that combined fluctuations in population and disease dynamics bias 
surveillance estimates of prevalence with respect to the true mean. It was also shown that 
the variability in the prevalence estimate is much larger (i.e. the precision of the estimate is 
much lower) than current methods (i.e. binomial theory) estimate and both effects increase 
with the size of fluctuations in the host‐pathogen system. Furthermore variation in 
prevalence depresses the probability of detection compared to current theoretical 
estimates, based on binomial arguments, which ignore such effects. Overall, these results 
demonstrate the importance of assessing the host‐pathogen system more carefully before 
designing surveillance strategies. 
This Chapter aims to show how by building on the generic theoretical framework described 
in Chapter 2 we can employ stochastic models describing the dynamics of wildlife disease 
systems as tools which enable assessment of surveillance in real disease systems of current 
interest.  We extend the stochastic model from Chapter 2 to model two endemic disease 
systems, and quantify surveillance in each in terms of the extent to which standard 
theoretical tools which ignore fluctuations are able to predict the performance of 
surveillance. Here we model badger and rabbit populations, simulating population dynamics 
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in conjunction with the spread of Bovine Tuberculosis (Mycobacterium bovis) (TB) and 
Paratuberculosis (Mycobacterium avium subsp. paratuberculosis) (paraTB) respectively. 
Both diseases are endemic in many countries, including the UK, and are associated with 
economic loss to livestock production systems and health risk to humans.  
In addition rabbits and badgers can be thought of as representative of, respectively, r and K 
species under MacArthur and Wilson’s (MacArthur & Wilson 1967) general theory.  An r 
species has large population fluctuations seen as booms and busts of growth, resulting from 
high birth and death rates and typically lives in an unstable environment. A K species has 
population growth limited by resources and competition, lives in a stable environment, and 
has a relatively low birth and death rate; and hence lower population fluctuations. Thus, as 
host population fluctuations were shown in Chapter 2 to impact on surveillance, the results 
we obtain for rabbits and badgers will be relevant to other r and K species.  
Badgers were first identified as a host for M. bovis in 1974 (Byrne et al. 2012b) and have 
since been included in TB control strategies in the UK. During the comprehensive 
Randomised Badger culling Trial (RBCT), which aimed to test the hypothesis that badger 
population reduction would reduce the TB prevalence in sympatric cattle, badgers were 
shown as a source of infection to cattle (DEFRA 2013). Under the RBCT proactive culling of 
badgers (population reduction irrespective of cattle TB status) was associated with an 
average of 16% reduction in TB incidence in cattle. However, reactive culling of badgers 
(population reduction in response to TB in cattle) was associated with an increase in TB in 
badgers (Carter et al. 2007) and cattle (Donnelly et al. 2003, 2006).  
Rabbits were identified as a host of M. avium subsp. paratuberculosis in 1997 (Greig et al. 
1997; Beard et al. 2001). Modelling studies suggest that the direct and indirect routes and 
rates of rabbit to rabbit transmission identified and quantified in the field (Judge et al. 
2006) are sufficient for the disease to persist in rabbit populations (Judge et al. 2007). 
Rabbits excrete millions of bacteria in their faeces (Daniels et al. 2001) which are not 
avoided and are therefore ingested by grazing livestock (Judge et al. 2005).  More recently 
paratuberculosis in rabbits has been associated with a failure of disease control operations 
in cattle (Shaughnessy et al. 2013), and may be associated with Crohn’s disease in humans 
(Naser et al. 2014). 
Wildlife disease surveillance is also subject to a number of well known inaccuracies and 
biases, including diagnostic limitations e.g. sensitivity, and biases in animal sampling e.g. 
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trapping biases. Diagnostic limitations are a result of the test sensitivity and specificity 
which determine how accurate test results are. The sensitivity and specificity of the test can 
bias results by reporting false information, giving the impression of more/less disease than 
is actually present in the population. Research funding in wildlife disease surveillance is 
limited and in any case developing more accurate tests may not always be feasible due to 
technical and scientific challenges. Sampling biases can also occur through the interaction of 
survey implementation and the behaviours of the sampled population. For example, 
animals burdened with disease can become more or less likely to be trapped (trap shy / trap 
happy) which can lead to unrepresentative results. 
Accurate surveillance and monitoring of infection in these disease systems is essential for 
the quantification of the biological processes underpinning disease persistence and spread, 
accurate assessment of risk, and for the efficiency of disease control operations. In the 
current chapter we seek to understand the potential impacts of the above effects on two 
contrasting host systems. Therefore whilst in the previous chapter we explored a range of 
demographic parameters here we consider a range of possible pathogens, characterised in 
terms of both transmission rate β and disease induced mortality rate μI, infecting 
populations of badgers and rabbits. Within this context TB in badgers and paratuberculosis 
in rabbits correspond to particular combinations of transmission rate β and disease induced 
mortality rate μI. As in Chapter 2, we consider one form of surveillance; active capture and 
release (the capture and testing of individuals which are then released back into the 
population). Simulations are run to assess to what extent the results found in Chapter 2 are 
relevant to specific wildlife populations and diseases. We also investigate how the 
performance (e.g. sensitivity) of the diagnostic test and wildlife sampling biases (e.g. 
trappability) influence the efficacy of the surveillance strategy in terms of the probability of 
detection and the bias and variance (SD) in estimating the prevalence. 
 
 
 
 
 
 
61 
 
3.3 Methods 
 
3.3.1 Stochastic Model Description 
 
The model represents a host population subject to demographic fluctuations (births, deaths 
and immigration) and the transmission of a single pathogen species/strain. At each point in 
time t, the state‐space represents the total population size N(t), with I(t) of these infected 
and S(t) = N(t) - I(t) susceptible. In addition the prevalence is then given by p(t) = 
I(t)/N(t). The birth rate of individuals is logistic, rN(1 – N/k), with intrinsic growth rate r  
and a  carrying capacity k  reflecting the assumptions that population growth is resource 
limited. Individuals have a per capita death rate μ and if there is disease induced mortality 
in the system, infected individuals have an additional disease induced death rate μI i.e. 
infected individuals have a total death rate of μ+ μI. Immigration occurs at a constant rate ν 
with a proportion γ of immigrants are infected. As immigration is set as a constant rate, this 
can push the population size above the carrying capacity K, at which point the birth rate is 
set to 0. 
Disease surveillance is incorporated into the model in the form of active capture, testing 
and release at per capita rate α for both susceptible and infected individuals. The time for 
which individuals are removed from the population is assumed negligible. Surveillance 
testing is undertaken assuming perfect tests, unless otherwise specified by the 
sensitivity/specificity level.  A summary of this conceptual model is given in Chapter 2 in 
Table 2.1 which shows all demographic, epidemiological and surveillance events with their 
corresponding rate and effect on the state‐space. However, in this chapter, note that death 
of invectives occurs at rate μ+ μI. For a more detailed description of the model and how the 
surveillance is modelled, see Chapter 2. 
3.3.2 Model Implementation 
 
The model is implemented firstly as a continuous time continuous state space Markov 
process, which is simulated using Stochastic Differential Equations (SDE) as described in 
Appendix 1. Secondly the model is implemented as a continuous‐time discrete‐state space 
Markov process, which is simulated using Gillespie’s exact algorithm (Gillespie 1976). 
Descriptions of the implementation can be seen in Chapter 2. As noted above all events 
with their corresponding rate and effect on population size for the Gillespie implementation 
can be found in Table 2.1 in Chapter 2. 
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3.3.3 Model Parameterisation 
 
Parameters used to simulate the badger and rabbit social groups were estimated using 
information gathered from the literature including Shirley et al. (2003) and Judge et al. 
(2007) respectively. Appendix 2.1 provides details but an outline of the procedure followed 
is described here. A key issue in establishing parameter values used here is the differences 
between the structure of our models and those used in the cited literature. As outlined 
above here we adopt a continuous time framework whereas Shirley et al. (2003) used a 
discrete time model. This difference necessitates a translation between transition 
probabilities associated with the characteristic time step used in the discrete time model 
and the event rates used here. Judge et al (2007) uses continuous time also, however the 
rates are calculated for time measured in months and therefore needed some adjustment. 
Furthermore both (Shirley et al. 2003) and (Judge et al. 2007) model several age classes and 
both males and females. In contrast here we neglect such population structure and 
therefore must consolidate transition probabilities across many different age by sex classes 
in order to calculate a single rate per event considered i.e. birth and death rates, disease 
induced mortality and disease transmission rates. Details of these calculations are provided 
in Appendix 2.1. 
In addition to the above figures for badgers we also chose to model the average badger 
group size to be around 18 individuals based on the average group size observed at the 
Woodchester Park study site (Zijerveld 2012). Since in most parts of the UK badger group 
sizes are typically below 10 (Neal & Cheeseman 1996; Delahay et al. 2000) we set the 
carrying capacity (the maximum population above which the group size can’t go) to be 
k=20. However, we note that our results and conclusions regarding the impact of 
fluctuations on surveillance in badgers are robust to alternative choices for the carrying 
capacity, k>20. We consider the mortality rates derived from (Shirley et al. 2003) to be 
accurate and therefore since births must match deaths at an equilibrium of approximately 
18 this determines the growth rate parameter r. Considering figures for the number of 
offspring per breeding female per year given by Shirley et al. (2003) we find our estimates 
of the birth rate are consistent with observational studies (Woodroffe and MacDonald, 
1995) which suggest approximately two breeding females. In the case of rabbits the birth 
rate was similarly determined from the derived mortality rate, the carrying capacity and the 
desired equilibrium population size. The parameterisations representing badgers and 
rabbits are shown in Tables S.2.1 and S.2.2 in Appendix 2.2.  
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3.3.4 Simulations 
 
In contrast to the previous chapter here we explore a range of different diseases while 
keeping the demographic parameters fixed to represent both badger and rabbit 
populations. Within the model disease is characterised by disease induced mortality and 
transmission rate. Simulations were run using the SDE implementation of our model, firstly 
varying the disease induced (excess) death rate, but keeping other parameters fixed, 
leading to a range of prevalence. These simulations are repeated for several different 
transmission rates (some of which correspond to bTB transmission in badgers and 
paratuberculosis in rabbits) to demonstrate the effects of population fluctuations and 
disease dynamics on surveillance estimates of prevalence and probability of detection in 
badger and rabbit populations. Simulations were also run for a range of transmission rates 
(generating a range of prevalence) with other parameters fixed but repeated for several 
different disease induced mortality rates. Capture rates and sample size were also varied to 
explore surveillance design and differences between binomial sample size theory covered in 
Chapter 2 and simulation results in badger and rabbit populations.  
Using the Gillespie implementation of the model, simulations were run firstly to show how 
trappability of infected individuals affects the probability of detection and prevalence 
estimates seen previously. Secondly, Gillespie algorithm simulations were run to show the 
effects of test sensitivity and transmission rate on the probability of detection and 
estimates of prevalence obtained by surveillance.  
Figure 3.1 shows example trace plots from both the SDE and Gillespie implementations for 
rabbit and paraTB and badgers and TB. In the rabbit‐paraTB system two transmission rates 
corresponding to the estimated range of transmission rates found by Judge et al 2006, are 
labelled low and high as they correspond to both ends of the likely prevalence range. In the 
case of badgers and TB we used one transmission rate which we consider representative of 
the literature (see above).  Figure 3.1 demonstrates what can be seen in a single simulation 
of badger and rabbit populations with TB and paraTB respectively. The badger population is 
noticeably smaller and more stable whereas the rabbit population shows greater 
population fluctuations. There are close similarities between the Gillespie trace plots and 
the SDE trace plots which demonstrate their comparative similarities.  
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Figure 3.1: Trace plots from SDE and Gillespie implementation runs of the model. Data are 
shown for total population N (green) and infected population I (red) for three different real 
disease systems; Badgers and TB, Rabbits and low paraTB and Rabbits and high paraTB 
(corresponding to the range of paraTB transmission rates estimated in the literature used). 
The left hand plots 3.1.a, 3.1.c and 3.1.e show results based on the Gillespie 
implementation of the model, whereas the right hand plots 3.1.b, 3.1.d and 3.1.f show 
results from the SDE implementation of the model.  The badger and TB results are shown in 
plots 3.1.a and 3.1.b. The rabbit‐paraTB results are shown in plots 3.1.c and 3.1.d (low 
prevalence case) and 3.1.e and 3.1.f (high prevalence case). The plots shown were run using 
the set of parameter values described in Tables S.2.1 and S.2.2 in Appendix 2.2. 
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3.3.5 Statistics generated from the model 
 
As previously discussed in Chapter 2, we assume long term averages are equivalent to 
ensemble expectations (approximated by averages over many realisations of the process). 
Each simulation is run for a period of time to allow the population to reach equilibrium 
before such statistics are calculated. For example, the expected mean E[N] and variance 
Var[N] of the population size are recorded along with the expected mean E[p] and variance 
Var[p] of disease prevalence. Similarly other statistics such as the covariance between the 
prevalence and population size are calculated as required. For a more detailed description 
of the calculation process see methods section of Chapter 2. 
 
3.4 Results 
 
In Chapter two we showed, for the case where there is no sample target and the period for 
which sampling is conducted is extended indefinitely, that the surveillance estimate of 
prevalence will always be biased unless the covariance of population size N and prevalence 
p is equal to 0 with the equation: 
 
E[  ̂   ]=  E[ ( )]+  
   [  ( ), ( )]
E[  ( )]
 
 
This result proved to be a reliable indicator of surveillance estimates of prevalence based on 
finite samples for the case where surveillance effort (capture rate) is low. Moreover 
simulations demonstrated that qualitatively these effects occur for a wide range of 
parameterisations. Building on these earlier results, simulations have been run to explore 
the same fundamental effects in models of demography and disease dynamics 
parameterised to represent badger and rabbit populations. In Chapter 2 simulations for a 
range of death rates were used to generate the full range of prevalence levels. However, 
varying the total death rate may have such an impact on the disease free demography of 
the population that respective model outputs are no longer representative of badgers and 
rabbits. We therefore consider varying the disease induced death rate so as not to majorly 
impact on the stability of the population itself but rather on the stability of the disease. 
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3.4.1 Estimating disease prevalence in badger and rabbit populations 
 
3.4.1.1 Effect of disease system 
 
Figure 3.2 explores the impact of different diseases in populations of badgers by varying 
disease induced mortality for several different values of β. These results illustrate the 
extent to which population fluctuations and stochasticity in disease dynamics in badger 
host‐pathogen systems affect the bias and variance of the surveillance estimate of 
prevalence.   
Figure 3.2.a shows the total population size N for a full range of disease prevalence, at three 
different levels of β.  In Figure 3.2.a zero prevalence corresponds to high levels of disease 
induced mortality that rapidly remove diseased individuals from the population. Moving 
from left to right prevalence increases and due to disease induced mortality this reduces 
the population size. However because the increase in prevalence is driven by reducing 
levels of disease induced mortality this effect of disease on the population size diminishes 
as prevalence increases. Moving further to the right the reduction in disease induced 
mortality starts to compensates for the corresponding increase in prevalence and the 
population size is less affected by disease losses. Ultimately for a prevalence of 1 disease 
induced mortality is negligible and the population size is the same as the case with no 
disease.  
At any given level of prevalence, as the contact rate β increases the underlying dynamics of 
the system are more unstable; they require greater levels of contact to maintain the disease 
at the given prevalence. A given level of prevalence results from a balance between 
transmission and disease induced mortality so as the contact rate β  increases so does the 
disease induced mortality required to generate the given prevalence. This increase in μI, 
when β increases at a given prevalence, explains why population size reduces with 
increased contact rate. The variation in population size shown in Figure 3.2.b also reflects 
the pattern described above, where for both the disease‐free state and the state of 
complete infection the variance in population size is at a minimum where it is determined 
purely by demographic, as opposed to epidemic, processes. However for other prevalence 
levels the variance is inflated by additional fluctuations produced by stochasticity in the 
disease dynamics.   
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Figure 3.2.c shows the bias in the surveillance estimate of prevalence E[p̂surv] - E[p(t )] for a 
sample size of 10 (i.e. sampling occurs at rate α until m  = 10 individuals have been caught 
and tested) as obtained from simulating 106 surveillance bouts using the SDE 
implementation of the model described above.  Figure 3.2.d shows the standard deviation 
in surveillance estimates of prevalence obtained from the same simulation results. 
Comparison with the variability expected under the zero fluctuation assumption reveals 
that fluctuations in our simulated badger population considerably reduce the precision of 
prevalence estimates obtained by surveillance. As we saw in Chapter 2 (and above) these 
effects increase with the contact rate, since at a given expected prevalence larger values of 
β are associated with more unstable dynamics. The β value of 0.057 (shown in yellow) 
represents TB in badgers. Although relatively little bias is observed, the SD in the prevalence 
estimate is seen to be just under double that of the constant prevalence prediction at the 
point where the prevalence is around 0.48 (for the yellow curve). This prevalence was 
selected as representative of badgers (for details see Appendix 2.2). 
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Figure 3.2: Effect of infected population stability and disease transmission on surveillance 
in Badgers. Data are shown for three different values of the transmission rate each for a 
range of values of the infected death rate μI which controls the stability and size of the 
infected population and thus determines disease prevalence for a given transmission rate 
(see text). Each quantity considered is plotted against the resulting expected value of true 
disease prevalence in the system, E[p(t)].   Plot 3.2.a shows that expected population size 
for three contact rates β (1.0 – full line, 0.5 – dash line, 0.057 – smaller dash line) with 
increased prevalence (i.e. as µI decreases). Plot 3.2.b shows the coefficient of variation of 
the population size for same values of β. Plot 3.2.c shows the bias E[p̂surv] - E[p(t )], and 
plot 3.2.d the standard deviation in surveillance estimates for three different β (1.0‐
purple,0.5‐red,0.057‐yellow)  (based on a fixed sample size m  = 10) of . The green lines 
show the bias (3.2.c) and standard deviation (3.2.d) obtained by assuming constant 
prevalence. Results shown are based on 106 surveillance bouts using the SDE 
implementation of the model (see Chapter 2) run using the set of parameter values 
described in Table S.2.3 in Appendix 2.2. 
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Figure 3.3 quantifies the same range of effects on prevalence estimates and population size 
and variance in our simulated rabbit population. Plot 3.3.a shows the total population N  at 
three different levels of β. Figure 3.3.b shows the coefficient of variation for the same 
values of β . Plot 3.3.c shows the bias in the surveillance estimate of prevalence          
E[p̂surv] - E[p(t )] for a sample size of 10 (i.e. sampling is occurs at rate α until m  = 10 
individuals have been caught and tested) as obtained from simulating 106 surveillance 
bouts using the SDE implementation of the model described above. Figure 3.3.d shows the 
standard deviation in surveillance estimates of prevalence obtained from the same 
simulation results. Similar effects to those found above from badgers are seen in the case of 
rabbits and over the whole prevalence spectrum. Moreover these results suggest that the 
effects described in a more theoretical context in Chapter 2 are of importance in these real 
wildlife‐disease systems. Both the β values of 0.225 (yellow) and 0.552 (red) represent 
paraTB in rabbits. For cases of no disease induced mortality (e.g. paraTB), corresponding to 
large prevalences, we can see that in this instance, the constant prevalence estimate is very 
accurate. The effects seen in badgers and previously in Chapter 2 are more likely when the 
population becomes unstable (i.e. by introducing disease induced mortality). We see in 
both badger and rabbit examples, the effects diminish in the limit when there is no disease 
induced mortality (see Figure 3.2 and 3.3). 
 
 
 
 
 
 
 
 
 
 
 
70 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: Effect of infected population stability and disease transmission on surveillance 
in Rabbits. Results shown are based on 106 surveillance bouts using the SDE 
implementation of the model (see Chapter 2) run using the set of parameter values 
described in Table S.2.4 in Appendix 2.2 except for constant prevalence theory estimates 
shown in green. Data from model simulations are shown for three different values of the 
transmission rate β (1.0‐purple/full line,0.552‐red/dash line,0.225‐yellow/smaller dash line) 
each for a range of values of the infected death rate μI which controls the stability and size 
of the infected population and thus determines disease prevalence for a given transmission 
rate. All results are plotted against the resulting expected value of true disease prevalence 
in the system, E[p(t)].  Plot 3.3.a shows the expected size and Plot 3.3.b the coefficient of 
variation of the population. Plot 3.3.c shows the bias E[p̂surv] - E[p(t )], and Plot 3.3.d the 
standard deviation in surveillance estimates (based on a fixed sample size m = 10).   
 
We can explore a different, but overlapping range of diseases by varying the transmission 
rate, β. We demonstrate similar effects in the bias and variance of the prevalence estimate 
in Figure 3.4 for both badgers (3.4.a and 3.4.b) and rabbits (3.4.c and 3.4.d) by varying the 
pathogen transmission rate, for three fixed disease induced mortality levels. The effects on 
the performance of surveillance, seen when varying β are similar to those seen when 
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varying the disease induced mortality rate. ParaTB can be found on plot 3.4.c and plot 3.4.d 
when disease induced mortality is 0 (yellow line) for prevalence between ~ 0.4 and ~ 0.8. 
Badgers and TB are located between the red and yellow lines for a prevalence of around 
0.48. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Effect of disease transmission and infected population death rate on 
surveillance. Plot 3.4.a shows the bias E[p̂surv] - E[p(t )], and plot 3.4.b the standard 
deviation in surveillance estimates (based on a fixed sample size m  = 10) of prevalence 
versus the expected value of true disease prevalence in the system, E[p(t)] for badger 
populations. Data are shown for three different values of disease induced mortality rate μI 
(1.0‐purple, 0.5‐red, 0‐yellow) each for a range of values of the infected death rate β. Plot 
3.4.c shows the bias E[p̂surv] - E[p(t )], and plot 3.4.d the standard deviation in surveillance 
estimates (based on a fixed sample size m  = 10) of prevalence versus the expected value of 
true disease prevalence in the system, E[p(t)] for rabbit populations. Data are shown for 
three different values of disease induced mortality rate μI (3.0‐navy, 2.0‐pink, 0.0‐yellow) 
each for a range of values of the infected death rate β. Constant prevalence theory 
estimates are also shown (green).  Results shown are based on 106 surveillance bouts using 
the SDE implementation of the model (see Chapter 2) run using the set of parameter values 
described in Table S.2.5 and S.2.6 in Appendix 2.2. 
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Effect of surveillance design 
In Chapter 2, it was shown that the surveillance strategy (sample size and capture rate) 
impact on the surveillance efficacy.  As in Chapter 2 sample size was found not to have a big 
impact on the levels of bias in the examples that were explored here. The standard 
deviation of the prevalence estimates decreases by about 5% very rapidly and then 
continues to decrease very slowly as the sample size increases and this decrease is still 
much slower than predicted when fluctuations are ignored. Figure 3.5 shows the more 
interesting effect of capture rate on a badger population where the bias and variance of the 
estimate of prevalence changes as the intensity of surveillance (capture rate α) increases for 
fixed sample size (plot 3.5.a and 3.5.b) .  
 
 
 
 
 
 
 
 
 
Figure 3.5: Effect of surveillance design. In all plots results are shown for surveillance in 
Badgers (β = 1 & μi = 1.75). Plot 3.5.a shows expected values of the surveillance estimate 
of prevalence (purple), the true prevalence (blue) and the continuous sampling theory 
prediction (black) for a range of values of the capture rate for a fixed sample size m  = 10. 
Plot 3.5.b shows the corresponding value of the expected standard deviation (σp) in the 
surveillance estimate of prevalence (purple) and the true prevalence (blue) for a range of 
values of the capture rate for sample size m  = 10 for a range of values of the capture rate 
α. Results shown are based on 106 surveillance bouts using the SDE implementation of the 
model (see Chapter 2) run using the set of parameter values described in Table S.2.7 in 
Appendix 2.2. 
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Figure 3.6 shows the same effects are seen in a rabbit population. It can be seen below how 
the differences in the two populations (turnover and stability) impact on how the capture 
rate and sample size affect the mean and SD of the prevalence estimate. 
 
 
 
 
 
 
 
  
Figure 3.6: Effect of surveillance design. In all plots results are shown for surveillance in 
Rabbits (β = 1 & μ = 4.4). Plot 3.6.a shows the expected values of the surveillance estimate 
of prevalence (purple), the true prevalence (blue) and the continuous sampling theory 
prediction (black) for a range of values of the capture rate for a fixed sample size m  = 10. 
Plot 3.6.b shows the expected standard deviation (σp) in the surveillance estimate of 
prevalence (purple) and the true prevalence (blue) for a range of values of the capture rate 
for sample size m  = 10 for a range of values of the capture rate α. Results shown are based 
on 106 surveillance bouts using the SDE implementation of the model (see Chapter 2) run 
using the parameter values described in Table S.2.8 Appendix 2.2. 
Figures 3.5 and 3.6 show similar effects of the capture rate on the estimate of prevalence. 
Whereby as α increases, the estimated prevalence moves from the continuous sampling 
theory to the true underlying prevalence in the system. The results show that less intense 
effort is needed in the rabbit population to achieve more accurate results (in comparison to 
the badger population). Given that α is the per capita capture rate this difference is largely 
explained by the contrasting size of the two host populations, for which a lower capture 
rate in rabbits yields the required sample size approximately three times faster than in the 
badger population (which is approximately the ratio of population sizes for these hosts). 
 
 
0 2 4 6 8 10
0
.2
5
0
.3
0
0
.3
5
0
.4
0
0
.4
5
0
.5
0
Capture Rate
E
[p
]
(a)
0 2 4 6 8 10
0
.1
5
0
.2
0
0
.2
5
0
.3
0
0
.3
5
0
.4
0
0
.4
5
0
.5
0
Capture Rate
S
D pC.S.
p^su rv
p(t)
(b)
74 
 
3.4.2 Detecting disease  
 
In chapter 2 we elaborated on the binomial estimate of the probability of detection, PDBin, 
showing through simulation and analysis that it can over‐estimate the probability of 
detection depending on the characteristics of the host‐pathogen system (see Chapter 2 for 
details). Figure 3.7.a and 3.7.c shows the effect on detection probability of the interaction 
between two aspects of disease dynamics in badger and rabbit populations respectively, by 
varying disease induced mortality for three different levels of disease transmission. As in 
the case of prevalence estimation, conditioned on a given expected prevalence, larger 
transmission rates β are associated with greater fluctuations in the underlying wildlife 
disease system which results in reduced probability of detection. Figure 3.7.b and 3.7.d 
show the effect of capture rate on the probability of detection. 
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Figure 3.7: Effect of host-pathogen and surveillance dynamics on the probability of 
detection. Plot 3.7.a Probability of detection PD   versus actual prevalence E[p] for badgers. 
Plots are generated by varying disease induced death rate as in previous figures with 
samples size m = 10 and capture rate α = 0.1. Green – shows the zero fluctuation binomial 
estimate for all prevalances [0,1] whilst simulations results accounting for fluctuations 
are:purple (β = 1.0); red (β = 0.5); yellow (β = 0.057). Plot 3.7.b  shows the case β = 0.5 
but for three capture rates α = 0.1, 1.0, 2.0. Plot 3.7.c shows the probability of detection 
PD   versus actual prevalence E[p] for Rabbits. Plots are generated by varying disease 
induced death rate as in previous figures with samples size m = 10 and capture rate α = 
0.1. Green – shows the zero fluctuation binomial estimate for all prevalances [0,1] whilst 
simulations results accounting for fluctuations are:purple (β = 1.0); red (β = 0.552); yellow 
(β = 0.225). Plot 3.d  shows the case β = 0.552 but for three capture rates α = 0.1, 1.0, 2.0. 
All simulation results are based on 106 surveillance bouts using the SDE implementation of 
the model (see Chapter 2) run using the set of parameter values described in Table S.2.9, 
S.2.10, S.2.11 and S.2.12 in Appendix 2.2. 
 
Figure 3.7 shows both the prevalence and transmission rate β affect the probability of 
detection. Disease induced mortality is varied giving rise to the range of prevalence plotted 
on the x axis. As prevalence increases, so does the probability of detection but at different 
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rates depending on the transmission rate. We can see that at lower transmission rates 
surveillance appears to have a better chance of detecting an infected individual for a given 
expected prevalence level E[p].  Comparing two transmission rates at the same prevalence 
the higher transmission rate corresponds to the more unstable infected population, leading 
to a lower probability of detection. The situation for badgers and TB can be seen on the 
yellow line in Plot 3.7.a at a prevaleance E[p] of approximately 0.48 (corresponding to a 
disease induced mortality rate of approximately 0.165 i.e. the estimate for TB in badgers – 
see Appendix 2.2 for details). This shows that in the two systems studied disease and 
demographic fluctuations drive a significant reduction in the ability of surveillance to detect 
disease compared with the prediction from theory ignoring such fluctuations. We note from 
Figure 3.7 that capture rate barely impacts on the probability of detection, with only a very 
slight difference seen in the rabbit population which could be attributed to stochastic 
fluctuations in the simulations. 
 
3.4.3 Explicit sources of bias 
 
Above we showed that bias can arise from the interaction between disease dynamics, 
demographic fluctuations and surveillance even in the absence of any explicit bias in 
sampling (capture of individuals). However we now consider an explicit source of bias 
driven by animal behaviour in response to disease status, namely, trappability. For example, 
it has been debated in the literature as to whether disease affliction will lead badgers to be 
trap happy or trap shy, that is more or less likely to be captured depending on their disease 
status (Tuyttens et al. 1999; Byrne et al. 2012a). Figure 3.8 shows the impact that both of 
these scenarios, as well as a neutral baseline, would have on the probability of detection 
and the mean and standard deviation of the prevalence estimate. We ran simulations 
varying both the surveillance capture rate and the transmission rate. This spanned scenarios 
of low and high transmissibility of disease and low and high effort. In order to ensure that, 
in the trap neutral example, bias is kept to a minimum, disease induced mortality is fixed at 
a relatively low level.  From here on in the Gillespie implementation of the stochastic model 
has been used to produce the results shown. As we are exploring specific details of the 
dynamics of the badger population in terms of individual behaviours and surveillance 
testing scenarios, the Gillespie algorithm provides a more appropriate representation of 
stochasticity. 
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Figure 3.8: Effect of trappability and surveillance dynamics in Badgers. Plots are generated 
by varying   the transmission rate β with samples size m = 10 for three trappability levels of 
infected indivduals modelled as different capture rates: yellow (Trap Shy – half less likely to 
catch an infected badger compared with an uninfected individual); red (Trap Neutral); 
purple (Trap Happy – twice as likely to catch an infected badger compared with an 
uninfected); For the same levels of trappability shown in Plot 3.8.a, Plot 3.8.b shows the 
bias E[p̂surv] - E[p(t )], and plot 3.8.c the standard deviation in surveillance estimates 
(based on a fixed sample size m  = 10) of prevalence versus the expected value of true 
disease prevalence in the system, E[p(t)]. Constant prevalence theory estimates are also 
shown (green). Results shown are based on 1000 surveillance bouts using the Gillespie 
implementation of the model (see text) run using the set of parameter values described in 
Table S.2.13 in Appendix 2.2. 
We can see in the graphs above that trap shyness leads to a reduction in the probability of 
detection as well as a negative bias in estimating the prevalence. Intuitively this relationship 
makes sense, if individuals are less likely to be trapped because of infection burden then it 
will be harder to detect the disease and this will also lead to a reduction in the prevalence 
estimate compared to the true underlying prevalence (hence negative bias). Conversely, 
trap happiness leads to an increased probability of detection and a positive bias in the 
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prevalence estimate. The parameterisations used here have been chosen to reduce the 
effects of fluctuations on the process of surveillance in order to highlight the impact of 
trappability. However in cases, such as those described earlier, where fluctuations have a 
greater impact, the effects of trappability will interact with the effects of demographic 
fluctuations and stochasticity in disease dynamics to determine probabilities of disease 
detection, and the bias and precision of prevalence estimates obtained via surveillance. 
Even in the results shown here the effect of population fluctuations on the standard 
deviation of the prevalence estimate can be seen for the neutral case where, as shown 
earlier, precision is reduced compared with standard theory. However, these effects are 
modified by animal behaviour. Trap shyness increases precision (reduces the standard 
deviation of the estimate) at low prevalence and reduces precision at high prevalence. In 
contrast, trap happiness on the part of infected individuals has the opposite effects i.e. 
precision is reduced at low and increased at high levels of prevalence. 
 
3.4.4 Imperfect diagnostic tests 
 
Our previous explorations of the effects of fluctuations and surveillance strategy on the 
efficacy of surveillance have assumed perfect diagnostic tests (i.e. sensitivity and specificity 
of the test = 1.0). It is worth recalling the definitions of both sensitivity and specificity of the 
test, namely 
 
 Sensitivity = probability  of detecting disease in an individual that is truly infected 
 Specificity = probability of a negative test in an individual that is truly uninfected 
 
Here we focus on the issue of false negatives, so consider sensitivities less than 1, whilst 
keep specificity = 1. In Figure 3.9 we demonstrate how the sensitivity of the test can impact 
on both the probability of detection and the bias in the prevalence estimate for a badger 
population. All parameters are held fixed at three different transmission rates (0.25, 0.057, 
0.025) with disease induced mortality = 0.165 whilst the sensitivity of the test is varied and 
specificity is constant at 1.0. 
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Figure 3.9: Effect of test sensitivity and disease dynamics in Badgers. 3.9.a shows the 
probability of detection PD   versus sensitivity of the diagnostic test for Badgers. Plots are 
generated by varying the sensitivity of the tests used in surveillance with sample size m = 
10 and capture rate α = 0.5  and μI = 0.165 for three transmission rates β: yellow (0.025); 
red (0.057); green (0.25) with associated prevleance of approximately 0.127, 0.483 and 
0.887 respectively. In each case simulaton results are shown by dots and theory based on 
constant prevalence by dotted lines. Plot 3.9.b shows the bias E[p(t )] - E[p̂surv] in 
surveillance estimates (based on a fixed sample size m  = 10) of prevalence versus the 
expected value of true disease prevalence in the system, E[p(t)]. Data are shown for three 
different levels of transmission rate β as in 3.8.a. Results shown are based on 1000 
surveillance bouts using the Gillespie implementation of the model (see text) run using the 
set of parameter values described in Table S.2.14 Appendix 2.2. 
Figure 3.9 shows that, scenarios in which the lack of a sensitive test can mask the effect of 
fluctuations in demography and disease dynamics on the probability of detection. In the low 
transmission rate examples shown here as the sensitivity of the test increases the 
discrepancy between the true probability of detection and the prediction based on 
assuming constant prevalence increases. In these cases as test sensitivity is increased the 
supposed gains in ability to detect disease predicted by binomial theory assuming constant 
prevalence are not realised.  We can see for β = 0.025 that even though the bias in 
prevalence estimate is highest at lower sensitivity levels, this is when the probability of 
detection follows the constant prevalence curve closely. It is only when sensitivity levels are 
increased, and bias in the prevalence estimate reduced, that there is a difference between 
the detection rate predicted by constant prevalence theory and the true (simulated) 
detection rate. It is important to note that the probability of detection does improve with 
increased sensitivity, but not at the same rate as would have been expected if fluctuations 
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are ignored. For the chosen disease induced mortality rate, the three values of the 
transmission rate correspond to low medium and high prevalence. Fluctuations have a small 
effect on detection rates at high prevalence and an increasingly large effect as prevalence 
decreases. This is why the above noted effect of sensitivity masking errors in the constant 
prevalence theory estimates of the probability of detection are most evident for lower 
values of β. 
The bias curves plotted in Figures 3.9 and 3.10 show E[p(t )]- E[p̂surv] and can largely be 
explained by  reference to constant prevalence theory (note here we have sought examples 
where the role of fluctuations is minimised). Consider a case where the prevalence is 
constant at a value of E[p(t )] and the test sensitivity is given by Se.  Then the expected 
value of the surveillance estimate of prevalence is Se*E[p(t)] and  
  
     =  E[ (  )]−   ∗ E[ (  )] 
The linear form of this equation is seen in the results plotted in Figures 3.9.b and 3.10.b. For 
example, when the sensitivity Se =1, the bias is zero as shown in Figures 3.9.b. Moreover, 
when Se =0 the bias plotted is simply the underlying prevalence E[p(t )]. Figure 3.10 
explores the sensitivity of the test for varying prevalence; this demonstrates how disease 
dynamics can interact with test sensitivity in determining surveillance efficacy. As 
prevalence increases bias increases linearly as predicted by the above linear equation. 
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Figure 3.10: Effect of disease dynamics and test sensitivity in Badgers Plot 3.10.a shows 
the probability of detection PD   versus actual prevalence E[p] for Badgers. Plots are 
generated by varying β with samples size m = 10 and α = 0.5 and μI = 0.165  for three 
sensitivity levels: yellow (0.2); red (0.6); green (1.0). Plot 3.10.b shows the bias E[p(t )] - 
E[p̂surv], based on a fixed sample size m  = 10, of prevalence versus the expected value of 
true disease prevalence in the system, E[p(t)]. Data are shown for three different 
sensitivity levels as in 3.10.a. Results shown are based on 1000 surveillance bouts using the 
Gillespie implementation of the model (see text) run using the set of parameter values 
described in Table S.2.15 in Appendix 2.2. 
Figure 3.10 shows that the bias in prevalence estimate increases as the prevalence 
increases for sensitivity levels <1.0 and the lower the sensitivity level, the greater the 
increase in bias as prevalence goes up. At any sensitivity < 1.0 there is a percentage of test 
results that return as a false negative. This percentage also depends on how many infected 
individuals there are available to be diagnosed as false positive. As prevalence increases, 
the amount of false positive results also increases, hence the bias in prevalence estimate 
increases as the results get less accurate. This is consistent with binomial theory that states 
if true prevalence = p and sensitivity is se with specificity =1 then estimated            
prevalence = p*se and thus bias = p‐p*se. The probability of detection is seen to be 
depressed away from the binomial theory estimate for higher sensitivities (especially 
sensitivity 1.0) which has been shown in Chapter 2. However for lower sensitivity levels, the 
probability of detection seems to follow the binomial line very well. Thus as noted above 
one effect of fluctuations is that improvements in test sensitivity may not lead to the gains 
in detection rates predicted by constant prevalence theory. Moreover the effects of 
fluctuations on disease surveillance, which are the focus of this chapter and Chapter 2, may 
be masked by relatively poor tests with low sensitivity. 
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3.5 Discussion 
 
 In Chapter 2 we characterised surveillance of wildlife disease in terms of a handful of 
parameters describing the key components of such systems, namely host demography, 
disease dynamics and the nature of the surveillance itself.  A simple but generic stochastic 
modelling framework was used to study interactions between these elements in 
homogeneous/well mixed populations. The results obtained from analysis and simulation of 
this model showed that combined fluctuations in population and disease dynamics bias the 
surveillance estimate of prevalence with respect to expected true prevalence of the 
underlying wildlife disease system. In addition the precision of these estimates and the 
probability that surveillance will detect disease are both lower than would be expected 
based on standard arguments which ignore such fluctuations. Thus our results suggest that 
power calculations or analyses which ignore fluctuations may lead to under powered 
wildlife disease surveillance programmes and/or over confidence in the results obtained. 
Such results would lead to incorrect characterisation of the risks posed by a given wildlife 
disease system. 
In this chapter we have shown how the theoretical framework and models presented in 
Chapter 2 can be further developed and applied as tools to assess the outcomes of wildlife 
disease surveillance in real systems. Chapter 2 explored a broad range of wildlife disease 
systems i.e. a range of host‐pathogen combinations where as in this chapter we asked if 
such effects are likely to be a feature of particular wildlife disease systems. Our aim was to 
build on the theoretical developments presented in Chapter 2 by parameterising stochastic 
models to represent two natural wildlife host populations (badgers and rabbits) for a range 
of disease dynamics (including TB and paraTB respectively). In so doing we have quantified 
the effects seen in Chapter 2 for these wildlife disease systems and can conclude that they 
are of practical concern for real systems and a range of diseases including the two specific 
examples which are of current interest. For example, such effects potentially undermine 
management strategies for TB in badgers because current surveillance designs may be 
under powered leading to poor characterisation of the risk posed to sympatric cattle 
populations. 
In addressing the above wildlife disease systems we have expanded our theoretical 
framework to accommodate sources of bias related to aspects of the disease (i.e. disease 
induced mortality), diagnostic tests (reduced test sensitivity) and host behaviour (biases in 
trappability). The research presented in this chapter characterised and quantified the 
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impact of these currently acknowledged sources of bias in the context of wildlife disease 
systems subject to demographic and disease related fluctuations. The fluctuations 
demonstrated in badger and rabbit populations are not at the extreme end of the scale, and 
could be viewed as similar to the fluctuations found in livestock and managed populations. 
The results shown have the potential to be amplified when considering populations with 
larger and more extreme population fluctuations which could be demonstrated in source‐
sink scenario.   
The effects of disease induced mortality are complicated by the fact higher rates depress 
both prevalence and size of infected populations. This alters the stability of both the disease 
and the populations and the resulting fluctuations reduce the efficacy of surveillance. For a 
particular wildlife host (identified by birth and background/natural mortality rates), a given 
level of prevalence results from the interplay between disease transmission and disease 
induced mortality. When both are relatively high resulting fluctuations in demography and 
disease dynamics can lead to biased and low precision estimates of prevalence and reduced 
rate of disease detection from surveillance programmes.  This may, for example, be a 
feature of Rabbit Haemorrhagic Disease which is documented to have both a large disease 
induced mortality rate and be highly transmissible (Cooke 2002; Calvete 2006).   
Bias in the trappability of an infected host, within different surveillance and disease 
prevalence scenarios, increases the bias seen in the prevalence estimate. This can happen in 
two ways; there will be a tendency towards positive bias (i.e. the surveillance over‐
estimates the prevalence) if individuals are trap happy. There are examples in the literature 
whereby animals become more likely to enter traps as they become weaker with the 
burden of disease and the food often used to bait traps becomes more attractive (Tuyttens 
et al. 1999; Coltherd et al. 2010; Byrne et al. 2012a) . Conversely, there will be a tendency 
towards negative bias (i.e. the surveillance under‐estimates the prevalence) if the 
individuals are trap shy (Tuyttens et al. 1999; Wilkinson et al. 2000). For example TB can 
affect social aspects of badger behaviour and infected individuals become more isolated 
from the social group which may make it harder for surveillance to capture them if the 
effort is concentrated on the main sett (as is often the case). This relationship between 
trappability and bias is intuitive as, taking the case of positive bias, infected animals are 
more likely to be trapped and there will be a disproportionate number of infected 
individuals being caught by surveillance leading to an over‐estimate of prevalence. The 
error (standard deviation) associated with prevalence estimates is also affected by 
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trappability status in the infected population. Standard deviation is reduced at low 
prevalence for trap shy individuals and increased at high prevalence compared to the 
neutral case. The converse is true for trap happy individuals. The probability of detection 
decreased for infected individuals exhibiting trap shy behaviour, and this is to be expected 
as a reduction in the likelihood of an infected individual being caught will lower the chance 
infection will be detected. The converse, again, is true for trap happy individuals. This 
explicit source of bias has the potential to counteract or inflate the impacts on surveillance 
induced by population fluctuations which we studied above and in Chapter 2. 
The effect of sensitivity on the prevalence estimate is well described by standard binomial 
theory which ignores fluctuations. Surveillance detection rates rise with sensitivity and bias 
in the surveillance estimates of prevalence reduces. In the presence of fluctuations, at 
lower sensitivity levels the true probability of detections is quite accurately predicted by the 
constant prevalence estimate. However, at higher sensitivity levels the probability of 
detection is lower than the constant prevalence theory prediction (previously we had 
examined perfect high sensitivity tests). As the sensitivity of the test increases, the 
probability of detection from surveillance is lower than the constant prevalence theory 
predicts, and this is particularly marked at lower transmission rates (i.e. at lower 
prevalence’s, all else being equal). For the case of perfect tests the message from both this 
chapter and Chapter 2 was that fluctuations in prevalence reduce the true probability of 
detection relative to the constant prevalence theory prediction.  However, here we see that 
such effects may be masked by imperfect tests, such that they are not apparent at low 
sensitivities but may become discernible as sensitivity increases. Therefore as better tests 
become available the effects of fluctuations on wildlife disease surveillance described in 
Chapter 2 (and above) may be more noticeable in practice. If predictions for the 
improvement of disease detection rates (probability of detection) with enhanced (more 
sensitive) tests are based on constant prevalence theory then our results suggest that actual 
gains in the performance of surveillance may not be as great as predicted. 
In summary we have demonstrated that the results of surveillance are determined by 
complex interactions between surveillance strategy, host demography and pathogen 
transmission dynamics. We have also explored the impact of a range of aspects of the 
ecology of wildlife disease (the impact of the disease on host mortality and behaviour) and 
the tools used for surveillance (sensitivity of diagnostic tests). In so doing we have 
illustrated how the models and framework we introduced in Chapter 2 and extended here 
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might be used as computational tools to design better surveillance programmes which take 
account of ecological and other effects. For example, rather than rely on binomial type 
calculations based on assuming fixed population size and prevalence, surveillance design for 
specific systems could be based on the simulated outputs from models like those used here 
if they can be suitably tailored to the wildlife disease system of interest. Moreover in this 
chapter and the previous one we have shown how to explore the efficacy of surveillance for 
a range of population and disease dynamics. The information obtained from these more 
generic studies could be used to inform surveillance when knowledge of host demography 
and/or pathogen characteristics is uncertain, or when the goal is to design generalised 
surveillance suitable for a range of hosts and pathogens. 
The work of this and the previous chapter has established the role of temporal 
heterogeneities induced by stochasticity in well mixed spatially homogeneous local 
populations. However, the impact of spatial heterogeneity on the spread and persistence of 
disease has been well documented in the literature and given the results described here 
this is likely to have significant impacts on surveillance in wildlife. In the next chapter we will 
turn our attention to spatially extended meta‐populations and the impact of spatial 
heterogeneity on the design and efficacy of surveillance. 
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Chapter 4 
 
 
 
Spatio-Temporal modelling of     
habitat composition, ecology and          
wildlife disease surveillance:            
impacts of emergent disease. 
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4.1 Abstract 
  
Spatial heterogeneity is known to be an influential factor in the spread and 
persistence of disease suggesting it is likely to impact on the efficacy of surveillance. 
The generic stochastic modelling framework introduced in Chapter 2 and further 
developed in Chapter 3 was extended to incorporate spatial heterogeneity. In order 
to study surveillance over an extended region we developed a stochastic and spatially 
explicit meta‐population model that describes demography, disease transmission and 
key aspects of surveillance.  The impact of various aspects of design on the ability of 
spatially distributed surveillance networks to detect emergent disease at a regional 
scale is assessed by the level of disease present in the system at the point of first 
detection. In particular we use the extended framework to explore key spatial aspects 
of surveillance design including within location effort, number of surveillance 
locations, and choice of such locations according to habitat suitability for the host 
species. In line with current practice we find that increasing effort/number of 
locations under surveillance and spatial stratification according to the habitat 
suitability improves the ability of surveillance networks to detect emerging 
outbreaks.  In addition we evaluate dynamic designs and find that, given the ability to 
conduct surveillance in a set number of locations, switching effort between locations 
is expected to lead to more rapid detection of disease than static designs. We 
conclude that spatial heterogeneity, disease dynamics and surveillance strategy 
should all be considered when assessing the ability of surveillance to detect emerging 
disease risk in a spatially extended wildlife population.  
 
4.2 Introduction 
 
In Chapters 2 and 3, it was shown that natural fluctuations in a target host population 
drive the efficacy of wildlife disease surveillance in terms of both estimating 
prevalence and the probability of detection. In many disease systems (host and 
pathogen combinations) fluctuations in host population size and disease prevalence 
lead to bias and reduced precision of estimates of prevalence and also lower the 
probability of disease detection when compared to standard binomial theory which 
ignores such effects. These results suggest that current surveillance programmes may 
be underpowered if designed using power calculations based on binomial theory. The 
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impact of the design of surveillance strategies (i.e. sample size and capture 
rate/effort) was also shown to impact surveillance efficacy in ways not predicted by 
standard theory. In particular capture rate can minimise bias in prevalence estimates 
and increasing sample size does not increase the probability of disease detection or 
the precision of prevalence estimates as fast as would be expected from standard 
arguments. These results were all shown in a non‐spatial context and for endemic 
(stable and unstable) disease scenarios. However, there are a range of spatial effects 
that have been shown to impact on both the host population size and stability and on 
disease persistence and spread e.g. intrinsic and extrinsic spatial heterogeneity driven 
by stochasticity and habitat composition (Tilman and Karieva, 1997; Keeling, 1999; 
Keeling et al 2001). In this chapter we aim to explore how spatial heterogeneity 
affects surveillance efficacy in the context of emerging infectious diseases.  
Emerging disease outbreaks are of particular importance when considering 
surveillance efficacy in a spatial context. Epidemiological modelling has shown that 
increased contact among populations can trigger epidemics (Hess 1996) and spatial 
composition of the environment (habitat) influences emergent disease risk (Ostfeld et 
al. 2005).  Emerging (and re‐emerging) disease outbreaks have the potential to be 
detrimental to wildlife (Bengis et al. 2004), including conservation efforts (Daszak et 
al. 1999, 2000), as well as livestock (Rhyan & Spraker 2010) and human health 
(Epstein 1995; Murphy 2008). In an emerging disease situation e.g. a disease 
incursion to a naïve population, the main goal of surveillance is to detect the disease 
as quickly as possible to limit spatial spread and risks to wildlife, livestock and human 
health. In order to do this effectively the premise of this chapter is that it is important 
to consider the spatial composition and structure of the environment (habitat quality, 
distribution, connectivity etc.) and the demography (births, deaths, immigration etc.) 
of the host population and how these are likely to affect the efficacy of surveillance. 
It has been repeatedly shown that spatial heterogeneity impacts on the spread and 
persistence of disease (Sattenspiel & Simon 1988; Cliff 1995; Keeling & Grenfell 
1998). Spatial effects have been found to be important in many types of systems, for 
example crops (Antle et al. 2003), human populations (Smith et al. 2002)  and 
predator‐prey systems (Hastings 1977) etc. In this chapter we will focus on spatial 
effects in wildlife meta‐populations. However, there is little literature addressing how 
intrinsic and extrinsic spatial heterogeneities would impact on the ability to carry out 
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effective surveillance and on the reliability of the results obtained from such efforts. 
Intrinsic spatial heterogeneity is driven by the dynamics of the population and is an 
emergent property of the system. Extrinsic spatial heterogeneities are driven by 
external conditions to which the population responds, such as habitat suitability. In 
term of surveillance design, efforts to account for extrinsic spatial heterogeneity have 
been made, for example tailoring surveillance to knowledge of wildlife habitat 
locations (i.e. extrinsic heterogeneity) (Walsh & Miller 2010). However, the effects of 
intrinsic spatial heterogeneity on surveillance have yet to be explored.  
In this chapter we will explore how the interaction between both intrinsic and 
extrinsic heterogeneity affect surveillance efficacy within an emerging infectious 
disease context. We aim to assess how the spatial distribution of habitat quality, 
disease dynamics and surveillance strategy can impact the amount of disease present 
within the system, at the point of first detection following an incursion event. In 
doing so the aim is to develop insights, general recommendations and tools which 
contribute to the design of better strategies for wildlife disease surveillance 
compared with current understanding and practice. 
 
4.3 Methods 
4.3.1 Stochastic Model Description 
 
The model represents a finite space, on which L so called patches are randomly 
distributed. Each patch supports a host population subject to demographic 
fluctuations (births, deaths and immigration) and the transmission of a single 
pathogen. At each point in time t and for each patch i=1,...,L, the state‐space 
represents the total population size N i (t), with Ii (t) of these infected and the 
remainder, Si (t) = N i (t) – Ii (t) susceptible. In addition the prevalence in patch i  is 
then given by pi(t) = Ii(t)/N i(t). The birth rate of individuals is logistic,                      
rNi (1 – N i /ki), with intrinsic growth rate r and a carrying capacity ki reflecting the 
assumptions that population growth is resource limited. The carrying capacity ki is 
determined by the suitability rating, σi, assigned to each patch multiplied by a 
maximum potential carrying capacity equal over all patches kmax i.e. ki = σi kmax. The 
suitability rating (or level) σi represents how suitable the habitat is on patch i  for the 
population and ranges from 0 to 1. Favourable patches are defined as those where    
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σ =1 and the carrying capacity is kmax, whereas less favourable patches refer to 
locations where σ <1  and the carrying capacity is less than kmax. It is therefore 
meaningful to talk about varying the suitability of less favourable patches in the 
interval [0,1). In the limit σ‐>1 less favourable patches become/would be classified as 
favourable. Individuals have a per capita death rate μ and secondary transmission 
within patch (contact with already infected individuals from the population) occurs at 
rate β0Si (t)Ii (t). 
Immigration into each patch occurs at a constant rate ν and a proportion, γ, of 
immigrants are infected, but otherwise all individuals enter the population (through 
birth or immigration) as susceptible as there is no vertical or pseudo‐vertical 
transmission. As well as within patch secondary transmission described above, 
susceptible individuals become infected through between patch secondary 
transmission. Between patch transmission is defined as an infected individual 
transmitting disease to a susceptible individual in a different patch. The distance by 
which the disease can transmit from one patch to another is controlled by the 
distance kernel, i.e. the probability of disease transmitting between patches 
decreases as the distance between them increases. Although other forms of distance 
dependence e.g. power‐law could easily be accommodated, in the model considered 
here between patch transmission is governed by an exponential kernel          where 
dkj is the Euclidean distance between infected individuals in patch k and the 
susceptible individuals in patch j  and θ controls the rate at which infection pressure 
decays with this distance. This means that at time t  the rate at which new infections 
occur in patch j due to infection by the Ik (t) infected individuals in patch k , given 
there are Sj (t) susceptible individuals in patch j, is  
    ( )  ( ) 
        
In the spatial context, surveillance is characterised by the set of locations (patches) 
currently under surveillance, the effort applied in each of these patches and the 
manner in which surveillance can switch from one location or set of locations to 
another. Within patches currently under surveillance we adopt the model used in 
earlier chapters, namely that disease surveillance is incorporated into the model in 
the form of capture, testing and release at per capita rate α, for both susceptible and 
infected individuals. All surveillance testing is undertaken assuming perfect tests, 
which means that our measures of the performance of surveillance reflect a best case 
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scenario. The set of patches where this capture rate is applied is determined by 
random allocation of a proportion of patches where surveillance is activated at any 
one time. In some cases this allocation will be weighted according to habitat quality 
as described in the text e.g. when we only sample favourable habitats (see above). As 
indicated in some cases the set of patches under surveillance is allowed to evolve 
over time. When this is allowed an initial set of patches is chosen as described above 
and then this initial set remains under surveillance for a period of time after which 
surveillance is ended in that set and started in another set currently not under 
surveillance but otherwise chosen at random using criterion consistent with those 
used to identify the initial set of patches under surveillance. In the model used here 
we assume a fixed time to switching for surveillance sets. In the text below we 
describe this interchangeably as surveillance switching rates and times.   
 
4.3.2 Model Implementation 
 
The model is implemented as a continuous‐time discrete‐state space Markov process 
(see Chapter 2), which is simulated using Gillespie’s exact algorithm (Gillespie, 1976). 
In contrast to the stochastic differential equation approach predominantly used in 
the previous two chapters, the Gillespie algorithm is computationally more intensive 
but exact. The discrete nature of the state‐space under the Gillespie algorithm is a 
more direct implementation of the model described above, and as discussed 
previously it therefore represents a more natural description of the population and 
the processes that affect it. Moreover, it provides a more accurate representation of 
population dynamics for populations which are important when considering spatial 
heterogeneity of meta‐popualtions (Keeling & Ross 2008). All events with their 
corresponding rate and effect on population size for the Gillespie implementation can 
be seen in Table 4.1 below. 
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Table 4.1: Event, Rate and Effect on the State Space of the model. Conceptually the 
effect of each event affects an individual and this is reflected in the discrete nature of 
the corresponding changes in the state space. However, given this underlying 
conception of the model there are a number of different implementations which can 
be considered including via the Gillespie algorithm and stochastic differential 
equations (see text for details). 
In Chapter 2 we explored a range of wildlife host species and their pathogens and in 
Chapter 3 we focused on two exemplar host species with contrasting population 
dynamics. In both chapters we showed that temporal heterogeneities induced by 
stochasticity in demographic and disease dynamics impacted on the efficacy of 
wildlife disease surveillance (see above for details). Since such stochasticity is known 
to play an important role in spatial systems (see e.g. Tilman and Karieva, 1997) we 
anticipate that these impacts on surveillance will also be apparent in spatially 
extended systems.  
In this chapter we therefore focus our efforts on studying the impacts on surveillance 
of spatial (rather than temporal) heterogeneities. To do so we parameterise the 
model to represent a relatively stable host population.  A range of simulations were 
then run to assess the impact of surveillance design i.e., targeting surveillance on 
different habitat types, the number of patches under surveillance, the effort applied 
in each patch and different switching rates. In addition the structure of habitat 
composition within the modelled area was explored by varying both the spatial 
habitat composition (varying the ratio of favourable to less favourable habitat type 
Event Rate Effect 
Birth    (1 −   / )    →    + 1 
Death of Susceptible        →    − 1 
Death of Infected        →    − 1 
Susceptible Immigration  (1 −  )      →    + 1 
Infected Immigration        →    + 1 
Between Patch 
Transmission 
       
−        →    − 1 
   →    + 1 
Within Patch 
Transmission 
          →    − 1 
   →    + 1 
Susceptible Capture and 
Release 
       →    
Infected Capture and 
Release 
         →    
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patches in the space) and habitat suitability (varying the suitability index of less 
favourable habitat type from 0 to 1).  Simulations were also run to explore the impact 
of within and between patch transmission rates. The results from all these 
simulations are described in detail below. The parameterisation of the model and 
details of the simulations run can be found in the relevant tables in Appendix 3 
(indicated in Figure descriptions in the results section).  
4.3.3 Statistics generated from the model 
 
In this chapter we are focussed on emergent disease and therefore we do not collect 
long term averages, but rather focus on ensemble expectations (approximated by 
averages over many realisations of the process) of out of equilibrium incursion events 
corresponding to the introduction of the disease and its spatial spread up to the point 
where it is detected by surveillance. Each simulation is run for a period of time to 
allow the population to reach equilibrium before a disease incursion is introduced 
into a random patch. A surveillance bout continues until a detection event occurs or 
until a maximum time, tmax, is reached. Statistics are calculated and averaged over the 
many realisations in which disease detection occurred. The calculations include; 
average number of infected at time of detection, the average number infected in 
infected patches, the average time of detection and the number of infected patches. 
Here a surveillance bout corresponds to a period starting with a disease incursion 
event where we conduct surveillance until an infected individual is detected, or until 
some large upper time limit is reached (this just covers cases where disease dies out 
prior to detection). Individuals within patches under surveillance are captured at per 
capita rate α, and patches under surveillance are switched at switching rate τ, as 
described in detail above.  The total number of infected individuals caught per patch 
are recorded until one of the totals reaches 1, i.e. all totals were previously 0 and this 
is the first infected individual to be caught in any patch. At this point, disease has 
been detected for the first time. Note this could be easily extended to account for 
imperfect disease diagnostics by recording the number testing positive. When 
surveillance ends, either because a detection event has occurred or because a time 
limit has been reached, the number of infected individuals and patches is recorded. In 
addition, the time taken for disease to be detected is also recorded. Therefore over 
repeated surveillance bouts it is straightforward to estimate the average amount of 
disease present in the spatial system at the point of first detection. 
94 
 
4.4 Results 
 
4.4.1 Static surveillance: spatial distribution of effort 
 
When disease first enters a naive population, surveillance aims to detect the disease 
before a significant risk has developed. The risk associated with a given level of 
spread will depend on factors including host species under surveillance, potential 
host range, pathogen virulence, the economic and cultural values attached to these 
species and many others. We measure how well surveillance performs by calculating 
the amount of disease in the space at the point of first detection. For any given 
wildlife disease system (host and pathogen characteristics) the way surveillance is 
distributed within the spatial system, and how much surveillance is undertaken, both 
in breadth of patches covered and within patch intensity (capture rate), will affect the 
amount of disease present at the point of first detection. Figure 4.1 demonstrates 
how the amount of disease present in the spatially extended system reduces at the 
point of first detection with increased number of patches concurrently included in the 
surveillance sample at three different capture rates. To explore the effect of the 
distribution of surveillance effort (i.e. the difference between spreading surveillance 
thinly with low effort compared to concentrating high effort on a small number of 
patches) the total effort was calculated as follows: 
 
               =    
                 ℎ                       
                         ℎ  
   ×                 
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Figure 4.1: Effect of the distribution of surveillance effort between patches. Data 
are shown for three different values of the capture rate α (1.0‐red,0.25‐green,0.1‐
blue) each for a varying range from 1 to 65 patches under surveillance (with no 
switching). Plot 4.1.a shows that the average number of infected individuals and plot 
4.1.b shows the average number of patches with infection both decrease as the 
number of patches in the surveillance sample increases. This improvement happens 
more quickly as effort increases (capture rate). Plot 4.1.c shows the average number 
of infected individuals for the “total effort” from the simulation values used in Plot 
4.1.a. The plots shown were run using the set of parameter values described in Table 
S.3.1 in Appendix 3.1. 
 
Figure 4.1 shows, as the number of patches included in the surveillance sample 
increases, the less disease is present on average at time of first detection. This is an 
intuitive result, as the more space that can be covered in surveillance, the higher the 
chance of detecting disease. However, these results also indicate that, somewhat less 
intuitively, the distribution of surveillance effort between patches does not impact 
significantly on the average size of the disease incursion at time of first detection. 
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4.4.2 Static surveillance: stratified designs 
 
Environmental factors, such as habitat suitability, can also influence the efficacy of 
surveillance. As discussed previously, habitat suitability is modelled in terms of the 
carrying capacity of each patch. This is characterised by a suitability level σi which 
ranges from zero to 1 and interpolates linearly between the carrying capacity of 
favourable patches and zero. In this chapter we consider two habitat types at any one 
time. Favourable habitat has the maximum possible carrying capacity σi=1 and less 
favourable habitat has σi <1  i.e. carrying capacity ranges from 0 to that of the 
favourable habitat. As previously discussed in the introduction, habitat distribution 
within the spatial system is integral to the spread and persistence of disease. Figure 
4.2 demonstrates the effect, on the amount of disease present at first detection, of 
varying proportions of favourable to less favourable habitat at three different capture 
rates for 1% patch surveillance set. Here less favourable habitat has a suitability index 
of σ = 0.5. Three different surveillance strategies are also compared: 1) only selecting 
more favourable habitat for the surveillance sample; 2) only selecting less favourable; 
and 3) selecting both with equal probability. 
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Figure 4.2: The effect of habitat quality on stratified sampling schemes. Amount of 
disease present at time of first detection for three differently stratified sampling 
strategies (surveillance in: Less favourable only – red; Favourable and less favourable 
equally – green; and Favourable only ‐ blue) as a function of the proportion of 
favourable habitat. Data are shown for effort level 1.0 in 1% of patches with a 
random disease incursion relative to the proportion of favourable and less favourable 
habitat in (a) the average number of infected individuals in the spatial system at the 
time of first detection and (b) the corresponding figure for the average number of 
infected patches. The plots shown were run using the set of parameter values 
described in Tables S.3.2 in Appendix 3.1. 
Figure 4.2 shows that as the proportion of favourable habitat increases the amount of 
disease in the system at first detection also increases, regardless of sampling strategy. 
This simply reflects the fact that the system as a whole is more susceptible to disease 
as there are more hosts to infect when the proportion of good quality habitat 
increases. In comparing the three sampling strategies Figure 4.2 shows that sampling 
only less favourable habitat patches leads to the highest level of disease in the 
system at the time of first detection. In contrast sampling only favourable habitat 
patches is the best performing strategy while the mixed strategy falls between the 
other two. When the proportion of favourable habitat patches approaches 1 the 
mixed strategy is equivalent to sampling only favourable habitat because there are 
fewer and fewer less favourable habitat patches. Similarly when the proportion of 
good habitat patches approaches zero the mixed strategy of sampling both  habitat 
type patches is equivalent to sampling only less favourable patches (because, in the 
limit, there are only poor quality patches). 
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Sampling good quality habitat patches is the superior strategy because hosts are 
more abundant in favourable habitat which is therefore more favourable for the 
pathogen and more likely to shelter infected individuals who can be sampled by 
surveillance. It is also evident from Figure 4.2 that this effect becomes more 
pronounced as the proportion of good quality habitat patches shrinks.  Initial disease 
incursion events occur into a randomly chosen patch and therefore when favourable 
habitat is rare incursion is most likely to occur in a poor quality patch. In such 
circumstances disease is less likely to spread far, but sampling in only less favourable 
habitat is most likely to detect disease. However, when disease incursion does 
(rarely) happen in a good quality patch not only will it be initially missed less 
favourable habitat sampling it is also likely to be a larger outbreak. This inflates the 
average outbreak size under this (and the mixed) sampling strategy. In contrast, in 
the limit of a low proportion of favourable habitat, when sampling in favourable only 
habitat the majority of outbreaks are small (because most patches are poor)but 
remain undetected. However, surveillance will detect disease quickly when an initial 
incursion occurs in, or an outbreak reaches, a favourable patch. In this case the size of 
outbreak on detection is likely to be small. These effects are amplified as the 
proportion of favourable patches shrinks and thus it makes most sense to develop 
stratified surveillance designs (based on habitat quality) when good quality habitat is 
rare. 
Figure 4.3 demonstrates the effect of varying the suitability level of the less 
favourable habitat  on the amount of disease in the system at the point of first 
detection, when the proportion of suitable and less suitable patches are equal i.e., 
0.5. We consider 4 levels of patch inclusion in surveillance ranging from 1% of 
patches to 25%. How hostile the environment is for the host species will not only 
impact on the population size but also on the disease and its ability to spread. This 
has implications for surveillance efficacy. 
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Figure 4.3 The effect of the suitability of less favourable on surveillance The 
proportion of favourable habitat patches is 0.5 i.e. 1‐0.5 have less favourable habitat. 
Data are shown for the difference between targeting surveillance on favourable 
habitat patches and random sampling of any habitat patch type (a positive difference 
indicates lower levels of disease at detection in the targeted case). In (a) the average 
number of infected individuals in the spatial system at the time of first detection and 
(b) the corresponding figure for the average number of infected patches.  Each graph 
shows four different percentages of patches under surveillance (1%‐red, 2%‐green, 
5%‐blue, 25%‐purple). The capture rate was set to 1.0 for any patch under 
surveillance. The suitability rating of the less favourable habitat type was varied 
range from 0 to 1 (as shown). The plots shown were run using the set of parameter 
values described in Tables S.3.3 in Appendix 3.1. 
Figure 4.3 shows that, generally, targeting favourable habitat patches is effective in 
reducing the amount of disease in the spatial system at the point of first detection, 
especially at low i.e. 1% patch inclusion rates. When considering only a small 
proportion of patches in the surveillance sample, it will generally take longer to 
detect disease and therefore there is likely to be more disease in the system at the 
point of first detection. As the habitat becomes more suitable for the host population 
infection levels will increase, as the disease is able to stabilise in the population and 
spread more easily within patches. When σi is low (i.e. when the less favourable 
habitat is really poor), sampling favourable habitat is a sensible approach; Figure 4.3 
demonstrates a clear reduction in disease levels. However as less favourable habitat 
improves (i.e. as σi increases) this benefit is reduced. This difference is greater when 
there are a smaller proportion of patches under surveillance. Finally as σi tends to 1, 
there is little difference between favourable and less favourable patches, and it 
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therefore makes no difference which is targeted as such targeting equates to random 
sampling of undifferentiated patches. 
Figure 4.4 shows the impact of both between patch and within patch transmission 
with varying surveillance effort. We can see from Figure 4.4 that the higher between 
patch transmission, the more effort required to decrease the level of disease at time 
of detection. From other simulations explored, it would appear that at fixed between 
patch transmission, the within patch contact rate does not have as big an impact on 
the amount of disease at time of detection. However we anticipate that this would 
have a greater effect at very low levels where the disease was on the limit of being 
locally stable.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: The effect of surveillance effort and secondary transmission. Data are 
shown for three different between patch transmission rates (0.1‐red, 1.0‐green, 5.0‐
blue) for varying surveillance effort from 0 – 1 (plots 4.4.a and 4.4.b) and three 
different within patch transmission rates (0.1‐red, 1.0‐green, 5.0‐blue) for varying 
surveillance effort from 0 – 1 (plots 4.4.c and 4.4.d). The percentage of patches under 
surveillance is set at 1% and disease incursion is introduced into a random patch. The 
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plots shown were run using the set of parameter values described in Tables S.3.4 in 
Appendix 3.1.   
The results above in Figure 4.4 show that the total effort and the distribution of that 
effort play a role in limiting the spread of emerging disease prior to detection. The 
design of surveillance is particularly important when habitat is heterogeneous with 
respect to its suitability for the focal host species. In such cases we have seen that 
stratifying sampling design with respect to habitat type results in more efficient 
surveillance.  We now consider the effect of disease transmission on the ability to 
conduct surveillance. 
4.4.3 Dynamic designs 
 
Although our results above showed that increasing the number of patches under 
surveillance improved the ability to detect emerging disease outbreaks, in real 
surveillance situations, resources are restricted and there will be a limit to how many 
patches can be brought under surveillance at any one time. A potential alternative 
strategy to increasing the number of patches in surveillance is fixing the number of 
patches under surveillance at any one time but to move this effort around by 
switching surveillance to a new set of patches. The rationale behind this approach is 
that if the disease is slow at transmitting over the spatial system, staying in a fixed 
spot could severely hinder the chance of detecting the disease early, whereas if 
surveillance is moving around the space at a faster rate than the disease, there is 
potential for earlier detection.  We do not consider the costs associated with such 
dynamic surveillance design (switching) here, but rather focus on quantifying the 
potential gains in terms of outbreak size at time of first detection. 
Figure 4.5 demonstrates the potential effects of switching on the amount of disease 
present at time of detection. Results are shown for different lengths of time 
(switching times/rates) surveillance effort is deployed in a patch before this effort is 
redeployed in another patch. As described earlier the patches to be subjected to such 
surveillance are chosen at random, but potentially weighted according to some 
selection criteria e.g. using a stratified design. These results are also shown for 
different numbers of patches under surveillance at any given time (percentage of 
patches under surveillance). 
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Figure 4.5: Effect of switching: Data are shown for four different percentage patches 
under surveillance (1%‐red, 2%‐green, 5%‐blue, 25%‐purple) each for a varying range 
from 0 to 1 of time spent in each combination of surveillance patch(es) before 
switching. Amount of disease is calculated at time of first detection for infected (a) 
individuals and (b) patches. Patches are split 50/50 into favourable and less 
favourable habitat. Between patch transmission was set to 0.1 and within patch 
transmission rate set to 0.5. The plots shown were run using the set of parameter 
values described in Tables S.3.5 in Appendix 3.1. 
Figure 4.5 shows switching can reduce the average amount of disease in the global 
population at time of first detection i.e. allows surveillance to detect outbreaks 
faster. Note that large switching times approach the limit of no switching whereas 
smaller ‘time before switching’ corresponds to increasingly fast switching. Therefore 
the potential gains from dynamic surveillance are measured to a good approximation 
from Figure 4.5 by comparing the average number infected for switching times 0 and 
1. The shorter the time spent in the current surveillance sample before switching, the 
less prevalent is disease at time of first detection. Figure 4.5 also shows that there is 
more to be gained from switching when a lower percentage of patches are under 
surveillance. If the number of patches surveillance sample is large, there will be no 
more to gain from switching the patches under surveillance periodically. Thus 
switching is potentially most useful when surveillance is relatively under resourced. 
This effect is amplified for low between patch transmission rates, i.e. when the 
disease is less likely to spread between patches. 
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Figure 4.6 considers the proportional difference between switching and not switching 
for varying effort and three switching rates.  The proportional difference (actual gain) 
of switching compared with not switching is defined as: 
 
 Proportional difference = (no switching – switching rate)/no switching  
 
 
 
 
 
 
 
 
Figure 4.6: Switching and deployed effort. Percentage improvement obtained from 
switching compared with not switching, measured in terms of the amount of disease 
present at time of first detection for infected (a) individuals and (b) patches. Data are 
shown for three different switching rates (0.01 switching‐red, 0.1 switching‐green, 
1.0 switching‐blue) as a function of surveillance effort from 0 – 1. Within and 
between patch transmission was set to 0.5 and all patches are favourable habitat. 
The plots shown were run using the set of parameter values described in Tables S.3.6 
in Appendix 3.1. 
Figure 4.6 shows that the biggest gain seen in terms of reduction of disease occurs 
when both the switching level is fast (i.e. the surveillance stays in each patch for a 
very short time before moving to the next patch) and the surveillance effort is 
highest. Figure 4.7 shows how between patch transmission and the rate at which 
surveillance switches between patches, affects the percentage difference in disease 
in the system at point of first detection compared to not switching at all. 
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Figure 4.7: The effect of between patch transmission for different switching levels. 
Data are shown for the difference between three different switching levels (0.01 
switching‐red, 0.1 switching‐green, 1.0 switching‐blue) and not switching for amount 
of disease at time of first detection for infected (a) individuals and (b) patches. 
Between patch transmission rate is varied from 0 – 1 for 1% of patches under 
surveillance. Within patch transmission was set to 0.5 and capture rate was set to 
1.0. The plots shown were run using the set of parameter values described in Tables 
S.3.7 in Appendix 3.1. 
Figure 4.7 shows that by switching surveillance around, the amount of disease 
present at first detection can be reduced (quite considerably in some cases). At low 
between patch transmission, the quicker switching between patches occurs, the 
greater the percentage reduction in the amount of disease at the point of first 
detection that can be seen compared with no switching.  Figure 4.7 also shows that 
switching at rate 0.01 gives reduction in disease of up to 80% compared to not 
switching. This is likely to be because in this case surveillance is moving around the 
region under observation faster than the disease is spreading and is therefore able to 
detect the outbreak before it becomes widespread.   
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4.5 Discussion 
 
Spatial heterogeneity is a big influencing factor on the spread, prevalence and 
persistence of disease (Keeling 1999; Fulford et al. 2002; Ostfeld et al. 2005). In this 
chapter we have explored the consequences of these effects on the efficacy of 
disease surveillance applied to disease incursions into pathogen free host meta‐
populations. Spatial structure and composition of the environment are important 
components in emerging infections (Favier et al. 2005; Suzán et al. 2008) as they will 
help determine the probability of the disease establishing within the population. The 
surveillance strategy (e.g. distribution of effort)  will also determine the time to 
detection of a disease incursion and thus how much and how widespread the disease 
is at the point of first detection (Morse 1995; Blanchong et al. 2008). If the 
surveillance effort is too low, or is deployed in an uninfected area for too long then it 
will be harder to detect disease before the infection has established widely within the 
modelled area. 
In this chapter we considered a relatively stable host population in order to more 
clearly explore the impact of spatial heterogeneity of habitat suitability on the 
performance of surveillance. However, in earlier chapters (2 & 3) we learned the 
importance of population fluctuations in determining the efficacy of surveillance. It 
would therefore be interesting to consider a wider range of host demographics in the 
context of surveillance in spatially extended systems. Moreover, the fact that, in a 
range of systems, spatial heterogeneity has been shown to interact with and typically 
increase the importance of local stochastic population fluctuations (Tilman & Kareiva 
1997) it is likely that the results of chapters 2 and 3 will be equally as important for 
spatially extended surveillance. Therefore, in addition to the effects shown here, 
spatially extended surveillance of wildlife systems are likely to lead to biased and 
lower precision estimates of prevalence and a reduction in the ability to detect 
disease compared with what would be expected under standard binomial 
assessments that ignore population and disease fluctuations. We have already 
explored these effects, driven by temporal heterogeneities in a non‐spatial setting 
and fully expect then to carry over to the spatial case. However, in this chapter we 
have applied a spatial model to explore the effects of spatial heterogeneities on 
surveillance rather than revisit the effect of temporal heterogeneities or consider 
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their interaction with spatial heterogeneity. Nonetheless this would be an interesting 
avenue for further research. 
The task of surveillance is to detect disease before infection becomes a major risk i.e. 
to limit the spread of infection prior to detection such that disease control remains 
logistically and financially possible and/or cost effective.  Firstly, we have explored 
how the number of habitat patches included in surveillance affects the amount of 
disease at first detection. It was shown that by increasing the number of patches that 
are under surveillance at any one time, the amount of disease at first detection 
reduces rapidly, even at low efforts. Increasing the area that surveillance can cover 
will always improve efficacy; however it is usually lack of resources (funding, 
manpower, knowledge etc) that prevent this from being a practical solution.   
As expected the number of patches infected in the space at time of first detection is 
highly sensitive to the between patch rate of transmission a pathogen. The further 
the pathogen can spread spatially, the greater number of sub populations it can 
infect and potentially colonise. In this spatial context, it was shown to have a 
generally larger impact on the amount of disease in the system as a whole compared 
to within patch transmission. Within patch transmission is only able to affect the level 
of disease found in an infected patch and the probability that when infection reaches 
a susceptible patch that it will be able to sustain. 
As mentioned previously, the composition of the environment (i.e. suitability and 
spread of the habitat) can impact surveillance efficacy. Factors which affect the 
stability and size of the population will also affect the stability and spread of an 
emerging disease. It has been demonstrated in this chapter that when the habitat is 
more favourable for the population, this can increase the amount of disease in the 
space at the point of first detection. If the population is stable, it will be easier for the 
pathogen to infect individuals and establish itself in the population. This effect can be 
partially mitigated against when surveillance is targeted in the most favourable 
habitat type. Utilising knowledge about the population and environment by targeting 
areas which are preferable to the population (i.e. due to food sources available, flora, 
and land type) or areas which are known to contain the population because of 
previous sightings for example, enables the surveillance strategy to gain the most 
from the resources available.  This result supports the stratification of surveillance by 
habitat type used by Nusser (2008). 
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While the biggest reduction in the amount of disease at time of first detection was 
arguably seen by increasing the number of patches under surveillance, this, as 
previously discussed, would very rarely be a viable option. Most national and regional 
surveillance strategies would only be able to cover a small percentage of the total 
area. Where resources limit the area under surveillance to only a small fraction of the 
region (1% in the simulations considered here) we have shown in this chapter the 
potential benefits of dynamically switching the surveillance from patch to patch. If 
the time between switching is sufficiently small, this can decrease the amount of 
disease in the system at first detection (i.e. improve the ability of surveillance to 
detect emerging outbreaks), when compared to not switching, by a significant 
percentage (in some cases this was shown to be over 80%). This effect is most 
apparent when the effort rate is high and when the between patch transmission is 
low. 
We have shown that there are alternative strategies to improving the efficacy of 
surveillance than simply increasing the area that surveillance covers. We have also 
demonstrated that, like non‐spatial demographic factors, the spatial ecology of host 
populations in relation to heterogeneous distributions of habitat resources affects 
the efficacy of disease surveillance. It is important to understand the ecology, 
demography and other factors that influence population and disease dynamics (i.e. 
habitat quality, quantity, structure and location). We have identified and 
characterised methods to improve the performance of surveillance when resources 
and thus effort are limited, as they always will be. Two main strategies were 
identified to improve the ability of surveillance networks to detect emerging and re‐
emerging disease threats, namely stratification by habitat suitability and dynamic 
reallocation of surveillance effort. The literature on wildlife disease surveillance 
makes limited reference to the first of these (Witmer 2005; Nusser et al. 2008; Walsh 
& Miller 2010), but we are unaware of any literature that discusses switching. Our 
characterisation of these aspects of surveillance design can be used to inform 
management strategies, as in many applications it will only be possible to cover a 
very small percentage of the total area over which surveillance is required. Therefore 
stratified designs and switching could be deployed to improve surveillance efficacy in 
these instances. The work presented here is a first step towards exploring spatial 
heterogeneity and how this impacts on the efficacy wildlife disease surveillance 
systems. There are many more attributes of ecology that could have been explored, 
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for example fragmentation of habitat (e.g. clumping, corridors), source‐sink dynamics 
and seasonality. As noted above we expect that the interaction of spatial and 
temporal heterogeneities will reduce the efficacy of surveillance in line with the 
results of Chapters 2 and 3. In addition, costs, including switching from one location 
to another, could also be accounted for in assessing efficacy of surveillance design. 
These aspects would be interesting next steps to take the research area forward. 
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Chapter 5 
 
General Discussion: Towards a new 
approach to wildlife disease 
surveillance  
 
5.1 Background 
 
The overall aim of this thesis was to explore how population and disease ecology in wildlife 
affects surveillance efficacy in a spatial and non‐spatial context. The first step of which was 
to seek out known theory and practice used in designing surveillance schemes. The 
literature on wildlife disease surveillance is somewhat lacking in terms of protocols used, 
how they are implemented in the field, approaches used for the analysis of results, and 
documentation describing what equations are used in the design of surveillance schemes. 
From the literature available, it seems that to a large extent, practice for wildlife disease 
surveillance (Artois et al. 2009a) is based on ideas developed for livestock systems. This 
includes both calculation of sample sizes needed for accurate prevalence estimation 
(Grimes & Schulz 1996; Fosgate 2005) and detection of disease within a population (Dohoo 
et al. 2005). Fluctuations in host populations and disease prevalence are ignored in these 
methods, and while constant population size and prevalence may be reasonable 
assumptions for the analysis of livestock systems, they are less appropriate in wildlife 
disease systems that are characteristically subject to much greater fluctuations in host 
population density and disease prevalence. Frosgate (2009) reviews current approaches to 
sample size calculations in livestock systems and emphasises the importance of basing 
analyses on realistic assumptions about the system under surveillance. The above 
discussion strongly suggests that current design and analysis for wildlife disease surveillance 
is not based on realistic assumptions.  
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Despite a long history of research which addresses how stochasticity impacts disease 
prevalence and persistence (Anderson 1991; Renshaw 1991; Marion et al. 2000; Smith et al. 
2005) we are not aware of literature explicitly addressing the implications for surveillance 
design or outcome. Similarly a great deal of work has explored the effects of spatial 
heterogeneity (Sattenspiel & Simon 1988; Cliff 1995; Tilman & Kareiva 1997; Keeling & 
Grenfell 1998; Keeling & Rohani 2007)  on  disease prevalence and persistence. However, 
for the case of intrinsically generated spatial heterogeneity (which emerges purely from 
system dynamics even in a homogeneous environment) again there is nothing to our 
knowledge that specifically addresses how such a fundamental characteristic of spatial 
systems affects the outcome of surveillance. On the other hand there have been papers 
which mention spatial stratification of samples based on extrinsic sources of heterogeneity, 
i.e. biasing surveillance effort towards favourable habitats where the host species will be 
more likely to be found (Nusser et al. 2008; Walsh & Miller 2010).   
As noted above current methods for assessing required sample size in wildlife disease 
surveillance also ignore temporal fluctuations in population size and disease prevalence. In 
addition, spatial heterogeneity is often a major factor in wildlife disease systems which are 
typically characterised by significant fluctuations in both space and time. This contrast 
between the spatial and temporal heterogeneity of real wildlife disease systems and the 
assumptions of homogeneity that underpin current approaches to the design and analysis 
of surveillance in such systems is the gap in knowledge which this thesis has sought to 
address.  
 
5.2 Fluctuations undermine wildlife disease surveillance 
 
This thesis has addressed the issues outlined above by firstly creating a stochastic model 
representing wildlife disease systems and comparing the results with what little common 
practice has been published in regards to surveillance design. This simple but generic model 
represents interactions between the three key elements of wildlife disease surveillance 
systems, i.e. host demographics, pathogen dynamics, and the surveillance effort itself. The 
efficacy of such surveillance was assessed in terms of the following measures: the 
probability with which the surveillance system detects disease, the bias of the prevalence 
estimate and the standard deviation (the inverse of precision) of the prevalence estimate. 
In Chapter 2 this framework was then used to address generic questions about the efficacy 
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of wildlife disease surveillance, by considering a range of parameterisations of host 
demography, representing a broad range of wildlife species, alongside a wide spectrum of 
different pathogens. Plotting the above measures of surveillance efficacy as a function of 
prevalence reveals the range of possible outcomes and allows the impact of key aspects, 
e.g. surveillance effort, sample size and pathogen transmission, to be explored.  
For a simplified surveillance scenario analytical results obtained show that unless the 
covariance of the population and prevalence fluctuations is zero (which is true e.g. if the 
population or prevalence are constant), there would be bias in the surveillance estimate of 
prevalence. This result was confirmed for more realistic surveillance scenarios by stochastic 
simulation of the model. In addition such results were compared with predictions based on 
standard theory which as noted above relies on binomial arguments and assumptions of 
constant population size and prevalence. The simulations showed the bias and standard 
deviation in the estimate of prevalence can be severely underestimated by such standard 
theory. 
Fluctuations in demography and disease dynamics were also shown to compromise the 
ability of surveillance programmes to detect disease. The results in Chapter 2 demonstrated 
that standard binomial theory which ignores such fluctuations can also under estimate the 
power of surveillance programmes to detect disease, i.e. the probability of detecting 
disease is predicted to be much higher than it actually is in reality. This misinformation gives 
rise to over‐confidence in the ability of the surveillance scheme which can only be 
detrimental to the design of surveillance, the interpretation of the results and ultimately to 
the actions taken based on them. This thesis has both highlighted such concerns and begun 
the development of a more complete theoretical underpinning describing how surveillance 
statistics are affected by key characteristics of wildlife systems. This work highlights 
reductions in the efficacy of wildlife disease surveillance caused by population fluctuations 
and stochasticity in disease dynamics. For example, we have highlighted how power 
calculations based on fixed prevalence calculations of the probability of disease detection 
would lead to under powered studies. Moreover the models presented in this chapter and 
the next could be used as the basis for more reliable power calculations. One area that 
deserves attention is the inverse problem, namely how to assess, say true prevalence, given 
only results from surveillance and some knowledge of the underlying wildlife disease 
system. However, this is beyond the scope of this thesis. 
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5.3 Tools for assessing wildlife disease surveillance in real 
systems 
 
In Chapter 3 we demonstrate how the modelling framework introduced in Chapter 2 may 
be adapted and employed as a tool to assess the efficacy of surveillance in real systems. 
Such an approach naturally provides an aid to the design of surveillance programmes if the 
efficacy of multiple surveillance designs are evaluated and compared. We sought to 
quantify the effects identified in Chapter 2 for two specific wildlife‐disease systems to both 
illustrate the power of the model and also to better understand surveillance in badger and 
rabbit populations. This work showed that the generic findings of Chapter 2 are relevant to 
real wildlife disease systems. Focusing on disease induced mortality as a natural source of 
bias found in wild populations, we have demonstrated that the interaction between disease 
dynamics and population stability impacts the ability to both detect disease and accurately 
estimate the prevalence in the population, as was shown for a wide class of systems in 
Chapter 2.  
We extended the theory quantified from Chapter 2 to explore other known, previously 
acknowledged, sources of bias to assess the effect they have on the efficacy of surveillance. 
Bias in the trappability of an infected host, biases the surveillance prevalence estimate. This 
can happen in two ways; there will be a positive bias (i.e. the surveillance over‐estimates 
the prevalence) if individuals are trap happy, and there will be negative bias (i.e. the 
surveillance under‐estimates the prevalence) if the individuals are trap shy. The probability 
of detection decreased for infected individuals showing trap shy behaviour, and this is to be 
expected as this lowers the likelihood of an infected individual being caught and lowers the 
chance the infection will be detected. 
The impact of the sensitivity of diagnostic tests of disease used in surveillance was also 
explored and showed some interesting results. Imperfections in diagnostic tests would 
appear to mask the effect of fluctuations on the ability of surveillance to detect disease in 
that for poor tests the resulting probability of detection (based on simulations that account 
for fluctuations) is close to the constant prevalence theory estimate. As test sensitivity 
increases the difference between the true probability of detection and the constant 
prevalence theory prediction widens. We can conclude that gains in the sensitivity of 
diagnostics are likely to be reduced in the field by the effects of fluctuations. On the other 
hand these results also suggest that as test sensitivities increase the inadequacies of 
standard theory should become more transparent.  
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In summary we can assert that there are clear differences between the constant prevalence 
theory estimates and our simulated results. The latter, account for fluctuations in host 
population and disease dynamics, and clearly show impacts on the efficacy of surveillance. 
These effects have the potential to impact management strategies for current disease 
challenges and should be assessed through simulation tools such as those introduced here 
and explored further in the field 
5.4 Spatial heterogeneity and the design of wildlife disease 
surveillance 
 
The generic framework was extended to incorporate spatial heterogeneity. The impact of 
design on the ability of spatially distributed surveillance networks to detect emergent 
disease at a regional scale was then assessed.  Moving on from the non‐spatial models used 
in the previous two chapters, chapter four aimed to explore how the ecology of populations 
in space would affect the efficacy of surveillance in an incursion scenario. We paid particular 
attention to how surveillance would be distributed and how habitat quality affecting the 
population would then go on to affect the surveillance outcome. By calculating the amount 
of disease in the system at the point of first detection it was clear that the more “patches” 
in space the surveillance was able to visit at one time greatly reduced the amount of disease 
seen in the system. In practice active surveillance can be prohibitively expensive and 
funding is often a limiting factor. Furthermore, the amount of time/manpower required to 
cover a large enough area of the habitat under surveillance may be unfeasible. 
 
To address this issue, we explored the idea of only visiting a select percentage of the spatial 
system, but switch periodically around the space using different strategies (i.e. only 
focusing on good habitat areas). When the time between each switching was very small and 
the effort (capture rate) of surveillance was large enough, there was a reduction in the 
amount of disease present at time of first detection. The biggest effect seen in switching the 
surveillance around the spatial system happened at high effort (capture rate), low between 
patch transmission and sampling the favourable habitat patches only. The first factor, high 
effort, is intuitively important in the efficacy of surveillance, and has been demonstrated to 
impact on surveillance in Chapter 2. The more effort that is put into surveillance, the 
quicker the disease will be detected, and therefore the less disease will be present at the 
time of first detection. Switching is more likely to be advantageous when the between 
patch transmission rate is low, as the spread between patch to patch will be limited and 
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surveillance (if the effort is high enough) will have a better chance of detecting disease 
before it has developed into a major risk.  
 
We have seen instances before of strategies targeting surveillance in order to improve the 
probability of collecting samples (Nusser et al. 2008; Walsh & Miller 2010) discussed in 
Chapter 2, here we have explored the effect of this strategy further. Comparing the 
reduction in disease at the point of detection when targeting favourable habitat to choosing 
patches randomly to be under surveillance, we have shown that there is an advantage in 
targeting habitats in which the population thrives. Again, this is intuitive as a surveillance 
strategy which targets areas in which the population lives (and preferably is stable) will 
have a higher probability of detecting infection if the population has been exposed to an 
incursion. Knowledge about the population and environment (i.e. food sources available, 
flora, land type, behaviours of host, social structure) should always be incorporated into 
management strategies as this enables the surveillance strategy to gain the most from the 
resources available.  
 
5.5 Future Work 
 
This thesis has demonstrated the importance of understanding demographic fluctuations 
and disease dynamics in the host population when undertaking surveillance. The potential 
for both implementations (SDE and Gillespie) of the stochastic model used in Chapter 2 
have been highlighted in Chapter 3, but there are still many other attributes of 
demography, surveillance, habitat and environmental factors that are still to be explored.    
In terms of surveillance, throughout this thesis we have only considered a type of active 
surveillance. However, in terms of national wildlife disease surveillance, passive surveillance 
is most often used around the world, as discussed previously, as resources for active 
surveillance can be limited. It would be interesting to explore the impact demographic 
fluctuations and disease dynamics have on passive surveillance, especially in cases of high 
disease induced mortality. Since passive surveillance is predominantly the collection of 
deceased animals (road kill, death by natural causes, hunting etc), there is a large scope for 
bias in the sample, especially when trying to estimate the prevalence. We have shown in 
Chapter 2 and Chapter 3 how much bias can be seen when dealing with active surveillance, 
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and as passive surveillance has an associated bias of its own, the results found previously 
have the potential to be magnified quite considerably. The demographic components 
associated with passive surveillance (decay of deceased individuals, scavenge rate of 
deceased individuals, probability of detecting deceased individuals, probability of public 
reporting a finding for potential testing etc) could be easily incorporated into the existing 
model as additional rates. The decay aspect for example could be included as an 
exponential rate increasing with time. This would multiply by the number of deceased 
individuals to determine the probability of full decomposition and removal from the 
deceased population. This approach would reflect that the probability of a dead body 
decomposing completely increases with the amount of time spent deceased.    
In an effort to keep the complexity of the stochastic model at a manageable level, and to 
leave scope for several different applications, there are common population traits that have 
not been included. It would be possible to distinguish between attributes such as, sex, age, 
dominance, added disease states etc, and to explore the effect of these on the efficacy of 
surveillance. For example, if there was a “recovered” state included in the disease 
dynamics, it would be interesting to explore how this would affect the bias seen previously 
in the prevalence estimate and probability of detection. This could be particularly significant 
when disease induced mortality is included in the disease dynamics. In addition inclusion of 
such a disease related state would complicate the modelling of surveillance since it is likely 
that different diagnostic tests would detect individuals in latent and infective states and the 
recovered state. The former would be targeted by pathogen recovery e.g. bacterial culture 
or DNA based tests for the presence and abundance of pathogens, whereas the latter would 
most likely be detected by tests based on serological analysis indicating exposure to a 
pathogen e.g. detecting antibodies (Teunis et al. 2002; Bidet et al. 2008; López‐Olvera et al. 
2010). The contrasting nature of these diagnostic tools would require identification of 
appropriate sensitivity and specificity levels associated with testing animals in different 
disease states. This would add to the complexity of modelling but such an analysis may 
reveal further sources of bias and uncertainty in wildlife disease surveillance.  
An external influence that has not been considered is climate; seasonality is known to affect 
the spread of disease (Dowell 2001; Altizer et al. 2006); and  climate change is predicted to 
have significant impacts on disease (Anderson et al. 2004; Trenberth 2008). Seasonality 
could impact the stochastic fluctuations of the population as many natural populations have 
specific breeding seasons. Limiting the growth of the population to certain seasons could, in 
116 
 
some cases, decrease the overall system stability if a disease had a high enough disease 
induced mortality rate. We have seen previously in this thesis that unstable population 
dynamics have a big impact on the bias and uncertainty of the prevalence estimate as well 
as in the probability of detection. Seasonal reproduction drives the total numbers of 
animals on the ground to dramatically increase in spring and summer compared to the 
autumn/winter population size. Furthermore the disease susceptibility profile of the 
population changes as disease‐resistant adult dominated populations are diluted with 
disease susceptible young. As well as this, winter is often associated with starvation and the 
adults surviving winter frequently emerge with a compromised immune system. There are 
well known and already characterised drivers of population fluctuation and disease 
dynamics, and the results obtained in this thesis strongly suggest that such factors need to 
be considered when designing wildlife disease surveillance. There is also scope for including 
such things as extreme weather events, for example. Climate change and extreme weather 
events have the potential to increase the prevalence of disease within a population 
(D’Amato et al. 2013) which could well have adverse consequences for the efficacy of 
surveillance i.e. if the influx of disease was rapid, surveillance might be too slow at 
detecting disease which would lead to increased disease risk.     
Spatial heterogeneity has been explored in Chapter 4 in terms of the ability of surveillance 
to detect disease incursion in spatially explicit wildlife disease system, but there are many 
more avenues to explore. Habitat distribution is known to influence both the host 
population demography and persistence of disease (Fahrig 2003). We have touched upon 
this by considering suitability of habitat and proportion of suitable habitat within the space. 
However another aspect we have yet to explore is clumping of habitat, i.e. the tendency of 
habitat patches of similar types be closer together than typical distances to habitats of a 
different type. If the habitat is clumped, this can mean that if disease is introduced into a 
clump then it will have a strong chance of spreading and sustaining itself in nearby habitats. 
However, other clumps of habitat patches of the same type (e.g. habitat suitable for a given 
host species) may be at less risk if the distance between such clumps is too far for the 
disease to travel. Clumping of habitats can lead to populations becoming isolated and to 
preserve species diversity, often corridors are introduced to allow animals to move from 
habitat clumps. While this can be good for the overall population level, it can also lead to an 
increase in the spread and persistence of disease. This has an obvious potential to impact 
on the efficacy of surveillance and it would be a worthwhile area to explore.  
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This thesis has been a first step in characterising how key ecological features of natural 
populations impact on surveillance efficacy. We have shown that currently standard 
assumptions made when designing surveillance strategies and design over‐look important 
stochastic fluctuations and biases found in estimating prevalence. Taking this research 
forward will hopefully benefit surveillance in the field by aiding more informed design, and 
interpretation of results. As the recent example of the West Africa Ebola outbreak has 
highlighted (Nishiura & Chowell 2014; PHE 2014), there is still a clear need for better 
disease surveillance strategies. The findings of this research should be investigated in the 
field to assess how important the relationships we have characterised are in practice. We 
have shown there are several factors which affect the efficacy of surveillance and at the 
very least should be considered when designing surveillance programs. Although wildlife 
disease surveillance has been our motivating example, there is no reason why the effects 
discussed in this thesis or related phenomena should not be applicable to human and 
livestock populations e.g. that are subject to large population fluctuations. It is difficult to 
give specific recommendations for wildlife disease surveillance, as each host‐pathogen 
system is unique. However we have presented results (e.g. specific graphs) that span a 
broad spectrum of wildlife disease systems, and these perhaps be used to design relatively 
robust surveillance systems (e.g. Figure 2.4) . In addition Chapter 3 demonstrated that we 
have developed tools in the form of our stochastic simulation models and the wider 
framework within which we have used them to assess the efficacy of different surveillance 
systems. This research demonstrated the potential to apply this framework to specific host 
populations and diseases of current interest, In addition the model we have developed has 
the scope to be adapted and used in many different situations. We conclude that host 
demography, disease dynamics and spatial heterogeneity do impact on the efficacy of 
surveillance and must be considered when undertaking/designing surveillance of wildlife 
disease systems. 
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  Appendices  
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Appendix 1  
 
1.1 Relationship between discrete and continuous (SDE) state-
space model implementations 
 
In this appendix we describe the relationship between the continuous time discrete state‐
space Markov process and the stochastic differential equation (SDE) implementations of the 
model described in the main text. 
Our starting point is the SI model described in Table 2.1 (main text) implemented as a 
continuous time discrete state‐space Markov process in which the number of infected 
individuals I(t) and total population size N(t) = S(t)+I(t), are represented as integer variables.  
The Gillespie algorithm exploits the fact that the time between events is distributed 
exponentially with parameter R(t) given by the sum of all the event rates in Table 2.1 and 
the probability that a given event occurs is given by the associated event rate divided by 
R(t).   
However, under this implementation one can also consider the expectation and variance‐
covariance of the change in the state‐space variables I(t) and N(t) during a small time 
interval. For convenience denote the state of the system at time t by X(t)={I(t),N(t)}. Then 
for example, conditional on the state of the system at time t, the expected change in the 
population size associated with birth events from time t to t+δt is given by EB[δN(t)|X(t)] = 
rN(t) (1 – N(t)/k)δt. Similarly, the variance in δN associated with birth events is VarB[δN(t)]= 
rN(t) (1 – N(t)/k)δt + O(δt2), and henceforth we will assume δt is sufficiently small to ignore 
the higher order terms. In the model described in the main text (see Table 2.1 and 
surrounding text) all individuals are born susceptible and therefore birth does not affect the 
infective population size I(t) i.e. EB[δI(t)|X(t)] = 0, VarB[δI(t)]=0, and CovB [δI(t),δN(t)|X(t)]=0. 
However, migration of infectives affects both I(t) and N(t) and to first order in δt we find 
that EmI[δN(t)|X(t)]= γνδt, VarmI[δN(t)]= γνδt, EmI[δI(t)|X(t)] = γ ν δt, VarmI[δI(t)]= γ ν δt  and 
CovmI [δI(t),δN(t)|X(t)]= γνδt. The full set of first‐ and second‐order statistics describing 
changes in the state‐space associated with each event type are given (up to first order in δt) 
in Table S.1.1.  
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Table S.1.1: Expectations and variance‐covariances in changes (during the time interval t to 
t+δt) to the state space {I(t),N(t)} associated with each event type in the discrete state‐
space model described in the main text (see Table 1.1). All such quantities are shown to first 
order in δt. Note: capture and release events are omitted since they affect neither I(t) or 
N(t). 
We now show how to construct a continuous time, continuous state‐space (diffusion) 
version of the model which is consistent with above implementation in that it preserves the 
means and variance‐covariance statistics shown in Table S.1.1. To do so we construct a set 
of stochastic differential equations (SDEs) which we later solve numerically in discrete time 
steps (Mao 1997; Higham 2001).  The following Itô stochastic differential equations 
represent the change in the system state variables during an infinitesimally small time 
interval dt 
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Here the quantities BB(t), BDS(t), BDI(t), BmS(t), BmI(t), B1ry(t), B2ry(t) are independent Brownian 
motions corresponding to each of the seven event types and the correct interpretation of 
these equations requires consideration of associated stochastic intergrals (REF). For small 
but finite dt the quantities dBB(t), dBDS(t), dBDI(t), dBmS(t), dBmI(t), dB1ry(t), dB2ry(t) can be 
interpreted as independent draws from a zero mean Gaussian with variance dt for each 
event type and each time point 0,dt,2dt, ... ,Tϵ(0,T).  Thus e.g. E[dBB(t)]=0, E[dBB(t)dBB(t)]=0 
and E[dBB(t)dBDS(t)]=0. This discretisation is the basis for the numerical simulation of these 
SDEs used in this paper. 
The so‐called drift, fN,B(X(t)), fN,DS(X(t)), fN,DI(X(t)), fN,mS(X(t)), fN,mI(X(t)), fN,1ry(X(t)), fN,2ry(X(t)) 
and diffusion, gN,B(X(t)), gN,DS(X(t)), gN,DI(X(t)), gN,mS(X(t)), gN,mI(X(t)), gN,1ry(X(t)), gN,2ry(X(t)), 
terms representing changes in the variable N(t) and the corresponding quantities 
representing changes in I(t) are deterministic functions of the state‐space X(t) determined 
as follows. 
Given the nature of the Brownian motions taking the expectation of the above equations 
yields 
 [   ( )| ( )]
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Which suggests that for each event type Etype fN,Eype(X(t)) and fI,Etype(X(t)) should be 
interpreted as the mean update shown in Table S1 for N(t) and I(t) respectively.  For 
example,    ,     ( )  and    ,     ( )  are both zero since only birth, death and migration 
change the population size, i.e. neither primary nor secondary infection changes the 
population size. 
The variance in the update for N(t) is given by  
Var[   ( )| ( )]=  [   ( ) | ( )]−  [   ( )| ( )]  
However, we have just shown that E[dN(t)|X(t)] is of order dt and therefore to first order in 
dt we can write 
  Var[   ( )| ( )]=  [   ( ) | ( )]=  
   ,    ( ) 
 
  +     ,     ( ) 
 
  +     ,    ( ) 
 
  +      ,     ( ) 
 
       
+     ,     ( ) 
 
  +    ,     ( ) 
 
  +     ,     ( ) 
 
   
and  
 Var[  ( )| ( )]=  [  ( ) | ( )]=   
  ,    ( ) 
 
  +     ,     ( ) 
 
  +     ,    ( ) 
 
  +   ,     ( ) 
 
      
+     ,     ( ) 
 
  +    ,     ( ) 
 
  +    ,     ( ) 
 
     
Here we have made use of the independent nature of the Brownian motions described 
above. 
 
These last two equations therefore suggest that for each event type Etype, gN,Etype(X(t))
2 and 
gI,Etype(X(t))
2 should be interpreted as the variance in update shown in Table S.1.1 for N(t) 
and I(t) respectively.   
The above calculations are summarised in Table S.1.2. Comparison with Table S.1.1 allows 
the functional form for each drift and diffusion term to be identified. 
Finally, the covariance  
Cov[   ( )  ( )| ( )]=  [   ( )  ( )| ( )]−  [   ( )| ( )] [  ( )| ( )] 
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to first order in dt is given by  
Cov[   ( )  ( )| ( )]=  [   ( )  ( )| ( )]= 
+      ,    ( )   ,    ( )   +      ,     ( )   ,     ( )      
where we have shown only the non‐zero terms. Comparison with the functional forms for 
the diffusion terms described above shows that this expression is consistent with the 
covariance terms shown in Table S.1.1. 
 
 
 
 
 
 
 
 
 
 
Table S.1.2: Expectation and variance‐covariances in changes (during the time interval t to 
t+dt) to the state space {I(t),N(t)} associated with each event type in the SDE model as 
described in Appendix 1. All such quantities are shown to first order in dt.  Comparison with 
Table S.1.1 enables both drift e.g. fN,B(X(t)) and diffusion e.g. gN,B(X(t)) functions to be 
identified. Note: capture and release events are omitted since they affect neither I(t) or 
N(t). 
 
  
  
E-
type 
Event E[δN|X(t)] E[δI|X(t)] Var[δN|X(t)] Var[I|X(t)] 
B    ,    ( )      ,    ( )        ,    ( ) 
 
      ,    ( ) 
 
   0 
DS    ,     ( )      ,     ( )        ,     ( ) 
 
      ,     ( ) 
 
   0 
DI    ,    ( )       ,    ( )        ,    ( ) 
 
      ,    ( ) 
 
      ,    ( ) 
×   ,    ( )    
mS    ,     ( )      ,     ( )        ,     ( ) 
 
      ,     ( ) 
 
   0 
mI    ,     ( )      ,     ( )        ,     ( ) 
 
      ,     ( ) 
 
      ,     ( ) 
×   ,     ( )    
1ry    ,     ( )       ,     ( )        ,     ( ) 
 
      ,     ( ) 
 
   0 
2ry     ,     ( ) dt    ,     ( )       ,     ( ) 
 
      ,     ( ) 
 
   0 
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1.2 Parameterisations used 
 
This section of the appendix describes in detail the parameter combinations used to 
produce the graphs in the main text. Values of the form: a,b,c,d etc refer to discrete values 
used for different lines shown on the Figures. Values of the form a;b;c refer to smallest 
value; largest value; step size describing the range of values (e.g. of the death rate) 
simulated to produce the Figures. Values of the form a – b refer to the range of values 
covered with a non‐constant step size. All other parameters with single values are held 
constant in simulations. 
 
 
 
 
 
 
 
 
Table S.1.3: Parameter values are shown for Figure 2.1 in the main text which demonstrates 
the effect of the death rate and transmission rate on the bias and variance of the 
prevalence estimate as well as the effect of the death rate on the population size and 
variance. 100,000 simulations are run of each combination and terminate when the sample 
target is reached, i.e. there is no time limit imposed. These parameters were implemented 
using the SDE version of the model.    
 
  
Rate Name Rate Value 
Secondary Transmission Rate β 1.0, 0.1, 0.04, 0.01 
Carrying Capacity k 120 
Growth Rate r 0.5 
Death Rate  µ 0.1;0.5;0.1 
Immigration  ν 0.1 
Infected Immigration Proportion γ 0.1 
Primary Transmission Rate β0 0 
Susceptible Active Capture α 0.1 
Infected Active Capture α 0.1 
Sample Target m 10.0 
125 
 
 
 
 
 
 
 
 
 
Table S.1.4: Parameter values are shown for Figure 2.2 in the main text which demonstrates 
the effect of the capture rate on the bias and variance of the prevalence estimate. 100,000 
simulations are run of each combination and terminate when the sample target is reached, 
i.e. there is no time limit imposed. These parameters were implemented using the SDE 
version of the model.    
 
 
 
 
 
 
 
 
Table S.1.5: Parameter values are shown for Figure 2.2 in the main text which demonstrates 
the effect of the sample size on the bias and variance of the prevalence estimate. 100,000 
simulations are run of each combination and terminate when the sample target is reached, 
i.e. there is no time limit imposed. These parameters were implemented using the SDE 
version of the model. 
 
 
  
Rate Name Rate Value 
Secondary Transmission Rate β 1.0, 0.1 
Carrying Capacity k 120 
Growth Rate r 0.5 
Death Rate  µ 0.4, 0.43 
Immigration  ν 0.1 
Infected Immigration Proportion γ 0.1 
Primary Transmission Rate β0 0 
Susceptible Active Capture α 0 - 10 
Infected Active Capture α 0 - 10 
Sample Target m 10.0 
Rate Name Rate Value 
Secondary Transmission Rate β 1.0, 0.1 
Carrying Capacity k 120 
Growth Rate r 0.5 
Death Rate  µ 0.4, 0.43 
Immigration  ν 0.1 
Infected Immigration Proportion γ 0.1 
Primary Transmission Rate β0 0 
Susceptible Active Capture α 0.1 
Infected Active Capture α 0.1 
Sample Target m 1 - 10000 
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Table S.1.6: Parameter values are shown for Figure 2.3 in the main text which 
demonstrates the effect of the death rate and transmission rate, as well as the sample 
size and capture rate, on the probability of detecting disease. 100,000 simulations are 
run of each combination and terminate when the sample target is reached, i.e. there is 
no time limit imposed. These parameters were implemented using the SDE version of 
the model. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rate Name Rate Value 
Secondary Transmission Rate β 1.0, 0.1, 0.04, 0.01 
Carrying Capacity k 120 
Growth Rate r 0.5 
Death Rate  µ 0.1;0.5;0.01 
Immigration  ν 0.1 
Infected Immigration Proportion γ 0.1 
Primary Transmission Rate β0 0 
Susceptible Active Capture α 10, 1.0, 0.1, 0.01 
Infected Active Capture α 10, 1.0, 0.1, 0.01 
Sample Target m 10 
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Table S.1.7: Parameter values are shown for Figure 2.4 in the main text which 
demonstrates the effect of the transmission, death rate, birth rate, carrying capacity, as 
well as the sample size, on the probability of detecting disease. 1000 simulations were 
run per parameter combination with a time limit of 45. If the simulation did not reach 
the sample target within the time limit, the run is discarded and not used in the 
statistical calculations. If out of 1000 realisations a parameter combination ceases to 
reach the sample target at least 15 times, that parameter combination is discarded 
totally as the results are deemed to be unreliable. Increasing the time limit bears little to 
no effect on the amount simulations which reach the target sample, so the precise value 
of the time limit does not affect the results obtained from the model. These parameters 
were implemented using the Gillespie version of the model.  
  
Rate Name Rate Value 
Secondary Transmission Rate β 0.01,0.05,0.09,0.2,0.6, 
1.0,2.0,5.0 
Carrying Capacity k 1;36.0;3.5 
Growth Rate r 0.5;23;2.5 
Death Rate  µ 0.25;14.0;1.25 
Immigration  ν 1.0 
Infected Immigration Proportion γ 0.01 
Primary Transmission Rate β0 0.01 
Susceptible Active Capture α 0.5 
Infected Active Capture α 0.5 
Sample Target m 10.0, 20.0 
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Appendix 2 
Appendix 2.1 
 
2.1.1 Estimating Badger Parameters 
 
The paper on which the badger parameter exploration was based, Shirley et al 2003, 
describes an individual based spatially explicit model, using discrete probabilities for all 
event types. The model obtains data from each badger at 6 month intervals to determine 
the life history. The model accounts for sex, three separate age classes (cub, juvenile and 
adult), TB status and breeding structure where only one dominant breeding pair produce 
offspring. This creates additional difficulties when deriving parameters for the models used 
in this thesis since not only do we need to translate from discrete to continuous time 
formulations we also need to define average rates in our model using information 
describing the various classes defined in Shirley et al. Information was also used from 
Rogers et al 2003 and Kruuk and Parish 1982 for the carrying capacity estimate. Below we 
discuss how we translate between the parameters given in Shirley et al 2003 and those 
required for the models used in Chapter 2. 
2.1.1.1 Discrete to continuous time 
 
Suppose under the discrete time model there is a time step which represents Δt units of 
time (e.g. 6 months in the above example) and a given event type happens with probability 
P during this interval. For example, this event might correspond to a transition from one age 
class to another (i.e. survival to a given age). Starting at time t=0 the probability that this 
event has yet to occur after n time steps i.e. by time t=nΔt is given by:  
(1 −  )  
On the other hand consider an analogous continuous time Markov process where the event 
rate is α, then as we saw in Chapter 1, the probability that the event has yet to occur by 
time t=nΔt is: 
   ∝  ∆  
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Equating the last two equations, taking logs and noting that the number of time steps n 
cancels we obtain: 
∝ = −
ln (1 −  )
∆ 
,  
which enables translation between discrete and continuous time parameterisations.  Also 
note that when P is small ‐ln(1‐P) ~ P and this can be approximated by α=P/ Δt. 
Considering the event described above as the survival of an individual through a stage class 
(e.g. relating to an age range or a developmental stage) the average time spent in the stage 
is given by the length of each time step multiplied by the average number of steps before 
the event occurs, i.e. Δt*1/P in the discrete time model. This results from the fact that the 
probability of making a transition to the next stage class at time step n is given by a 
geometric distribution with a probability P of success per trial – which has mean 1/P (Consul 
et al. 2006). In the continuous time model the time to the next event is an exponential 
distribution (as shown above) which has mean 1/α. Equating these expected times from the 
discrete and continuous time models leads to:  
∝ =
 
∆ 
 ,  
which as we saw is equivalent to the previous formula when P is sufficiently small. 
2.1.1.2 Translating from multi- to single-stage models 
 
Where parameters are available for multiple stages e.g. age or developmental stages, one 
approach to parameterising a model with only a single stage is to focus on the expected 
time spent transiting all the stages. For example Shirley et al 2003 consider cubs, juveniles 
and adults and therefore if we wish to consider mortality we need to estimate the expected 
lifespan i.e. the average time taken to transit all three of these stages from birth to death.  
Suppose in a discrete time stage structured model, the length of the first two stages are 
both a single time step and the probability of surviving the cub stage is A and the probability 
of surviving the juvenile stage is B. Thereafter if the probability of surviving each time step 
as an adult is C, then as we saw above the average number of time steps spent as an adult is 
1/C i.e. time spent as an adult = Δt*1/C. However, since it takes two time steps to reach the 
adult stage then the expected life time would be Δt*(2+1/C) if the survival of  
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cubs to juveniles and juveniles to adults were both assured i.e where A=B=1.  
In cases where A,B<1 and only a fraction of cubs and juveniles survive we calculate the 
expected life span in terms of the contribution from three groups, namely those that die as 
cubs, those that die as juveniles or those that die as adults. To do so, we consider the 
probability that an individual is in each category multiplied by the length of life in each 
category. However, note that in the discrete time model we only count in full time steps 
and therefore individuals that die as cubs do not contribute to the expected lifespan.  
The probability that an individual dies as a juvenile is A*(1‐B) i.e. they survived the cub stage 
but died during the juvenile stage. Individuals in this category live for one but less than two 
time steps and therefore each contributes Δt*1 to the expected lifespan.  
The probability that an individual dies as an adult is A*B*1 since any individual that reaches 
adulthood will die as an adult. The fact that such individuals have survived both the cub and 
juvenile stages means their age is at least  Δt*2. However, once an individual reaches 
adulthood its chance of survival per time step is C, and as we saw above this means that the 
expected number of time steps it spends as an adult is 1/C. Therefore, on average, 
individuals that die as adults will have lived (2+1/C)* Δt.  Putting these calculations together 
leads to an expected lifespan τ of: 
  =  (1 −  )∆ +     2 +
1
 
  ∆  
Which simplifies to:  
  =    1 +    1 +
1
 
    ∆  
As discussed above, this expected lifespan can be used to define the death rate in an 
unstructured continuous time model as 1/τ. 
We have utilised the methods above to estimate the badger parameters as follows. 
 Carrying Capacity used in the continuous time model K = 20 
 
European badger social groups documented in the literature range from 1 or 2 (Kruuk & 
Parish 2009) up to 27 (Rogers et al. 1997). Using this information the total carrying capacity 
used in the simulations presented here was chosen to be 20 to simulate a group large 
enough (around 18) to calculate meaningful statistics but not so large as to be extreme. We 
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tested the parameter choice for robustness and found that using a larger carrying capacity 
had little effect on the overall results. 
 
 Death rate used in the continuous time model d = 0.313 
 
This rate was derived using information from (Shirley et al. 2003) and calculating the life 
expectancy (LE) for Males and Females separately using a geometric distribution, as the 
model uses discrete time. Female badgers born have a probability 0.76 of dying while in the 
cub stage per 6 month period, probability 0.771 of dying in the adolescent stage and 
probability 0.122 of dying in the adult stage, the corresponding probabilities for Males are 
0.76, 0.704 and 0.161 respectively. Using information we can calculate the LE for females 
and males as follows: 
 
Female: 
 
     .      .      
 
 .   
   
= 3.5745 
 
Male:  
 
     .      .      
 
 .   
   
= 2.8091 
 
Averaged over sex, the average lifespan is calculated to be 3.1918. Therefore the annual 
mortality rate using a geometric distribution with mean 1/p is 1/3.1918 = 0.313. 
 
 
 Per capita growth rate used in the continuous time model r = 5 
 
Again, using information from (Shirley et al. 2003)  we find that the average litter size for a 
breeding pair is  2.97 and the average number of litters per pair is 1.1206. We can deduce 
therefore that the breeding pair will contribute 3.328 to the population per year. However, 
in our continuous time model we do not represent breeding structure and therefore need 
to translate this average number of offspring produced per year into an average annual 
growth rate per capita. This of course is dependent on the typical population size which in 
turn depends on the birth rate (given the death rate defined above). We therefore ran a set 
of simulations in which the birth rate was varied until we obtained a relatively stable 
population with an average population of 18 which lead to the choice of r = 5.  
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 Disease induced mortality rate used in the continuous time model μI = 0.165 
 
A small percentage of badgers infected with TB will become super‐excretors. These 
animals shed a lot more virus and also have a higher mortality rate associated with 
them. In the Shirley et al paper, only super‐exretors had added life history 
consequences, whilst both excretors and super excretors are infectious. Shirley et al 
2003 quote figurers describing the average length of time individuals spend as excretors 
and super‐excretors which reveals that as a fraction of the time spent infectious 0.6308 
was spent as a super‐excretor experiencing higher levels of mortality.  The mean super 
excretor mortality over both genders was calculated to be a probability of 0.2415 and 
therefore we estimate the probability of death for infections individuals to be  0 x (1‐
0.6308)+ 0.2415*0.6308. Therefore, using the formula for conversion between discrete 
and continuous time models described above our disease induced mortality rate is 
0.165 
 
 Disease transmission rate used in the continuous time model β = 0.057  
 
From Shirley et al 2003, transmission rate for both excretors and super excretors are 
said to “vary”. Therefore, through simulation of the stochastic model transmission rate 
for TB has been set at 0.057 to get an average prevalence around 48%. There are 
various reports of prevalence from badger studies and we we’re aiming for an average 
between 40% – 60%. Considering information from Zijerveld (2012), the estimated 
overall death rate = 0.4 but the author did not look at disease induced mortality 
separately. Therefore the average death rate for the parameters considered in this 
research should equal (n*0.313+I*0.165)/n=0.4 => 0.313+(I/n)*0.165=0.4, assuming  n 
individuals of whom I are infected. This then leads to a prevalence of (I/n) = (0.4‐
0.313)/0.165=0.5272~0.53. This is approximately consistent with the average 
prevalence levels simulated in this research. 
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2.1.2 Estimating Rabbit Parameters 
  
The paper on which the rabbit parameter exploration was based, Judge et al 2007, 
describes an individual based continuous time, stochastic process with state‐space defined 
by sex, age, disease status and location of each animal.  
 Carrying Capacity used in the continuous time model K = 115 
 
Using information from Judge et al 2007, rabbit social groups have a typical maximum 
population size of around 90 individuals. We set the carrying capacity based on the birth 
and death rate so that the population can peak around this number but the equilibrium is 
below (around 65). 
 
 Per capita death rate used in the continuous time model μ = 5.7 
 
Using monthly death rates for rabbits at different life stages (i.e. adult, adolescent, infant) 
we calculated ((0.0909+0.667+0.25+0.66)/4)*12 = 5.0 as an approximate death rate not 
taking into account time spent in each stage. Using simulation results we increased this 
slightly to 5.7 to produce realistic population fluctuations. 
 
 Intrinsic growth rate used in the continuous time model r = 13.5 
 
From the adult female birth rate in Judge et al 2007, a straight forward calculation of 
1.67*12 (i.e. birth rate multiplied by 12 months) would give approximately 20.0 as the birth 
rate. However, as the model in Judge et al 2007 differentiated sex and age, we might expect 
this estimate to be a little crude and indeed simulations where we employ the above death 
rates and carrying capacity, but vary the birth rate to target a typical population size of 
around 65 unsurprisingly do suggest a lower birth rate. This process led to the selection of a 
birth rate of 13.5 as this gave a more realistic depiction of rabbit population dynamics. 
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 Disease transmission rate interval β = 0.156 – 0.565  
 
Judge et al 2007 employed a statistical estimate of the disease transmission rate per 
susceptible‐infective pair used in the range 0.013‐0.046 per month. Therefore, based on 
these values, the range was calculated as 0.013*12 and 0.046*12 = 0.156 – 0.565. Rates 
chosen were within this calculated interval. 
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Appendix 2.2 
 
2.2.1 Parameterisations used 
 
This section of the appendix describes in detail the parameter combinations used to 
produce the graphs in the main text. Values of the form: a,b,c,d etc refer to discrete values 
used for different lines shown on the Figures. Values of the form a;b;c refer to smallest 
value; largest value; step size describing the range of values (e.g. of the death rate) 
simulated to produce the Figures. Values of the form a – b refer to the range of values 
covered with a non‐constant step size. All other parameters with single values are held 
constant in simulations. 
Badgers 
 
 
 
 
 
 
 
Table S.2.1: Parameter values are shown for part a in both sections of Figure 1 in the 
main text which demonstrates 1 realisation of the badger population through time using 
the Gillespie and SDE implementation. The Gillespie example is shown from time 0 until 
time 25 and the SDE model is shown from time 60 until time 80 to allow a longer burn in 
period. 
 
 
 
 
 
 
Rate Name Rate Value 
Secondary Transmission Rate β 0.057 
Carrying Capacity k 20 
Growth Rate r 5 
Death Rate  µ 0.313 
Infected Death Rate µi 0.165 
Immigration  ν 0.1 
Infected Immigration Proportion γ 0.1 
Primary Transmission Rate β0 0.1 
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Rabbits 
 
 
 
 
 
 
 
Table S.2.2: Parameter values are shown for part b and c in both sections of Figure 1 in the 
main text which demonstrates 1 realisation of the rabbit population through time using the 
Gillespie and SDE implementation. The Gillespie example is shown from time 0 until time 25 
and the SDE model is shown from time 60 until time 80 to allow a longer burn in period. 
 
 
 
 
 
 
 
 
Table S.2.3: Parameter values are shown for Figure 3.2 in the main text which 
demonstrates the effect of the infected death rate and transmission rate on the bias 
and variance of the prevalence estimate as well as the effect of the death rate on the 
population size and variance in a badger population. 100,000 simulations are run of 
each combination and terminate when the sample target is reached, i.e. there is no time 
limit imposed. These parameters were implemented using the SDE version of the model.    
 
 
Rate Name Rate Value 
Secondary Transmission Rate β 0.156, 0.552 
Carrying Capacity k 115 
Growth Rate r 13.5 
Death Rate  µ 5.7 
Infected Death Rate µi 0 
Immigration  ν 0.1 
Infected Immigration Proportion γ 0.1 
Primary Transmission Rate β0 0.1 
Rate Name Rate Value 
Secondary Transmission Rate β 1.0, 0.5, 0.057 
Carrying Capacity k 20 
Growth Rate r 5 
Death Rate  µ 0.313 
Infected Death Rate µi 0;2.5;0.05 
Immigration  ν 0.1 
Infected Immigration Proportion γ 0.1 
Primary Transmission Rate β0 0.1 
Active Capture α 0.1 
Sample Target m 10.0 
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Table S.2.4: Parameter values are shown for Figure 3.3 in the main text which demonstrates 
the effect of the infected death rate and transmission rate on the bias and variance of the 
prevalence estimate as well as the effect of the death rate on the population size and 
variance in a rabbit population. 100,000 simulations are run of each combination and 
terminate when the sample target is reached, i.e. there is no time limit imposed. These 
parameters were implemented using the SDE version of the model.    
 
 
 
 
 
 
 
 
Table S.2.5: Parameter values are shown for Figure 3.4.a and 3.4.b in the main text which 
demonstrates the effect of the transmission rate at three fixed level of disease induced 
mortality in a badger population. 100,000 simulations are run of each combination and 
terminate when the sample target is reached, i.e. there is no time limit imposed. These 
parameters were implemented using the SDE version of the model. 
 
 
Rate Name Rate Value 
Secondary Transmission Rate β 1.0, 0.552, 0.225 
Carrying Capacity k 115 
Growth Rate r 13.5 
Death Rate  µ 5.7 
Infected Death Rate µi 0.0;7.4;0.2 
Immigration  ν 0.1 
Infected Immigration Proportion γ 0.1 
Primary Transmission Rate β0 0.1 
Active Capture α 0.1 
Sample Target m 10.0 
Rate Name Rate Value 
Secondary Transmission Rate β 0.005;1.5;0.005 
Carrying Capacity k 20 
Growth Rate r 5 
Death Rate  µ  0.313 
Infected Death Rate µi 0,1,2 
Immigration  ν 0.1 
Infected Immigration Proportion γ 0.1 
Primary Transmission Rate β0 0.1 
Active Capture α 0.1 
Sample Target m 10 
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Table S.2.6: Parameter values are shown for Figure 3.4.c and 3.4.d in the main text which 
demonstrates the effect of the transmission rate at three fixed level of disease induced 
mortality in a rabbit population. 100,000 simulations are run of each combination and 
terminate when the sample target is reached, i.e. there is no time limit imposed. These 
parameters were implemented using the SDE version of the model. 
 
 
 
 
 
 
 
 
 
Table S.2.7: Parameter values are shown for Figure 3.5 in the main text which 
demonstrates the effect of the capture rate on surveillance efficacy a badger 
population. 100,000 simulations are run of each combination and terminate when the 
sample target is reached, i.e. there is no time limit imposed. These parameters were 
implemented using the SDE version of the model. 
 
 
Rate Name Rate Value 
Secondary Transmission Rate β 0.05;1.5;0.05 
Carrying Capacity k 115 
Growth Rate r 13.5 
Death Rate  µ 5.7 
Infected Death Rate µi 0,2,3 
Immigration  ν 0.1 
Infected Immigration Proportion γ 0.1 
Primary Transmission Rate β0 0.1 
Active Capture α 0.1 
Sample Target m 10 
Rate Name Rate Value 
Secondary Transmission Rate β 1 
Carrying Capacity k 20 
Growth Rate r 5 
Death Rate  µ  0.313 
Infected Death Rate µi 1.75 
Immigration  ν 0.1 
Infected Immigration Proportion γ 0.1 
Primary Transmission Rate β0 0.1 
Active Capture α 0.1;10;0.1 
Sample Target m 10 
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Table S.2.8: Parameter values are shown for Figure 3.6 in the main text which demonstrates 
the effect of the capture rate on surveillance efficacy in a rabbit population. 100,000 
simulations are run of each combination and terminate when the sample target is reached, 
i.e. there is no time limit imposed. These parameters were implemented using the SDE 
version of the model. 
 
 
 
 
 
 
 
 
 
Table S.2.9: Parameter values are shown for Figure 3.7.a in the main which demonstrates 
the effect of the transmission rate and disease induced mortality on the probability of 
detection in a badger population. 100,000 simulations are run of each combination and 
terminate when the sample target is reached, i.e. there is no time limit imposed. These 
parameters were implemented using the SDE version of the model. 
 
 
Rate Name Rate Value 
Secondary Transmission Rate β 1 
Carrying Capacity k 115 
Growth Rate r 13.5 
Death Rate  µ 5.7 
Infected Death Rate µi 4.4 
Immigration  ν 0.1 
Infected Immigration Proportion γ 0.1 
Primary Transmission Rate β0 0.1 
Active Capture α 0.1;10;0.1 
Sample Target m 10 
Rate Name Rate Value 
Secondary Transmission Rate β 1,0.5,0.057 
Carrying Capacity k 20 
Growth Rate r 5 
Death Rate  µ  0.313 
Infected Death Rate µi 0;2.5;0.05 
Immigration  ν 0.1 
Infected Immigration Proportion γ 0.1 
Primary Transmission Rate β0 0.1 
Active Capture α 0.1 
Sample Target m 10 
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Table S.2.10: Parameter values are shown for Figure 3.7.b in the main text which 
demonstrates the effect of the capture rate and disease induced mortality on the 
probability of detection in a badger population. 100,000 simulations are run of each 
combination and terminate when the sample target is reached, i.e. there is no time limit 
imposed. These parameters were implemented using the SDE version of the model. 
 
 
 
 
 
 
 
 
Table S.2.11: Parameter values are shown for Figure 3.7.c in the main text which 
demonstrates the effect of the transmission rate and disease induced mortality on the 
probability of detection in a rabbit population. 100,000 simulations are run of each 
combination and terminate when the sample target is reached, i.e. there is no time limit 
imposed. These parameters were implemented using the SDE version of the model. 
 
 
 
Rate Name Rate Value 
Secondary Transmission Rate β 0.5 
Carrying Capacity k 20 
Growth Rate r 5 
Death Rate  µ  0.313 
Infected Death Rate µi 0;2.5;0.05 
Immigration  ν 0.1 
Infected Immigration Proportion γ 0.1 
Primary Transmission Rate β0 0.1 
Active Capture α 0.1, 1, 2 
Sample Target m 10 
Rate Name Rate Value 
Secondary Transmission Rate β 1, 0.552, 0.225 
Carrying Capacity k 115 
Growth Rate r 13.5 
Death Rate  µ 5.7 
Infected Death Rate µi 0.0;7.4;0.2 
Immigration  ν 0.1 
Infected Immigration Proportion γ 0.1 
Primary Transmission Rate β0 0.1 
Active Capture α 0.1 
Sample Target m 10 
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Table S.2.12: Parameter values are shown for Figure 3.7.d in the main text which 
demonstrates the effect of the capture rate and disease induced mortality on the 
probability of detection in a rabbit population. 100,000 simulations are run of each 
combination and terminate when the sample target is reached, i.e. there is no time limit 
imposed. These parameters were implemented using the SDE version of the model. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rate Name Rate Value 
Secondary Transmission Rate β 0.552 
Carrying Capacity k 115 
Growth Rate r 13.5 
Death Rate  µ 5.7 
Infected Death Rate µi 0.0;7.4;0.2 
Immigration  ν 0.1 
Infected Immigration Proportion γ 0.1 
Primary Transmission Rate β0 0.1 
Active Capture α 0.1, 1, 2 
Sample Target m 10 
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Table S.2.13: Parameter values are shown for Figure 3.8 in the main text which 
demonstrates the effect of trappability and transmission rate, as well as the sample size and 
capture rate, on the probability of detecting disease. These parameters were implemented 
using the Gillespie version of the model. 1000 simulations were run per parameter 
combination with a time limit of 45. If the simulation did not reach the sample target within 
the time limit, the run is discarded and not used in the statistical calculations. If out of 1000 
realisations a parameter combination ceases to reach the sample target at least 15 times, 
that parameter combination is discarded totally as the results are deemed to be unreliable. 
Increasing the time limit bears little to no effect on the amount simulations which reach the 
target sample, so the precise value of the time limit does not affect the results obtained 
from the model. These parameters were implemented using the Gillespie version of the 
model. 
 
 
 
 
 
 
 
 
Rate Name Rate Value 
Secondary Transmission Rate β 0.0025;0.75;0.0025 
Carrying Capacity k 20 
Growth Rate r 5 
Death Rate  µ 0.313 
Infected Death Rate µi 0.165 
Immigration  ν 0.1 
Infected Immigration Proportion γ 0.1 
Primary Transmission Rate β0 0.1 
Active Capture α 0.1;1;0.1 
Sample Target m 10 
Trappability Rate τ 0.5,1, 2 
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Table S.2.14: Parameter values are shown for Figure 3.9 in the main text which 
demonstrates the effect of the sensitivity of the test at three different transmission rates on 
the probability detecting disease and the bias in estimating prevalence in a badger 
population. Specificity is 1.0 in all simulations. 1000 simulations were run per parameter 
combination with a time limit of 45. See description of Table S13 for simulation details. 
 
 
 
 
 
 
 
 
 
Table S.2.15: Parameter values are shown for Figure 3.10 in the main text which 
demonstrates the effect of the transmission rate at three different test sensitivities on the 
probability detecting disease and the bias in estimating prevalence in a badger population. 
1000 simulations were run per parameter combination with a time limit of 45. See 
description of Table S13 for simulation details. 
  
Rate Name Rate Value 
Secondary Transmission Rate β 0.25,0.057,0.025 
Carrying Capacity k 20 
Growth Rate r 5 
Death Rate  µ 0.313 
Infected Death Rate µi 0.165 
Immigration  ν 1.0 
Infected Immigration Proportion γ 0.01 
Primary Transmission Rate β0 0.01 
Active Capture α 0.5 
Sample Target m 10.0 
Test Sensitivity s 0;1;0.01 
Rate Name Rate Value 
Secondary Transmission Rate β 0.0025;0.75;0.0025 
Carrying Capacity k 20 
Growth Rate r 5 
Death Rate  µ 0.313 
Infected Death Rate µi 0.165 
Immigration  ν 1.0 
Infected Immigration Proportion γ 0.01 
Primary Transmission Rate β0 0.01 
Susceptible Active Capture α 0.5 
Sample Target m 10.0 
Test Sensitivity s 0.2,0.6,1.0 
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Appendix 3 
 
3.1 Parameterisations used 
 
This section of the appendix describes in detail the parameter combinations used to 
produce the graphs in the main text. Values of the form: a,b,c,d etc refer to discrete values 
used for different lines shown on the Figures. Values of the form a;b;c refer to smallest 
value; largest value; step size describing the range of values (e.g. of the death rate) 
simulated to produce the Figures. Values of the form a – b refer to the range of values 
covered with a non‐constant step size. All other parameters with single values are held 
constant in simulations.  
The total number of patches, L, is set constant at 130. The simulation has a “burn in” period 
of 10, at which point a disease incursion event is triggered in a randomly selected patch of 
any suitability type. After a single infected individual is introduced into a random patch; the 
statistics are collected until time of first detection or time tmax. The proportion of favourable 
to less favourable habitat is set at 50/50 unless otherwise stated and the habitat suitability 
level of the favourable habitat type is fixed at 1.0.  
 
 
 
 
 
 
 
 
 
 
Table S.3.1: Parameter values are shown for Figure 4.1 in the main text which demonstrates 
how the number of patches included in the surveillance set affects the level of disease in 
the spatial system at the point of first detection.  
Rate Name Rate Value 
Within Patch Transmission Rate β0 0.5 
Maximum Carrying Capacity k 50 
Growth Rate r 20 
Death Rate  µ 1.5 
Immigration  ν 1.0 
Infected Immigration Proportion γ 0.1 
Between Patch Transmission Rate β1 0.1 
Capture rate α 0.1, 0.25, 1.0 
Switching Rate τ 0 
Less Favourable habitat Suitability 
index 
σ 0.5 
Less favourable habitat proportion ρ 0.5 
Number of patches under 
surveillance  
n 1;65;1 
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Table S.3.2: Parameter values are shown for Figure 4.2 in the main text which 
demonstrates how the suitability index affects the level of disease in the spatial system at 
the point of first detection.  
 
 
 
 
 
 
 
 
 
 
 
Table S.3.3: Parameter values are shown for Figure 4.3 in the main text which 
demonstrates how the proportion of good and bad habitat, as well as the type of patch 
targeted by surveillance, affects the level of disease in the spatial system at the point of 
first detection.  
  
Rate Name Rate Value 
Within Patch Transmission Rate β0 0.5 
Maximum Carrying Capacity k 50 
Growth Rate r 20 
Death Rate  µ 1.5 
Immigration  ν 1.0 
Infected Immigration Proportion γ 0.1 
Between Patch Transmission Rate β1 0.1 
Capture rate α  1.0 
Switching Rate τ 0 
Less Favourable habitat Suitability 
index 
σ 0.02;1.0;0.02 
Less favourable habitat proportion ρ 0.5 
Number of patches in surveillance 
set 
n 1, 3, 7, 33 
Rate Name Rate Value 
Within Patch Transmission Rate β0 0.5 
Maximum Carrying Capacity k 50 
Growth Rate r 20 
Death Rate  µ 1.5 
Immigration  ν 1.0 
Infected Immigration Proportion γ 0.1 
Between Patch Transmission Rate β1 0.1 
Capture rate α  1.0 
Switching Rate τ 0 
Favourable habitat Suitability 
index 
σ 1.0 
Favourable habitat Suitability 
index 
σ 0.5 
Less favourable habitat proportion ρ 0.02;1.0;0.02 
Number of patches in surveillance 
set 
n 1 
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Table S.3.4: Parameter values are shown for Figure 4.4 in the main text which 
demonstrates how the effort (capture rate) of surveillance and the within patch and 
between patch transmission rate affects the level of disease in the spatial system at the 
point of first detection.  
 
 
 
 
 
 
 
 
 
 
Rate Name Rate Value 
Within Patch Transmission Rate β0 1.0, 2.0, 5.0 
Maximum Carrying Capacity k 50 
Growth Rate r 20 
Death Rate  µ 1.5 
Immigration  ν 1.0 
Infected Immigration Proportion γ 0.1 
Between Patch Transmission Rate β1 1.0, 2.0, 5.0 
Capture rate α 0.02;1.0;0.02 
Switching Rate τ 0 
Favourable habitat Suitability 
index 
σ 1.0 
Favourable habitat Suitability 
index 
σ 0.5 
Less favourable habitat proportion ρ 0.5 
Number of patches in surveillance 
set 
n 1 
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Table S.3.5: Parameter values are shown for Figure 4.5 in the main text which 
demonstrates how the time before switching of surveillance and percentage number of 
patches in the surveillance set affects the level of disease in the spatial system at the point 
of first detection.  
 
 
 
 
 
 
 
 
 
 
Rate Name Rate Value 
Within Patch Transmission Rate β0 0.5 
Maximum Carrying Capacity k 50 
Growth Rate r 20 
Death Rate  µ 1.5 
Immigration  ν 1.0 
Infected Immigration Proportion γ 0.1 
Between Patch Transmission Rate β1 0.5 
Capture rate α 0.1, 0.25, 1.0 
Switching Rate τ 0.02;1.0;0.02 
Favourable habitat Suitability 
index 
σ 1.0 
Favourable habitat Suitability 
index 
σ 0.5 
Less favourable habitat proportion ρ 0.5 
Number of patches in surveillance 
set 
n 1, 3, 7, 33 
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Table S.3.6: Parameter values are shown for Figure 4.6 in the main text which 
demonstrates the difference between switching (at different rates) and not switching and 
the effect of the effort put into surveillance has on the level of disease in the spatial system 
at the point of first detection.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Rate Name Rate Value 
Within Patch Transmission Rate β0 0.5 
Maximum Carrying Capacity k 50 
Growth Rate r 20 
Death Rate  µ 1.5 
Immigration  ν 1.0 
Infected Immigration Proportion γ 0.1 
Between Patch Transmission Rate β1 0.1 
Capture rate α 0.02;1.0;0.02 
Switching Rate τ 0, 0.01, 0.1, 1.0 
Favourable habitat Suitability 
index 
σ 1.0 
Favourable habitat Suitability 
index 
σ 0.5 
Less favourable habitat proportion ρ 0.5 
Number of patches in surveillance 
set 
n 1 
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Table S.3.7: Parameter values are shown for Figure 4.7 in the main text which 
demonstrates the difference between switching (at different rates) and not switching and 
the effect of between patch transmission has on the level of disease in the spatial system at 
the point of first detection.  
  
Rate Name Rate Value 
Within Patch Transmission Rate β0 0.5 
Maximum Carrying Capacity k 50 
Growth Rate r 20 
Death Rate  µ 1.5 
Immigration  ν 1.0 
Infected Immigration Proportion γ 0.1 
Between Patch Transmission Rate β1 0.02;1.0;0.02 
Capture rate α 1.0 
Switching Rate τ 0, 0.01, 0.1, 1.0 
Favourable habitat Suitability 
index 
σ 1.0 
Favourable habitat Suitability 
index 
σ 0.5 
Less favourable habitat proportion ρ 0.5 
Number of patches in surveillance 
set 
n 1 
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